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Abstract  
Inflammation is a biological response to injury – a fundamental part of which 
involves the influx of leukocytes to the affected area. Circulating neutrophils are 
typically the first responders to an inflammatory insult. Orchestrated interactions 
between neutrophils and the underlying endothelium and occurs in a process 
termed the “multi-step leukocyte adhesion cascade”. L-selectin, a cell adhesion 
molecule, expressed on all circulating neutrophils, and facilitates the initial 
tethering and rolling events. Previously, L-selectin on CD14-positive 
(“inflammatory”) monocytes was shown to undergo ectodomain “shedding”, 
exclusively during transendothelial migration (TEM) and not before. The 
consequence of this was to establish monocyte polarity within the subendothelial 
space. The primary aim of this project was to determine if L-selectin shedding 
during TEM was exclusive to monocytes or extended to neutrophils. Perfusion of 
primary human neutrophils over activated endothelial monolayers revealed that 
L-selectin shedding was also activated specifically during TEM. Ectopic expression 
of L-selectin tagged to green fluorescent protein (GFP) in HL-60 cells (a 
neutrophil-like cell line that does not express endogenous L-selectin) significantly 
increased their invasive potential across activated endothelial cells under flow. 
Blocking L-selectin shedding (either pharmacologically in primary neutrophils or 
genetically in HL60 cells) promoted cell elongation in fully transmigrated cells, 
which significantly impacted cell polarity and directional persistence in 2D and 
3D collagen scaffolds. Additionally, manufacturing bespoke microfluidic flow 
chamber devices revealed that blocking L-selectin shedding impacted the 
neutrophil chemotaxis towards classic “end-stage chemoattractants”, such as 
fMLP.  Taken together, L-selectin shedding ensures that fully transmigrated 
neutrophils can establish front-back polarity so that they can home optimally to 
their inflamed targets. As fMLP is secreted during sterile injury, the potential 
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Inflammation is defined as a biological response to injury, which culminates in 
healing of the afflicted site. The Romans originally termed inflammation as 
“inflammare”, which literally means “on fire”. The physician and medical writer 
Aulus Cornelius Celsus was the first to characterise inflammation, and defined it 
as having four cardinal signs; rubor et tumor cum calore et dolore (redness and 
swelling with heat and pain)(1). Approximately 100 years later, the physician 
Aelius Galenus added a fifth cardinal sign: “loss of function”. Typically, any organ 
or tissue afflicted with inflammation will be suffixed with “itis”, for example: ilitis, 
pancreatitis, rhinitis. Although the cardinal signs of inflammation have been 
observed for approximately twenty centuries, the underlying cellular and 
molecular mechanisms that govern this process are only beginning to be 
appreciated in the past 70 years.  Inflammation can be defined as acute or chronic, 
which are elaborated on within the sections below.  
1.1.1 Acute inflammation 
Acute inflammation is a short-lived response that typically lasts for days to weeks. 
Acute inflammation is initiated by infectious (bacteria, fungal, parasitic, viral) or 
non-infectious (chemical/physical, trauma, foreign bodies) agents, causing 
localised tissue damage. The response is often initiated by tissue-resident mast 
cells and/or macrophages, releasing vasoactive components (histamine and 
serotonin), which mediate vasodilation and increased permeability of the local 
microvasculature. Secretion of cytokines, such as TNF-, by stromal cells (e.g. 
fibroblasts), tissue-resident macrophages and mast cells stimulate endothelial 
cells within local microvessels to up regulate cell adhesion molecules and 
chemokines, which collectively direct leukocytes from the circulation towards the 
site of damage (2). Increased vascular permeability leads to the delivery of blood 
plasma components into the affected area, which contains a multitude of anti-
microbial weaponry, such as complement and antibodies. Increased 
microvascular permeability also results in the slowing down of blood, allowing 
leukocytes to “marginate” close to the vessel wall. Contact between leukocytes 
(such as neutrophils and monocytes) and activated endothelial cells will drive 
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neutrophil diapedesis and extravasation into the affected area. The invading 
monocytes and neutrophils migrate towards the site of damage by virtue of their 
surface pattern recognition receptors (PRRs), which can recognise a multitude of 
structures. Broadly speaking, PRRs can recognise “non-self” or intracellular “self” 
components. The non-self components include pathogen associated molecular 
patterns (PAMPs). In the case of “sterile injury”, where intracellular self-
components are recognised, neutrophils will respond rapidly to these structures, 
as they are released by necrotic cells (i.e. cells that have undergone uncontrolled 
death). The intracellular self structures are called damage associated molecular 
patterns (DAMPs) (3). Resolution of inflammation is determined when the 
noxious stimulus is no longer present and production of pro-inflammatory 
mediators (leukotrienes) are exchanged to anti-inflammatory molecules 
(lipoxins) leading to subsequent tissue healing (4)(5). Failure to resolve an acute 
inflammatory insult can lead to chronic inflammation. 
1.1.2 Chronic inflammation 
The pathway that determines the transition from acute to chronic inflammation is 
unclear and can be unique to any given pathology. What is clear is that the 
“cellularity of inflammation”, which describes the timely influx and efflux of 
immune cells, is disturbed. Persistent inflammation leads to continued necrosis 
and severe tissue remodelling, and the deposition of tough fibrous scar tissue, 
which over time may result in permanent organ dysfunction. Literature and 
current studies have linked chronic inflammation to cancers, diabetes and 
autoimmune and cardiovascular diseases (6)(7)(8)(9)(10). The impact of 




1.2 The multi-step leukocyte adhesion cascade 
The migration of leukocytes from the circulation towards an extravascular site of 
damage requires a series of highly organised events, collectively termed the 
“multi-step leukocyte adhesion cascade” (11). The classical leukocyte adhesion 
cascade is depicted in (figure 1.1). Discreet stages of the pathway will be 




Figure 1.1: The leukocyte adhesion cascade 
The recruitment of leukocytes to sites of inflammation requires interaction between the 
endothelium and the leukocyte. Initially, leukocytes are captured from blood flow and form 
transient tethers through the interaction of selectins and PSGL-1. Selectin/ligand interactions are 
also involved in leukocyte rolling. Chemokine mediated inside-out activation of integrins and 
subsequent inside-out integrin signalling results in the leukocyte arrest. Leukocyte survey the 
endothelium for permissive transmigration routes, this step is ICAM-1/MAC-1 dependent. 
Transmigration through the endothelium can occur either between endothelial cell junctions 
(paracellular route) or directly through the body of an endothelial cell (transcellular route). Both 
routes are dependent on the PECAM-1, JAMs and CD99. For abbreviations see Abbreviations 




























1.2.1 Leukocyte initial capture and tethering 
Activation of the endothelium is the decisive first step in establishing a weak 
interaction between the leukocyte and endothelium. Upon tissue 
damage/infection resident macrophage release cytokines (IL-1 and TNF-) to 
stimulate the expression of cell adhesion molecules (CAMs) on the luminal surface 
of the endothelium(2). Mast cells release histamine, among other mediators of 
acute inflammation, which stimulate the delivery of secretory granules to the 
plasma membrane. These secretory granules include Weibel-Palade bodies, which 
contain presynthesised P-selectin (12).  The decrease in bloodline velocity (as a 
consequence of increased permeability) concentrates the leukocyte number 
locally in the microvasculature, together these biophysical processes dramatically 
increase the likelihood of a leukocyte–endothelium interaction (13)(14). The 
initial contacts between the two cell types are transient and collectively termed 
“tethers”, thin elastic cell membrane protrusions, which effectively reduce the 
leukocyte’s velocity.  It is suggested that tethers are nucleated from actin rich 
“microvilli” structures, which elongate in length upon exertion of hydrodynamic 
force (15). It has been proposed that microvilli are crucial in penetrating the thick 
glycocalyx (~0.5-1.2m), but this still remains a point of controversy (16). 
Characterisation of the microvillus tip by Immunogold labelling and electron 
microscopy techniques revealed the presence of dense populations of CAMs. One 
such CAM is L-selectin, 78% of which is localised to microvilli (17).  The selectin 
family, a group of three cell adhesion molecules, L-selectin, P-selectin and E-
selectin, mediate tethering of the leukocyte. Both E-selectin and P-selectin and 
found on the endothelium, while L-selectin is found on virtually all leukocytes. 
Collectively, the selectin/ ligand interactions actively recruit leukocytes to sites of 
inflammation. P-selectin glycoprotein ligand-1 (PSGL-1) plays a dominant role as 
the archetypal ligand for all selectins, (figure 1.2) (18). L-selectin was originally 
shown to be primarily responsible for homing of naïve lymphocytes to the 
peripheral lymph node (PLN) (19), but has since been shown to play an important 
role in regulating leukocyte recruitment to sites of inflammation(20). L-selectin 
was discovered as a primary contact to endothelial cells through the use of 
function-blocking antibodies(19). Treatment with such antibodies impaired L-
selectin-dependent tethering of lymphocytes, neutrophils and monocytes 
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endothelial monolayers under flow conditions (21)(22). Initial contact of L-
selectin with the endothelium is perhaps facilitated due to its anchorage within 
the microvilli, poised at the most distal aspect of the cell body. The integrin very 
late antigen 4 (VLA-4) also potentiates tethering, demonstrating this process is 
not solely driven by selectins (figure 1.2)(23). Interestingly, tethering is 
mitigated completely in vessels smaller than 20 m, implying that in this situation 
leukocyte close contact with the endothelium would be enough for initial capture 
(24). Bystander leukocytes (that are in blood flow) can also tether to endothelial-
bound leukocytes via L-selectin/PSGL-1 interaction. This phenomenon is known 
as “secondary tethering”, which occurs when the endothelium supports an 
overwhelming number of adherent leukocytes that the endothelial-derived ligand 
becomes inaccessible to the bystander leukocyte(24). As such, the L-selectin and 
PSGL-1 on static and flowing leukocytes become the appropriate ligand/receptor 
interactions. This interaction will continue until the tethering leukocyte reaches a 
stretch of endothelium that it can adhere to (25). Secondary capture can account 
for up to 70% of total leukocyte accumulation given the right hydrodynamic and 
vessel conditions(25)(26). This mechanism of leukocyte capture has been 
observed to form “long strings” in the murine cremaster (27)(28). However in 
another in vivo study secondary capture does not play an important role in 
leukocyte capture. Here, Kunkel et al. observed that leukocyte-leukocyte 
interactions accounted for only 1.2% of total recruited leukocytes in an TNF- 
stimulated vessel (29). It is however likely that secondary capture is employed in 
a vessel dependent manner, in a vessel where the diameter is of comparative size 
to the leukocyte diameter leukocytes will be forced to deform and involuntarily 
contact the vessel wall. In this scenario the use of the secondary capture is 
redundant. Eriksson et al., have demonstrated that secondary capture events in 
small venules, with low wall shear rate, was infrequent, yet, a higher secondary 
capture frequency was observed in larger vessels with higher shear forces 
(27)(25). It is possible that secondary capture is important for high leukocyte 
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Figure 1.2: The cell adhesion molecules on EC and leukocytes responsible for tethering, 
rolling and arrest. 
The schematic illustrates the cell adhesion molecules (CAMs) found on both the endothelium and 
leukocyte in the three stages of the adhesion cascade, tethering, rolling and arrest. Full names of 
CAMs can be found in the Abbreviations section.  
 
1.2.2 Leukocyte rolling 
For tethering to progress to rolling there needs to be sufficient available ligand 
presented by the endothelium. Leukocyte rolling is a vital biological process as it 
provides sustained intimate contact between the leukocyte and endothelium, 
providing the first opportunity for information to be exchanged between the 
inflamed endothelium and the sensing leukocyte(11). Rolling is a continuous 
movement, heavily dependent on the fast on/off rate of the selectin/ligand 
interactions(11). The selectin family are the major mediators of rolling, a triple 
L/E/P-selectin knock-out mouse revealed a dramatic decrease in rolling flux 
(30)(31). All three selectin molecules are involved in rolling; however, they 
regulate different rolling velocities (32)(33). Deletion of the last 11 amino acids at 
the C terminus of L-selectin completely abolishes lymphocyte rolling on 
glycosylation-dependent cell adhesion molecule-1 (GlyCAM-1) in vitro (34). In rat 
mesenteric venules, introduced human neutrophils, pre-treated with a function-





















selectin is the first selectin molecule to be expressed on the surface of the 
endothelial cell (EC), this occurs within a minutes of stimulation(12). EC 
activation stimulates P-selectin release from pre-stored granules called Weibel-
Palade bodies, the molecule then becomes expressed at the plasma membrane 
through membrane fusion of intracellular stores(12). P-selectin involvement in 
rolling has been demonstrated both in vivo and in vitro. Exteriorised cremaster 
vessels from a P-selectin knockout mouse showed leukocytes lack the ability to 
roll (37)(38). In vitro, treating neutrophils and monocytes with neutralising 
antibodies for PSGL-1 completely blocked rolling when perfused over 
recombinant purified P-selectin, suggesting PSGL-1 is the only ligand for P-
selectin that is expressed on leukocytes (36)(37). Together, these experiments 
conclude the vital role P-selectin and L-selectin play in rolling. E-selectin requires 
de-novo synthesis, delaying its expression at the plasma membrane to around 
four hours post cytokine stimulation (38). Unlike P-selectin, blocking E-selectin 
function in vitro and in vivo does not completely reduce rolling (37)(36). This is 
likely due to the complementary roles of P-selectin and E-selectin. In fact 
leukocytes in an E-selectin knockout mice increased rolling velocity compared to 
their WT counterparts; this led to E-selectin being identified as a mediator of slow 
rolling(39). Paradoxically, it was noted that P-selectin and L-selectin could not 
mediate rolling below a critical shear stress(40)(41). This can be explained using 
the “catch-slip” model of adhesion (39)(40). The selectin/ligand interaction 
transitions between two forms of bonding “Catch” or “Slip”. The strength of 
bonding is increased with increasing shear stress (Catch), after the shear stress 
increases to a non-optimal value the bonds become weaker and break at a higher 
frequency (Slip). On a tethered leukocyte the hydrodynamic force exerted on the 
cell rear is high and non-optimal producing short-lived bond formation, 
conversely, at the cell front the bonds are longer lived. Together, this 
phenomenon encourages the leukocyte to roll in the direction of the blood flow. 
Of the three selectin molecules L-selectin mediates the fastest rolling velocity 
(~100m/second), in comparison P-selectin mediates rolling at a velocity of 
~50m/second(32)(41). Rolling provides an appropriate ligand/receptor 
interaction lifetime for the leukocyte to survey the apical aspect of the 
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endothelium for chemokines, which are involved in activating another set of 
CAMs – the integrins(11). 
 
1.2.3 Leukocyte arrest 
Leukocyte arrest relies on the activation of integrins. Integrins are heterodimers 
composed of an  and  subunit, which are both type I transmembrane 
proteins(42). The three most studied integrins within the leukocyte adhesion 
cascade are: (i) lymphocyte function-associated antigen-1 (LFA-1), which is 
composed of L2 and expressed on virtually all leukocytes; (ii) macrophage-1 
antigen (MAC-1), is composed of M2 subunits and expressed on neutrophils 
and monocytes; (iii) very late antigen-4 (VLA-4) is composed of 41 and 
expressed on monocytes and eosinophils and neutrophils under certain 
conditions (43)(44). Integrins bind to members of the immunoglobulin (Ig) 
superfamily expressed on the endothelium. Integrins can transition from 
“inactive” to “intermediate” to “active” states(42). The outcome of each integrin 
activation state is driven by different stimuli.  During inflammation, endothelial 
cells distribute chemokines in a polarised manner, with abluminal chemokines 
being transported via transcytosis for presentation on glycosaminoglycans 
(GAGs) on the luminal surface. In the circulation, integrins decorate the leukocyte 
in low numbers and in a bent conformation. The bent conformation has a low 
affinity state for ligand binding (figure 1.3). Integrins can signal bidirectionally, 
referred to as inside-out and outside-in. Typically intracellular signalling initiates 
inside-out signalling, allowing the integrin to bind to its appropriate ligand, 
conversely, the interaction between integrin and ligand can induce outside-in 
signalling which allows the cell to response to its environment, for example 
induce cell spreading or migration. One common example of inside-out signalling 
occurs when a leukocyte becomes in contact with the chemokine decorated 
endothelial cells(11), G-protein coupled receptors (GPCRs) become engaged, 
activating downstream signalling to release endoplasmic reticulum (ER) stored 
calcium.  In turn, the influx of calcium into the cytosol leads to activation of 
calcium dependent kinases and modulates talin and 2 (integrin subunit) 
interactions(45). Talin binding to the cytoplasmic tail of 2 induces a 
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conformational shift forcing the 2 and  subunits of the integrin apart “pushing” 
the integrin into the active state (45). In this conformation integrins bind with 
high affinity to their endothelial ligands, vascular cell adhesion molecule 1 
(VCAM-1) intracellular cell adhesion molecule–1 (ICAM-1), which allows for the 
leukocyte to firmly adhere to the endothelium (figure 1.2). Alternatively, 
integrins can be activated through the interaction of CAMs (figure 1.3). 
Leukocytes binding to either E-selectin or P-selectin or ligand binding to L-
selectin have all been shown to activate integrins(46).  For example E-selectin 
binding to PSGL-1 leads to activation of tyrosine kinases (MAPK, Syk), which 
shifts the conformation of LFA-1 from the bent to the extended (high affinity) 
state (46).  
 
Outside-in signalling has been suggested to operate discreetly from inside-out 
signalling and be involved post leukocyte arrest(47).  Removing the protein 
kinases hck and fgr (both required for mediating the outside-in signalling 
pathway) did not effect chemokine dependant integrin activation (inside-out 
signalling), yet neutrophil spreading over 2 ligand was severely reduced and 
neutrophils rapidly detached (47). Finally, ligand induced integrin clustering can 
form a signalling hub known as “signalosomes”, delivering intracellular messages 












Figure 1.3: Integrin bent-extended conformation change 
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To initiate leukocyte firm arrest to the endothelium, integrins alter their conformation to result in 
high affinity ligand binding. Integrin activation is evoked through many signalling processes. 
Image adapted from Totani and Evangelista, Arterioscler Thromb Vasc Biol, 2010 (49).  
 
The importance of selectins and integrins are acknowledged in human leukocyte 
adhesion deficiencies (LAD I, LAD II &LAD III), which occur due to defects in 2 
integrin structure and also mutations in the major ligand for selectins Sialyl-Lewis 
(x). Here, patients present with severe immunodeficiencies due to insufficient 
integrin activation and leukocyte capture (50).  
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1.2.4 Intraluminal crawling 
Following firm adhesion and spreading, leukocytes often migrate away from their 
initial site of arrest in order to identify an appropriate exit point. Crawling has 
been observed in all different directions with respect to blood flow(51). 
Leukocytes adopt a cellular morphology that is similar to migration on 2D 
substrates, e.g. formation of a leading edge with a lamellipodium and a retracting 
rear (sometimes referred to as a “uropod”). MAC-1 was identified as a  critical 
integrin involved in mediating intraluminal crawling, murine neutrophils lacking 
MAC-1 were seen to emigrate without any intraluminal crawling(52). The 
emigration of MAC-1-deficient neutrophils was sub-optimal, which manifested in 
prolonged transmigration times compared to neutrophils in WT littermate 
control mice (52)(53). In comparison, LFA-1-deficient neutrophils adhered poorly 
to inflamed venules, yet normal intraluminal crawling was observed in the 
population of neutrophils that could adhere to the endothelium, again 
highlighting a unique role for MAC-1 in intraluminal crawling(52). However, a 
study using a combination of function-blocking antibodies against LFA-1 and 
MAC-1, demonstrated that monocytes require both LFA-1 and MAC-1 to undergo 
intraluminal crawling and reach junctions (52). Together, this demonstrates the 
complexity of how integrins on the leukocyte are employed for the adhesion and 
crawling steps of the adhesion cascade. It also alludes to how different leukocyte 
subtypes, or even leukocytes from different species, may use integrins to mediate 
the steps prior to and during transmigration.   
1.2.5 Endothelial docking structures 
The endothelium actively participates in transendothelial migration (TEM) 
through the formation of apical actin rich protrusive structures. These structures 
have been given a multitude of names: docking structures, endothelial adhesion 
platforms and transmigratory cups (54)(55)(56).These structures are enriched in 
ICAM-1, VCAM-1 and the tetraspanin proteins CD9 and CD15 (57)(58). Evidence 
has emerged that irrespective of which route of transmigration (paracellular or 
transcellular) the majority of diapedsis events in vitro are aided with the 
formation of these structures. Live cell imaging showed that greater than 70 % of 
neutrophils migrated across a HUVEC monolayer were supported by these 
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structures (59). Over the past decade ICAM-1 has emerged as a pivotal protein in 
the formation of these docking structures. Clustering of ICAM-1, which is driven 
by integrin binding (LFA-1 or MAC-1) promotes the assembly of F-actin driven 
docking structure formation(60). Additionally, the GTPase RhoG and its upstream 
regulator SH3-containing guanine nucleotide exchange factor (SGEF) have 
recently been implicated in the molecular pathway for docking structure 
formation;(60) this was prompted by a previous finding demonstrating that 
expressing SGEF in fibroblasts induced the formation of dorsal membrane ruffles 
and enhanced macropinocytosis (60). So far the pathway breaks down as follows; 
ICAM integrin engagement rapidly activates Rho G, and both RhoG and SGEF 
colocalise with clustered ICAM-1 (61). It has been suggested that these 
endothelial docking structures have a protective physiological function, shielding 
the leukocytes from shear stress (62). Interestingly, observations in vivo have 
shown docking structures mature to fully envelope the leukocyte, termed 
endothelial domes (63). Recently an F-actin binding protein, leukocyte-specific 
protein 1 (LSP1) was shown to be important for the formation of endothelial 
domes in vivo in response to the neutrophil chemokine called keratinocyte-
derived chemokine (KC) (64)(65). LSP1 is actively recruited from the cytosolic 
and nuclear compartments to the cytoskeleton in response to endothelial 
activation. Studies in Lsp1-/- mice not only revealed a significant reduction in the 
number of endothelial domes formed in response to KC stimulation, but also 
increased vascular permeability (65). This permeability data may underpin the 
physiological role for endothelial domes and specifically the role of LSP1 in 
endothelial barrier integrity (65).  
1.2.6 Transendothelial migration (TEM) 
Leukocytes can undergo two distinct modes of diapedesis: paracellular (between 
adjacent endothelial cells) or transcellular (through the body of a single 
endothelial cell), (figure 1.4). Both modes have been observed in vitro and in vivo, 
although ~70-90 % of all studied TEM routes occur via the paracellular pathway 
(66)(67). There are however certain exceptions when the transcellular route is 
thought to be favoured – for example where adjoining endothelial junctions are 









Figure 1.4:  Leukocyte transmigration 
Crawling: Leukocytes initiate transmigration through the extension of leukocyte membrane 
protrusions into the endothelial cell body or at EC junctions, triggering MAC-1/ICAM-1 interaction, 
clustering and subsequent increased intracellular Ca2+, downstream activation of p38 MAPK and 
RHO. Collectively, these intracellular signalling events promote myosin contractility within 
endothelial cells, and separation of adjoining endothelial cells. Paracellular pathway: Homotypic 
VE-cadherin binding is disrupted, facilitated by the addition of new membrane from the LBRC (not 
shown discussed in the text). Leukocyte-endothelial cell interactions can now form using 
homotypic interactions between CD99 and PECAM-1. Transcellular pathway: ICAM-1 signalling 
fuses vesiculo-vacuolar organelles (VVOs) to form an intracellular channel. For abbreviations 
used, see Abbreviations section. Image adapted from Ley et al. Nat, Rev, Immunology, 2007, (11).  
 
1.2.6.1 Paracellular transmigration 
Successful paracellular transmigration relies on the “unzippering” of junctional 
molecules joining two adjacent endothelial cells. The loosening of the junctions 
occurs through initial clustering/cross linking of luminally expressed ICAM-1 and 
VCAM-1, leading to transmissions of numerous signalling pathways (71). One 
such pathway involves transient increases in cytosolic calcium, which activates 
myosin light chain kinase to mediate cell contraction (72). This introduction of 
internally contractile forces encourages separation of adjoining endothelial cells. 
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Additionally, ICAM-1 clustering can promote phosphorylation of VE-cadheren and 
subsequent redistribution away from adherens junctions (73). In vitro culture 
assays demonstrated that ICAM-1 clustering mediates Src and Pyk2 kinases to 
phosphorylate VE-cadherin at regions that are necessary for p120 and  catenin 
binding (74). VE-cadherin relies on such binding partners for its localisation at 
adherens junctions. It has been hypothesised that phosphorylation of VE-cadherin 
prevents p120 binding(75)(76). Overexpression of p120 leads to VE-cadherin 
remaining at the junctions, again supporting the hypothetical view that p120 
stabilises endothelial junctions (77).  
 
Using electron microscopy, investigators observed endothelial-derived 
intracellular vesicles surrounding leukocytes at the point of TEM (78).These 
vesicles were defined as the “lateral border recycling component” (LBRC), 
considered to be a unique organelle composed of multiple vesicles. Each vesicles 
~50nm in diameter contains many junctional molecules; PECAM-1, JAM-A, CD99, 
but notably not VE-cadherin (67)(78). Approximately one third of leukocyte 
PECAM-1 resides in the LBRC, PECAM-1 mutation studies have indicated that 
tyrosine 663 is responsible for maintaining PECAM-1 within the LBRC (79)(80).  
The LBRC is responsible for the continual turn over of plasma membrane at the 
cell borders. The function of this constitutive recycling of membrane is poorly 
understood, however it has been strongly linked to driving successful TEM. 
Blocking the transport of membrane from LBRC consequently blocks TEM (81). 
Given the high-energy expenditure required to break the large concentration of 
homophillic interactions at the EC-EC contact points, one theory suggests that 
LBRC inserts new membrane to dilute endothelial junctions with bound 
CAMs(82). This newly added membrane would contain unengaged PECAM-1, 
JAM-A and CD99 to form interactions in trans with the same molecules expressed 
on the transmigrating leukocyte and aid passage. Genetic ablation or antibody 
function blocking studies have delineated unique roles for PECAM-1 and CD99. 
Disrupting PECAM-1 function led to leukocyte arrest on the apical surface of the 
endothelium, whilst blocking CD99 interactions traps leukocytes mid-way 
through TEM (83)(84)(85). Taken together, these results imply that PECAM-1 
works upstream of CD99.  Although, there appears to be conflicting data from in 
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vivo studies regarding the sequential order in which CAMs are involved in TEM. In 
the C57B1/6 mouse strain the site of arrest was examined in mice lacking either 
JAM-A or PECAM-1, here neutrophils arrested between the abluminal surface of 
the endothelium, partway through the junctions, or at the basement membrane, 
respectively (86). Additionally, the role of PECAM-1 in regulating neutrophil TEM 
in C57Bl/6 mice appears to be cytokine-specific. PECAM-1 knockout mice 
challenged with TNF- mimicked  the results found in WT littermate controls. In 
contrast, IL-1 stimulation led to a significant decrease in neutrophil 
recruitment(87). This would suggest PECAM-1 recruitment is dependent on the 
inflammatory stimuli; with PECAM-1 redundant for TNF-  activation, but non-
redundant for IL-1 activation (87). These studies highlight that the 
requirement of CAMs may change over the course of an inflammatory response. 
As these studies were conducted in the peritoneum and cremaster muscles, more 
work is required to determine what recruitment profiles are dependent and 
independent on other CAMs in disease models. Upon the leukocyte reaching the 
basaolateral surface of the endothelium, the endothelial junctions re-seal behind 
the transmigrating leukocyte to maintain endothelial barrier integrity and 
minimise oedema formation.  
1.2.6.2. Transcellular transmigration 
In 1998 the Dvorak lab provided the first evidence that transcellular migration 
occurs in vivo (88). Electron microscopy revealed neutrophils indisputedly 
passing directly through a single endothelial cell. Transcellular migration has 
been suggested to be favourable in a number of circumstances, one example being 
neutrophils migrating through an endothelial cell at the thinnest region, 
presumably to coincide with the region of lowest resistance in that immediate 
environment (89). Additionally, this route may be adopted if leukocytes have 
impaired intraluminal crawling and cannot migrate towards a junction. 
Neutrophils lacking the integrin MAC-1 could adhere to the endothelium, but 
could not migrate towards endothelial cell junctions(52). Although the efficiency 
of TEM was low, those that could undergo TEM exited via the transcellular route 
(84)(53). Leukocytes are believed to commence transcellular migration by 
probing the endothelial monolayer with “invasive podosomes”, presumably to 
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“sense” for regions of low resistance (66). During transcellular migration ICAM-1 
enriches at sites of diapedesis. Engagement of ICAM-1 by leukocytes leads to it’s 
clustering, which in turn recruits caveolin-1 and filamentous actin (90). The LBRC 
and caveolin-1 containing vesiculo vacuolar organelles (VVOs) have both been 
described for the formation of the membrane fenestra observed. VVOs are small 
continuous links of internal vesicles rich in caveolin-1, it is hypothesised that 
these internal vesicles provide a transcellular channel permissive for leukocyte 
migration through a single endothelial cell.  Depleting cellular levels of caveolin-1 
by siRNA significantly decreased the transcellular pathway (91)(90), while 
overexpressing ICAM-1 lead to an increase in transcellular 
transmigration(90)(91). It is believed that ICAM-1 lines the internal channel 
through which the leukocytes can pass via integrin-based migration (90)(91). 
Interestingly, VVO’s and LBRC share many of the same adhesion molecules found 
at junctions, for example PECAM-1 and JAM-A. Currently it remains unclear if 
these two organelles (VVOs and LBRC) work synergistically or independently of 
one another.  
1.2.6.3 Reverse transmigration 
The term TEM describes the movement of a leukocyte crossing the endothelial 
barrier via a luminal-to-abluminal direction. However, with the increasing 
advances in technologies supporting intravital microscopy, neutrophils have 
recently been observed to undergo abluminal to luminal TEM. This process, 
termed reverse transmigration (rTEM), has been observed in vivo and in vitro. 
Furthermore, most major leukocyte subsets have been observed to undergo 
rTEM: monocytes, neutrophils and T cells (92) (93) (93). Woodfin and colleagues 
revealed that rTEM is enhanced following pharmacological blockade or genetic 
deletion of the endothelial CAM called junctional adhesion molecule-C (JAM-C) 
(94)(95).The model for neutrophil rTEM outlined by Colom et al.,(95) will be 
described below (figure 1.5).  In response to ischemia reperfusion injury, a type 
of sterile injury, leukotriene B4 is synthesised and secreted from tissue resident 
leukocytes(95). Blood borne neutrophils react to this pro-inflammatory signal 
through their LTB4 receptor BLTR, in turn this induces neutrophil elastase (NE) 
production and secretion. The interaction of MAC-1 with NE, allows NE to be 
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spatially regulated and brought close to JAM-C, as MAC-1 is a known ligand for 
JAM-C. NE proteolytically cleaves JAM-C, (figure 1.5) (96). So far, the 
physiological relevance for reverse transmigration is unclear. Potentially, rTEM 
might be linked to dampening the immune response; rTEM neutrophils may act as 
cellular sentinels(97)(98). Alternatively, the role may encourage systemic 
inflammation(95)(97). Leukocyte undergoing rTEM have a distinctive ICAM-1 hi 
phenotype, allowing these cells to be tracked. Studies which have following rTEM 
neutrophils, exiting either the cremaster muscle or the ear after ischemia 
reperfusion injury or LTB4 administration, have detected these ICAM-1 hi 
neutrophils in the lung vasculature, and their presence is associated with lung 
inflammation and priming of reactive oxygen species (ROS) production (99). The 
work above highlights the ability for rTEM neutrophils to dramatically spread a 















Figure 1.5: Leukocyte reverse transmigration  
Following ischemia reperfusion injury (I-R) the lipid chemoattractant leukotriene B4 (LTB4) is 
produced and secreted by tissue resident macrophages. Relseased LTB4 can now bind to the 
neutrophil receptor (BLTR) aiding neutrophil elastase (NE) stimulation. Binding of NE to MAC-1 
supports JAM-C cleavage, producing soluble JAM-C. Cleavage of JAM-C resulted in reverse 
transmigration. Image adapted from Colom et al., Immunity, 2015 (95).  
 
1.2.7 Leukocyte migration beyond TEM  
After successful TEM, leukocytes are confronted with other physical obstacles. 
The first is the pericyte sheath, made up of pericytes - contractile cells that wrap 
























angiogenesis, there is now a growing body of evidence highlighting pericytes as 
regulators of the inflammatory response (100) (101) (102). Pericytes provide an 
ICAM-1 dependent adhesive platform for the leukocytes to bind (103).  
Inflammatory signals also dictate the pericyte shape, which, if contracted, can 
create large gaps between adjacent pericytes to provide an exit portal for the 
leukocyte (104) . Emigration of leukocytes through a pericyte via a transcellular 
route have been observed in strongly activated tissues, indicating that in some 
cases the pericyte sheath may act as a true barrier (88).  Like the endothelium, 
pericytes are responsible for secreting components that form the basement 
membrane (BM), a complex mesh work of fibrous proteins namely laminins and 
collagen IV which cross-link together through glycoproteins(105). Early electron 
microscopy noted that most leukocytes were captured between the endothelium 
and BM interface rather than in the process of passing between endothelial cells, 
suggesting that the BM offers more resistance (105). Immunofluorescence studies 
of inflamed cremasteric tissue revealed the presence of “low expression regions” 
(LER), where the BM is less densely packaged. Interestingly this LER coincided 
with areas of low pericyte coverage, suggesting that pericytes are involved in 
shaping permissive exit points for transmigrated leukocytes (106). Interestingly, 
leukocytes exiting the endothelium display protrusive pseudopods, suspected to 
be used to probe and identify the permissive LER (66)(107). 
1.3 Leukocyte migration in 3D environments 
Single cell migration can be broadly defined into two categories: amoeboid and 
mesenchymal. Mesenchymal migration describes a slow (less than 1 m/min) 
locomotion, which is dependent on strong adhesive linkage to the ECM and 
metoproteinase remodelling of the ECM(112). The mesenchymal mode of 
migration is adopted by: cancer cells, fibroblasts, smooth muscle cells and 
endothelial cells. In contrast, immune cells use the amoeboid mode (108), which 
is fast moving (up to 30 m/min) and  independent of integrins and strong 
linkage to the ECM (109). Figure 1.6 demonstrates the fundamental differences 
between mesenchymal and amoeboid styled migration. How a leukocyte polarises 





Figure 1.6: The differences between mesenchymal and amoeboid migration 
Graphical representation and tabulation of differences observed from the two different 
migration modes. Figure adapted from (110). 
 
 
The establishment of leukocyte front-back polarity is critical for migration to be 
achieved; this can be influenced through external cues for example cytokines, 
chemokines and extracellular matrix fragments (111) (112). Alternatively, when 
faced with a homogenous chemokine environment a leukocyte can spontaneously 
polarise (113)(114). Figure 1.7 depicts a typical polarised leukocyte; the leading 
































Figure 1.7:  A polarised leukocyte  
The cell has adopted a polarised leukocyte. At the leading edge, surface receptors, GPCRs, activate 
PI3K that phosphorylate PIP2 to PIP3. Rac is activated through both PI3K and p38 MAPK mediated 
pathways, to facilitate actin polymerisation and branching. The mid-body, contains actin fibres 
that are under control of Rho and ROCK. The uropod forms a highly contractile rear that contains 
ERMs and septins. For abbreviations used see Abbreviations section. Image adapted from Friedl 
and Weidelin, Nature Immunology, 2008 (115).  
Leukocyte migration can be described through four stages; i) the leading edge 
protrudes, generating one or more short lived pseudopods or alternatively form 
blebs ii) the protruding membrane interacts with the substrate in a low adhesive 
manner iii) actomyosin mediated contractile forces occur at the mid-body and 
rear regions increasing the hydrostatic pressure at the front of the cell iv) the cell 
rear moves forward. These four stages are repeated in a cyclic manner to 
generate forward movement (115).  
 
Cytoskeletal dynamics are regulated by the Rho GTPase family, in mammals the 
Rho family consists of 22 members, however the most commonly studied 
members contributing to leukocyte migration are the three proteins; Cdc42, Rho 
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forms through binding guanine diphosphate (GDP) and guanine triphosphate 
(GTP) respectively. How Cdc42, Rac and Rho A contribute to leukocyte migration 
will be discussed below.  
The leading edge  
To initiate a leading edge there must be a breakage of cytoskeletal symmetry, 
which can be triggered by G-protein-coupled receptor (GPCR) signalling (115). In 
leukocytes most GPCRs transmit through the G protein subtype Gi(115). Here, 
for example, chemoattractants such as N-formylmethionine-leucyl-phenylalanine 
(fMLP) bind to GPCRs and activate phosphoinositide 3-kinase (PI3K), which in 
turn converts phosphatidylinositol (4,5) bisphosphate (PIP2) to 
phosphatidylinositol (3,4,5) trisphosphate (PIP3). PIP3 serves as a docking site for 
pleckstrin-homology domain containing proteins; one example being the kinase 
Akt which through its downstream effector the Rho GTPase Rac induces actin 
polymerisation leading to pseudopod protrusion (116)(117). PIP3 is 
predominantly found at the leading edge. Alternatively, in neutrophils the formyl 
peptide receptor (FPR) can activate Rac through p38 MAPK (118). Activated Rac 
induces actin polymerisation through the WAVE complex and branched actin 
filaments are created by the actin nucleator protein Arp2/3. Actin growth pushes 
the plasma membrane outwards propelling the  leading edge. Cdc42 shortens the 
stability of the leading edge (119). Together this work suggests different roles for 
the two GTPases found at the leading edge; Rac is involved in producing cell 
polarity, whilst Cdc42 maintains the stability of the leading edge. 
The mid-body  
In the mid-body there is a contractile ring of actin filaments, cross-linked through 
the motor protein myosin II. This contractile ring prevents lateral protrusions 
forming, further encouraging polarity, and additionally can distort the shape of 
the nucleus. Neutrophils have a segmented, “pearl chain nuclei”, and making 
traversing small pores within the ECM more manageable.  Deformation of the 
nucleus is dependent on myosin II, pharmacologically inhibiting myosin II activity 
rendered the nuclei of dendritic cells spherical and migration was severely 
reduced (120). At the uropod and mid-body, PIP3 is dephosphorylated by PIP3 
phosphatases (PTEN & SHIP), which convert PIP3 back to PIP2 (121).The 
distribution of PIP3 is crucial: Heit et al., demonstrated that PTEN-deficient 
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neutrophils display random migration rather than directed migration in response 
to chemokine stimulation (122). Recently, work in fibroblasts has suggested that 
the nucleus can act as a piston, physically compartmentalising the rear and front 
of the cell to increase the hydrostatic pressure at the leading edge (123), this 
behaviour is yet to be characterised in leukocytes.   
The uropod 
 The uropod contains the microtubule organising centre (MTOC), the Golgi 
complex and an abundance of mitochondria (115). The enrichment of 
mitochondria is presumably due to the high levels of ATP driven actomyosin 
contractility (115). RhoA is found most abundantly at the uropod and activates 
Rho-associated protein kinase (ROCK), which phosphorylates myosin light chain 
(MLC). Phosphorylation of MLC increases MLC ATPase activity, sliding adjoining 
actin filaments over one another to drive cell contraction; this in turn propels the 
cell forward via cytosolic hydrostatic pressure. A lack of RhoA leads to the 
formation of multiple lamellipodia in monocytes, whereas expression of its 
dominant negative form results in a non-protrusive cells (124)(125). Hence, it has 
been proposed that RhoA must be actively inhibited at the leading edge to allow 
lamellipodial protrusion formation, but must be active at the rear to confer 
“backness”. The uropod is enriched in proteins to strengthen cortical integrity 
(ERMs and septins) ensuring that protrusion formation is not favoured at the rear 
of the cell (126)(127)(128).  
1.4 Leukocyte chemotaxis  
Chemotaxis describes the movement of a cell towards a chemical stimulus. In 
order for a leukocyte to chemotax, the cell must polarise and migrate towards the 
chemical cue.  The most classically studied chemoattractants are formylated 
peptides (bacterial or mitochondrial derived peptides), C5a (a product of the 
complement cascade), LTB4 (a product of phospholipid metabolism) and 
chemokines (secreted by numerous different cell types)(3). Upon a 
chemoattractant binding to its appropriate GPCR receptor, a series of symmetry 
breaking events occur, described in section 1.3, to allow the cell to follow its 
chemotactic cue.  The formylated tri-peptide fMLP is frequently used within this 
thesis; this potent chemoattractant can mimic sterile injury, as it is analogous 
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with eukaryotic mitochondrial derived N-formyl-methionine proteins. Upon 
sterile injury, necrotic tissue, specifically the rupture of mitochondria releases 
chemotactic formylated proteins (129).  
1.4.1 Chemoattractant signalling and hierarchy  
Once within the perivascular space, the leukocyte is confronted with a multitude 
of conflicting chemotactic signals. Several studies have demonstrated that 
neutrophils prioritise their responses to chemoattractants in a hierarchical 
manner (130)(131)(132). Chemoattractants have been categorised as either end-
target (a signal emanating from the site of infection or damage) or intermediary 
(a signal encountered on route)(118).  Intermediary chemoattractants include: IL-
8, Gro- and LTB4, while end-target chemoattractants include fMLP and C5a(118). 
Leukocytes place their highest priority response to end-target cues, irrespective 
of concentration (118).Seminal work by Heit et al. and colleagues demonstrated 
that neutrophils migrated towards end-target chemoattractants via p38 MAPK-
dependent signalling, whilst migration towards intermediary signals was 
governed by PI3K/Akt signalling(118).Interestingly, each chemoattractant can 
activate different integrin sub-sets. Two-dimensional chemotaxis assays were 
conducted on a composition of integrin ligands (fibronectin, fibrinogen, ICAM-1 
and VCAM-1) neutrophils responding to fMLP required MAC-1 integrins, while 
neutrophils migrating towards IL-8 required LFA-1 integrins (133). This data was 
reflected in neutrophil integrin surface expression, neutrophils stimulated with 
fMLP or IL-8 led to respective increases in MAC-1 and LFA-1 expression. The 
phosphatase PTEN (phosphatase and tensin homolog) is also thought to be 
responsible for “prioritising” chemoattractants. In opposing gradients PTEN 
distribution becomes uniform, moving from the rear of the cell. PTEN activity 
inhibits PI3K activity (section1.3), thus only permitting the p38 MAPK directed 
signals. Pten -/- neutrophils could not effectively clear bacterial infections in vivo 
due to becoming “distracted” by intermediary chemokines (122). 
 
Additionally, heterologous desensitisation (also known as cross-desensitisation) 
may explain leukocyte preference to migrate towards fMLP. Briefly, heterologous 





phosphorylation by a secondary messenger, which has been activated through a 
different chemoattractant receptor signalling. A prominent messenger 
responsible for receptor desensitisation is protein kinase C (PKC). Under cross-
desensitisation conditions, PKC has previously been shown to phosphorylate and 
down regulate CXCR1, C5aR and platelet-activating factor receptor PAFR, 
surprisingly FPR receptors remained unaffected (i.e. not phosphorylated) by PKC 
(134)(135). Therefore, when interstitial leukocytes are exposed to multiple 
chemotactic cues, the fact that FPR remains untargeted by PKC, allows 
downstream signalling to dominate from this receptor.  
 
Chemoattractant receptors can also exhibit “homologous desensitisation” where 
the receptor decreases its response to the chemoattractant following prolonged 
exposure to a high concentration. The widely accepted model for homologous 
desensitisation describes a system where the chemoattractant receptor becomes 
phosphorylated by a G-protein coupled receptor kinase (GRK). This 
phosphorylated receptor now acts as a binding substrate for a group of proteins 
called the arrestins. -arrestin knockout mice exhibited a dramatic prolonged 
response to the alengesic effect to morphine, consistent with impaired GPCR 
opioid receptor desensitisation (136).  -arrestin interaction with the GPCR 
sterically precludes binding to the G-protein. GPCR bound -arrestin acts as a 
adaptor protein binding to components of the clathrin endocytosis machinery 
(137)(138). Once internalised, GPCR receptors display two behaviours dependent 
on the strength of binding between the specific -arrestin and GPCR. Transient 
GPCR--arrestin complexes encourage rapid recycling of GPCR back to the plasma 
membrane; alternatively a stable GPCR--arrestin complex favours GPCR 
degradation. Eliminating GPCR--arrestin interaction stability through the 
receptor mutation R137H, re-establishes GPCR trafficking to the plasma 










1.4.2 The extracellular matrix and neutrophil migration 
The extracellular matrix (ECM) describes the protein/glycoprotein scaffold within 
the perivascular space. It is produced through secretion by endothelial cells, 
pericytes and fibroblasts (140),(141).The ECM can include: (i) the basement 
membrane, which is composed mainly of laminins and collagen IV; (ii) the 
interstitial matrix, which is composed largely of collagens and elastins. 
Functionally, the ECM is not solely limited to the structural role of supporting 
blood vessels; it also contributes to numerous signalling roles. Collins et al., 
identified an ECM specific mechanosensitive signalling pathway and found that 
ECM composition has a profound effect on endothelial cell stiffness (142). 
Alongside this, the ECM can have a direct impact on leukocyte recruitment, either 
acting as a chemoattractant or coupling to chemoattractants. The best-known 
examples so far for the ECM acting as a chemoattractant, are the cleaved 
fragments of type I collagen, the acetylated tri-peptide Pro-Gly-Pro (acetyl PGP) 
(143). Using a lung inflammation model, this tri-peptide has been shown in vivo to 
mimic the chemotactic effect of IL-8 on neutrophils (144). Interestingly, a large 
proportion of all known chemokines interact with glycans that decorate the ECM, 
such as heparan sulphate (145). There is mounting evidence suggesting that 
binding to heperan sulphate renders the chemokine active (146). In addition, the 
glycans that decorate the ECM can be altered quite radically between states of 
health and disease. Such changes in ECM glycosylation will add to the complexity 
of how the ECM contributes to chemoattractant immobilisation and influences 
inflammatory cell recruitment during disease. In summary, the ECM plays a 




1.5 Neutrophil effector functions 
Once neutrophils have reached a site of damage, they will undergo a series of 


























Phagocytosis	 Degranula on	 NETosis	
 
Figure 1.8: The neutrophil effector functions 
After neutrophil chemotaxis to the foci of insult/injury the neutrophil initiates its assault, through 
one of the three effector functions, phagocytosis, degranulation and NETosis. Image adapted from 
Kolaczkowska and Kubes, Nat Rev Immunology. 2013 (147). 
1.5.1 Phagocytosis  
Phagocytosis is an active receptor-mediated response. Neutrophils express a large 
array of PPRs that recognise PAMPs and DAMPs, which include Toll-like 
receptors, Nod-like receptors and Fc class receptors(3). Of the three mentioned 
above the Fc receptors are the most studied, these receptors traditionally 
harbour the immunoreceptor tyrosine based activation motif (ITAM) within their 
cytosolic tails, from which signalling adaptors bind and transduce downstream 
signals (148). Briefly, ligand interaction leads to phosphorylation of tyrosine in 
the cytoplasmic ITAM motif, which leads to NADPH oxidase activation, actin 
polymerisation and granule secretion (149).  Neutrophils are extremely efficient 




downstream of the Fc receptor drive cytoskeleton remodelling, which 
contributes to the production of an engulfing membranous cup to internalise the 
targeted pathogen or pathogen-like substance. Once engulfed the pathogen 
remains in a “phagosome”, where the internal environment is made toxic through 
two means; firstly, assembly of NADPH oxidase on the phagosomal membrane 
drives reactive oxygen species (ROS) production in the form of superoxide ions, 
and secondly fusion of the phagosome with serine protease-containing granules 
(150).  
1.5.2 Degranulation 
Degranulation is also a receptor-mediated response to a pathogen or pathogen-
like substance, yet, in this circumstance, anti-microbial cytotoxic granules are 
actively transported and released via a microtubule-dependent process to the 
plasma membrane where they undergo excocytosis(3). There are at least four 
different types of granules within a neutrophil: (i) primary or azurophilic 
granules (containing elastase, myeloperoxidase and cathepsins); (ii) secondary 
granules or specific granules; (iii) tertiary granules (both secondary and tertiary 
granules containing matrix metalloprotease), and (iv) secretory granules 
(containing human serum albumin)(3).   
1.5.3 NETosis  
A final and more recently discovered neutrophil effector function is NETosis. This 
process is when neutrophils undergo cell death through the expulsion of nuclear 
chromatin into the extracellular environment. The act of nuclear extracellular 
traps (NETs) formation is often described as “NETosis”. The obvious function for 
this sticky (negatively charged) meshwork of fibres is to trap pathogens, this has 
been confirmed in basophils, neutrophils, macrophages, and interestingly plant 
root tip cells, suggesting that NETosis is evolutionary conserved (151)(152). 
NETosis can be triggered by an array of different pathogens; Gram negative 
bacteria, Gram positive bacteria, HIV virus particles, and candida albicans (153) 
(154) (155) (156). NETosis has also been observed in non-infectious diseases 
such as cancers and atherosclerosis (157). A lot of attention has been given to 
understanding the mechanism underpinning NETosis, which is molecularly and 
morphologically distinct from apoptosis. Commitment of a neutrophil to undergo 
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NETosis leads to nuclear envelope disintegration and cell contraction. At the 
molecular level, NETosis is initiated through translocation of neutrophil elastase 
(NE) and myeloperoxidase (MPO) to the nucleus, which degrades the linker 
histone H1 and de-condenses chromatin respectively (158). Neutrophils isolated 
from NE-deficient mice or patients lacking MPO cannot be stimulated to undergo 
NETosis (158). Seminal work by Branzk and colleagues has demonstrated that 
neutrophils competitively chose between NET formation or phagocytosis, 
dependent on pathogen size (159). In response to large pathogens for example 
Candida albicans hyphae and bacterial aggregates NET formation was preferential 
over phagocytosis, in comparison unicellular yeast or single bacteria drove 
phagocytosis. Here, the decision to release one killing mechanism over the other 
was driven by NE. In phagocytosis NE is sequestered away from the nucleus 
preventing proteolytic cleavage of the histones and the ultimate driving of 
chromatin decondensation that is fundamental for NETosis.  
1.5.4 The role of neutrophils in chronic inflammation 
Neutrophils are typically described as the first cellular defence in acute 
inflammation. There is a wealth of data using clinical and experimental 
approaches examining neutrophils crucial role in infection clearance 
(160)(161)(162).However recently, the neutrophil function has been extended to 
highlight pathophysiological consequences. Below are two selected examples 
indicating how neutrophils aid chronic inflammatory disease progression.  
 
Atherosclerosis 
Atherosclerosis is a cardiovascular disease that is the underlying cause of 50% of 
all deaths in the western world (163). Briefly, it is the build-up of crystalized 
cholesterol within the intima of arteries, leading to a chronic inflammatory 
situation that persists and remains clinically silent for decades. Continued 
progression of inflammation ultimately leads to the formation of an 
atherosclerotic plaque that grows into the vessel lumen. This causes gradual 
constriction of the blood that supplies oxygen to vital organs such as the heart 
and brain. If left untreated this can lead to hypertension, thrombus formation (if 
the plaque is unstable), and stroke and/or myocardial infarction. Neutrophils 
have been implicated in promoting atherosclerosis (164)(165). Typically, Deleted: atherosclerosis(
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monocytes have been classically described as the driver of atherosclerotic plaque 
growth, but through more sensitive immunohistochemistry staining of aortic and 
coronary artery sections, neutrophils were detected in early human and mouse 
plaques (164)(165).Proteins found in neutrophil granules including azurocidin, 
and -defensins has been found in human atherosclerotic lesions(166). Whilst in 
murine models, neutropenia induced through CXCR2 deficiency resulted in a 
reduction in plaque size (167). Recently, neutrophils NETs have been implicated 
in plaque development; NET deficient mice displayed reduced plaque growth 
(168). Additionally, cholesterol crystals trigger NET formation which in turn 
prime macrophages to release cytokines to amplify monocyte recruitment to the 
plaque and further progress plaque growth. These studies taken together build a 
strong case for the neutrophils role in this disease progression.  
Acute Myocardial infarction 
Myocardial infarction (MI) is commonly referred to as a heart attack. Occlusion of 
a coronary vessel can result in an anoxic low nutrient tissue environment also 
referred to as the infarct zone, within this area cardiomyocyte necrosis takes 
place, releasing mitochondrial DAMPs, which signal to activate tissue resident 
immune cells for example mast cells (figure 1.9) (169)(170). Mast cells release 
histamine, TNF and IL-1 to activate the endothelium to encourage neutrophil 
TEM(2).  Additionally, neutrophils release the complement protein C5, amplifying 
neutrophil infiltration (figure 1.9). Once within the infarct zone, neutrophils 
produce numerous proteases that further tissue damage and release more 
inflammatory amplifying DAMP signals. Above, describes the biological activity 
during the acute phase (first 3 days of MI) and leading to an increase in infarct 
size, which ultimately lowers patient outlook. The true extent of neutrophil 
behaviour is demonstrated in a canine model. Here, induced neutropenia 
decreases infarct size and the extent of damage (171)(172). 
 
 




Figure 1.9 Neutrophil responses to early phase myocardial infarction 
In the early stages, first 3 days post myocardial infarction necrotic cardiomyocyte within the 
infarct zone release DAMPs, which directly or indirectly activate the endothelium. Endothelial cell 
activation allows neutrophil TEM. Infiltrated neutrophils release proteinases and collagenases to 
negatively remodel the local tissue environment, ultimately increasing the infarct zone size. For 




Now that the mechanism by which leukocytes exit the vasculature, use 
chemoattractant signalling to gain access to the site of damage, and undergo 
neutrophil effector functions have been described, the final section of this 
introduction will focus on the contribution that L-selectin plays in regulating 
neutrophil effector function. Before its contribution to neutrophil effector 
function can be discussed, a series of sub-sections below will detail the structure 
and function of L-selectin. 
1.6 The selectin molecules 
The selectins are a family of three cell adhesion molecules that mediate leukocyte 
adhesion to the vasculature. All the selectins bind to carbohydrate-based ligands. 
The three members L-selectin, P-selectin and E-selectin were discovered in the 
1980s (174) (175)(176) with the selectin nomenclature describing how each 
selectin was first discovered. L-selectin (CD62L) is expressed on virtually all 
circulating leukocytes, but was initially identified on lymphocytes. P-selectin and 
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E-selectin were first discovered on platelets and endothelial cells, respectively. P–
selectin (CD62P) is also expressed on endothelial cells and is stored in granules 
known as Weibel–Palade bodies (WPB). After activation by pro-inflammatory 
mediators, WPB fuse with the plasma membrane and mobilise P-selectin to the 
apical surface (177). E-selectin (CD62E) is not expressed under basal conditions, 
with the exception of the microvasculature of the bone marrow and skin(178) . E-
selectin undergoes de novo transcription and translation in response to pro-
inflammatory stimuli. Earlier work in cultured primary human endothelial cells 
and knock-out mice revealed that E-selectin expression peaks at a time when P-
selectin expression begins to decline (179). Expression of E–selectin mRNA has 
been noted two hours post-stimulation and maximal protein expression peaks 
between 6-12 hours (180). In contrast to E-selectin and P-selectin, L-selectin is 
constitutively expressed at the plasma membrane and following stimulation it is 
proteolytically cleaved through a recognised mechanism known as “ecto-domain 
shedding” (section 1.9.2). 
1.6.1 Structure of the selectins 
The selectins are a family of single-pass type I transmembrane proteins. All the 
selectins share similar domain structures: (i) an N-terminal C type lectin domain, 
which binds to glycans in a calcium-dependent manner; (ii) a single epidermal 
growth factor (EGF)-like domain; (iii) two to nine short consensus repeat (SCR) 
domains, which share homology with complement proteins; (iv) a 






































Figure 1.10: The domain structure of the selectin family of cell adhesion molecules 
L/E/P-selectin are all composed of an N-terminal calcium-dependent (C-type lectin), which is 
responsible for the binding of carbohydrates. The epidermal growth factor (EGF)-like domain is 
followed by a series of short consensus repeats (SCR). The number of SCR is dependent on the 
selectin molecule. L-selectin possesses a unique membrane-proximal cleavage domain. Each 
selectin has a transmembrane domain, followed by a short cytoplasmic tail. There is very little 
homology between the cytoplasmic tails, suggesting that regulation at this site could be unique to 
the each selectin.  
 
 
 N-terminal C-type lectin domain 
The lectin domain is a calcium-dependent glycan-binding domain responsible for 
binding the tetrasaccharide Sialy Lewis (x)(181).  The lectin domain possesses 
two calcium-binding sites; occupancy of these sites induces a conformational 
change exposing the epitope responsible for ligand binding (181)(182). All 
selectins share ~52% homology for the lectin domain (37). 
EGF domain 
Amongst the selectin family members, the epidermal growth factor (EGF)-like 
domains carry approximately 47% homology at the amino acid level (37). 
Interestingly, there appears to be a higher evolutionary conservation of the EGF-
like domain ~60% (between the same selectin molecule yet in different 
mammalian species)(37). The function of the EGF-like domain has been 
confirmed by X-ray crystallography (183)(184), where the EGF-like domains are 
required for optimal ligand binding. P-selectin and L-selectin EGF-like domains 
were captured in either a bent or extended conformation(185). The shift towards 
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the extended conformation is achieved when the selectin is exposed to tensile 
forces. The linker region between the lectin domain and EGF-like domain acts as a 
hinge, allowing the selectins to interact with ligands via a “catch slip” mechanism; 
(see section 1.2.2). The higher the “pulling force” the stronger the bond.This is 
confirmed by observations that non-optimal tethering of leukocytes was 
achieved when the hydrodynamic stressed was below a certain 
threshold(186).   
SCR domain 
The short consensus repeats vary in number between the selectin family 
members. L-selectin in all species so far described have two SCR repeats, while 
E-selectin and P-selectin vary between four to nine repeats (37).  In humans, 
E-selectin contains 6 SCR while P-selectin contains 9 SCR (187)(188). Domain 
swap experiments, where SCR domains were interchanged between the 
selectins showed very little change in function, suggesting that its main 
purpose is to act as a structural spacer between the lectin domain and the 
plasma membrane (189). In other words, the SCR domains act to extend the 
ligand-binding domain away from cell body.  L-selectins relatively few SCR 
may be explained by its sub-cellular location, where it is typically anchored to 
the tips of microvilli(17). Unique to L-selectin is a membrane-proximal 
cleavage site, which is where the ectodomain of L-selectin is proteolytically 
removed from the rest of the molecule (figure 1.10). The regulation of L-
selectin “shedding” will be discussed in more detail in section 1.9.2. 
The transmembrane domain 
P-selectin has been shown to form homodimers within the plasma membrane, 
which is dictated by the presence of the GxxxG motif within the 
transmembrane domain (190)(191). Additionally, P-selectin purified from 
platelets forms oligomers and dimers in detergent solution (192). The 
functional significance of P-selectin dimerization has been suggested to 
contribute to rolling stability and cell rebinding during rolling events (193). In 
comparison, L-selectin is monomeric in the plasma membrane and it is the 
transmembrane domain has been implicated in microvilli positioning(17). 
Transmembrane domain-swap experiments between CD44 (a hydaluronan 
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binding transmembrane protein) and L-selectin revealed that the transmembrane 
domain is responsible for L-selectin location at the microvilli (194).  
The cytoplasmic tail of the selectin family members  
The cytoplasmic tail is short for all family members, consisting of 35 amino acids 
(aa) for P-selectin, 32 aa for E-selectin and 17 aa for L-selectin (37). Interestingly, 
the cytoplasmic tail shares very little homology between selectin family members. 
E-selectin has been reported through biophysical and biochemical assays to 
interact with -actinin, vinculin and filamin (195) (196). The cytoplasmic tail of E-
selectin is phosphorylated at serine residues. However, in IL-1 activated HUVEC, 
where E-Selectin is constitutively expressed antibody or ligand induced cross-
linking induces dephosphorylation of the cytoplasmic tail(197). In vitro studies 
reveal that phosphorylation of the cytoplasmic tail of P-selectin is required for 
trafficking into granules and internalisation from the plasma membrane(198).  In 
vivo truncation of P-selectin, lacking the cytoplasmic domain, severely 
compromised the storage of P-selectin in endothelial cells (198). The cytoplasmic 
tail of L-selectin and its cytosolic binding partners will be discussed in greater 
detail in section 1.7.  
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1.7 Binding partners of the L-selectin cytoplasmic tail 
Despite its small size of 17 amino acids, the cytoplasmic tail of L-selectin is known 
to bind multiple partners (figure 1.11). The binding partners of L-selectin include 
-actinin and the ERM proteins ezrin and moesin, (note that radixin is absent in 
leukocytes), calmodulin (CaM) and PKC isoforms. These interactions will be 





Figure 1.11: The binding partners of the cytoplasmic tail of L-selectin 
The 17 amino acid tail of L-selectin interacts with CaM (L358 and K359), ERM (R357 and K362) 
and -actinin (K363 to Y372). The two serines, S364 and S367 can become phosphorylated. The 
consequence of specific protein bindings and phosphorylation is highlighted (blue arrows).  For 




The interaction between the actin binding protein, -actinin, and L-selectin was 
identified through co-immunoprecipitation, and was shown to be mediated by the 













last 11 amino acids of the L selectin tail (200). The L-selectin/-actinin 
interaction has been implicated in leukocyte tethering and rolling as truncating 
the final 11 and 15 amino acids of L-selectin tail significantly reduced tethering 
efficiency and abrogated rolling, respectively (200). However, removal of these 11 
aa residues did not alter microvilli positioning of L-selectin (figure1.10). L-
selectin and -actinin are thought to form a complex with talin and vinculin (200). 
1.7.2 The ezrin-radixin-moesin (ERM) proteins 
ERM proteins act as essential linker proteins between the plasma membrane and 
the cortical actin-based cytoskeleton. ERM remain inactive in the cytosol, where 
they adopt an auto-inhibited folded conformation (203)(202). In their inactive 
state, the N- and C-terminal domains of the same ERM bind to one another, which 
mask its ability to bind the tails of transmembrane proteins (such as L-selectin) 
and F-actin. Upon binding of the N-terminal domain to PIP2, which is enriched 
specifically within the inner leaflet of the plasma membrane, ERM unfold to 
expose their binding sites for cytoplasmic tail interaction and F-actin(201). 
Phosphorylation at a conserved C-terminal threonine is involved in stabilising the 
unfolded molecule (202) (203). The threonine residue phosphorylated is T567 in 
ezrin, T564 in radixin and T 558 in moesin (204)(205)(206). The kinase 
responsible for phosphorylating the C-terminal threonine is cell-type and 
stimulus-specific. In addition to having a structural role in the cell, ERMs can also 
act as signalling adaptors. Numerous reports have shown ERM act both upstream 
and downstream of Rho GTPases (207)(208). Abrogating L-selectin/ERM 
interaction can be achieved through mutagenesis of the L-selectin tail: arginine at 
position 357 (R357) or lysine at position 362 (K362) (209) (210). Replacing 
either R357 or K362 with alanine (i.e. R357A and K362A) resulted in a significant 
reduction of L-selectin located on microvilli, which manifested in reduced cell 
tethering efficiency on immobilised recombinant PSGL-1 (210). Both R357A and 
K362A L-selectin failed to shed as efficiently as WT L-selectin when stimulated 
with the phorbol ester, phorbol 12–myristate acetate (PMA), implying ERM can 
act as pro-shedding factor (210)(209). PMA is a mimic of DAG, which is a potent 










The functions of moesin and ezrin have often been thought as redundant to one 
other, however this appears to not be the case in relation to L-selectin interaction. 
An affinity column carrying a 17 aa synthetic peptide that corresponds to the tail 
of L-selectin selectively retained ezrin from resting lymphocyte cell lysates(199). 
Interestingly, the affinity column retained both ezrin and moesin only from 
lysates derived from lymphocytes pre-treated with PMA. These biochemical 
findings would suggest that ezrin binds constitutively to the L-selectin tail, 
whereas moesin binds to L-selectin in response to cell stimulation that drives 
shedding.  
1.7.3 Calmodulin and its regulation of binding to the L-selectin tail 
Another binding partner is the ubiquitous calcium binding protein, calmodulin. 
Calmodulin is thought to associate constitutively with the cytoplasmic tail of L-
selectin. This interaction imposes a conformational constraint on the cleavage site 
to an extent that renders it protected from proteolytic attack. Indeed, incubation 
of cells with the calmodulin antagonists, calmidazolium and W7, can promote 
rapid shedding of L-selectin (211). The amino acids contributing to calmodulin 
binding are leucine L358 and lysine K359. More recently, serine phosphorylation 
of the L-selectin tail at position 364 (S364) was shown to be important in 
abrogating binding of calmodulin from L-selectin (212). Interestingly, S364 is 
conserved in humans and mice, hinting at a preserved mechanism for calmodulin 
displacement. The exact mechanism by which calmodulin negatively regulates 
shedding is not fully understood. Biophysical studies suggest that calmodulin may 
actively pull the proximal cleavage site of L-selectin into, or closer to, the plasma 
membrane, restricting access of its protease ADAM-17 (see section 1.9.2) from 
clipping L-selectin at the appropriate site (213). This hypothetical model suggests 
displacing a series of hydrophobic residues from the transmembrane domain into 
the cytosol, and hydrophilic residues from the ectodomain into the lipid bilayer of 
the plasma membrane. Collectively, this displacement of amino acids into 
conflicting microenvironments would be energetically unfavourable.  
 
Deleted: . 
Deleted: PMA . 
Deleted: 83
 55 
1.7.4 Calmodulin and ERM as signalling adaptors during ligand-induced clustering of 
L-selectin  
Ligand induced L-selectin clustering results in multiple signalling pathways; 
promoting 1 and 2 integrin activation, and mobilisation of the chemokine 
receptor CXCR4, these will both be reviewed more closely in section 1.11.1 and 
section 1.11.2 respectively (214)(215). A detailed study by Killock et al., 
employed molecular modelling to better understand how such a short 
cytoplasmic tail can accommodate more than one binding partner. They 
demonstrated that L-selectin/ERM/Calmodulin form a 1:1:1 ternary complex 
(216). This data has recently been supported by two additional papers which 
predict that ERM binding is required to desorb the highly basic L-selectin tail 
from the inner leaflet of the plasma membrane, which then allows calmodulin to 
bind (217)(218). Upon L-selectin ligand induced clustering novel protein 
interactions may form as a consequence of L-selectin tails being brought together. 
Brenner and colleagues demonstrate that L-selectin clustering activated the 
GTPase Ras (219). Ras is activated upstream by the activator son of sevenless 
(SOS) (220). Biochemically calmodulin has been shown to interact with K-Ras 
(221). Molecular modelling revealed that CaM and ERM within the 1:1:1 ternary 
complex L-selectin/ERM/Calmodulin can bind to Ras and SOS respectively (216). 
Downstream, Ras activates both MEKK and PI3K pathways and is implicated in 
cancer progression, cell migration, adhesion, and differentiation (222) 
(223)(224)(225). 
1.7.5 PKC isoforms  
Kilian et al., showed that the PKC isozymes  and  interact with L-selectin and 
subsequently phosphorylate L-selectin at the serine residues S364 and 
S367(226). Once the L-selectin tail is phosphorylated it interacts with another 
member of the PKC family, PKC. PKC and calmodulin have been shown to 
compete for overlapping binding sites (226), it is therefore not inconceivable that 
L-selectin shedding is regulated by PKC and calmodulin competition. It is possible 
that transient association of PKC  with the L-selectin tail leads to S364 
phosphorylation, forcing the dissociation of CaM and subsequent shedding. 
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Although, it is currently unclear whether PKC associates exclusively with 
phosphorylated S364. 
1.8 L-selectin ligands 
The selectin family recognise an array of simple and complex carbohydrate 
ligands. These ligands are modified through sulfation, fucosylation and 
sialylation(227). The most common ligand building block for all the selectins is 
the tetracasaccharide Sialyl-Lewis (x) also known as sLex. The covalent 
attachment of sLex can be mediated through either O or N type glycans 
(228)(229). O-linked glycans are sugar moieties linked to the protein via an 
oxygen molecule from either a serine or threonine side chain, while N-linked 
glycans are sugar moieties linked to a protein via a nitrogen molecule from a 
asparagine side chain.  Selectins can identify and bind to different sugar moieties, 
for example E-selectin ligand binding does not require sulfation, however this is 
important for L-selectin and P-selectin ligand binding (230). There are a 
multitude of ligands that have been identified for L-selectin; the table below 







































Leukocytes  Leukocyte – leukocyte 
interactions in secondary 
tethering  
(231) 
Nepmucin HEV Lymphocyte rolling and 
adhesion  
(232) 




Ligation of L-selectin via 
GlyCAM-1 enhances 2 
integrin function in naïve 
T cells 
(215) 
CD34 Mesenteric lymph 
nodes. 
HEV in tonsils. 
Peripheral lymph 
nodes.  
Supports rolling in 
lymphocytes 
(233)(234)(235) 
Peripheral lymph node 
addressin (PNAd) 
HEV within tonsils Lymphocyte trafficking to 





HEV Tethering and rolling of 
lymphocytes in vitro. 
(237) 
MadCAM-1  Mesenteric lymph 
nodes 
Rolling of lymphocytes  (238) 
Versican  Extravasculature in 
the kidney 
Potential role of leukocyte 
trafficking into the kidney 
under disease conditions 
(239)(240) 
Biglycan  Endometrium  Tethering and rolling of 
NK cells.  
(241) 
Collagen XVIII ECM of rat kidney  Possible linking molecule 
binding both L-selectin on 
a leukocyte and the 
chemokine MCP-1.  
(242)(243)  
E –selectin  Endothelial cells  Supports leukocyte 
adhesion in-vitro  
(244) 
Table 1.1:  L-selectin ligands 
This is an in exhaustive list of L-selectin ligands, alongside the details of the location of the ligand. 
For the abbreviations used see Abbreviations section. 
 
1.9 Regulation of L-selectin expression  
1.9.1 Transcriptional and post-translational control 
Human L-selectin is encoded on chromosome 1 and its short gene name was 
originally termed: leukocyte adhesion molecule- 1, or LAM-1. The human L-
selectin gene is formed of 10 exons, of which 9 are translated in to the L-selectin 
protein(245). Recently in 2015, a novel isoform was revealed in humans, a result 
of alternative splicing, excluding the 7th exon which encodes the transmembrane 
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region, rendering this variant of L-selectin soluble. The mRNA of this splice 
variant was isolated, alongside the conventional transcript, from lymphoid 
organs. The function of this soluble form of L-selectin is currently unknown, but 
human T cells markedly increased this splice variant mRNA upon 
activation(246).Transcriptional regulation has also been reported in pathological 
conditions, mice exposed to live scabies mites exhibited decreased L-selectin 
mRNA expression in the primary follicle and the marginal zone of the spleen 
(247)(248). Once translated L-selectin is post-translationally modified through 
glycosylation, glycosylation patterns appear to be cell type specific (245). 
Differences in glycosylation denote a change in weight of the protein, human 
soluble L-selectin has a MW of ~62kDa in lymphocytes and a MW of ~80 in 
neutrophils (249)(250). 
1.9.2 Proteolytic cleavage of L-selectin 
Cleavage of L-selectin, also termed shedding, occurs at the proximal cleavage site 
(K283-S284). Shedding splits L-selectin into two fragments, a 6 kDa 
transmembrane fragment and a 68 kDa soluble fraction (251).  L-selectin has 
been reported to be cleaved by three A Disintegrin and metalloproteases; ADAM-
8, ADAM-10 and ADAM-17 (also known as TNF- converting factor–TACE) (252) 
(253) (254) (255). ADAM-17 is known as the predominant L-selectin cleavage 
enzyme, however there are exemptions when ADAM-8 and ADAM-10 are 
responsible for L-selectin shedding (253)(256). In neutrophils ADAM-8 is present 
on the cell surface and in granules. Upon inflammatory activation ADAM-8 
translocates from intracellular granules to the plasma membrane, increased levels 
of ADAM-8 was also observed in synovial fluid of rheumatoid arthritis (RA) 
patients which directly corresponded to shedding of L-selectin (253). Co-
transfection of ADAM-8 and L-selectin into HEK293 cells, showed an increase in 
the amount of soluble L-selectin in the supernatant (253). In an ADAM 17-/- 
background, ADAM-10 could shed L-selectin in primary B cells (256). However, 
ADAM-17 deficient neutrophils, monocyte and lymphocytes failed to shed L-
selectin in response to PMA, as did neutrophil infiltrating the peritoneum under 
inflammatory conditions, suggesting that specific ADAM activation may be cell 
type specific or depend on the inflammatory stimulus(255).Shedding of L-selectin 
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can either be “prompted” through cell activation or can occur basally(255)(257). 
Soluble L-selectin is present within the circulation at ~1.6g/ml in healthy 
humans (258)(259). This soluble form within the circulation remains activate 
able to bind ligand (260), leading to the hypothesis that soluble L-selectin acts to 
buffer the immune response, competitively binding endothelial ligands and 
preventing excess leukocyte adhesion to the vascular walls. Soluble levels of L-
selectin increase in patients suffering from chronic inflammatory diseases; 
systematic lupus erythematosus, obesity and type 1 diabetes (261)(262)(263). 
Perhaps this increase in soluble L-selectin has a protective function, as described 
above, preventing excess leukocyte infiltration. Basal shedding occurs at the same 
cleavage site but a definite mechanism remains elusive. Stimulation of L-selectin 
shedding has been reported through numerous means; PMA, fMLP, TNF-, LPS, 
C5a, IL-8 and hydrogen peroxide (264)(265)(266)(267)(209). The above is  list of 
a few of the biological/biochemical triggers of shedding. However, biophysical 
conditions such as osmotic pressure and mechanical force have also been shown 
to induce shedding (268). Killock et al., clearly identified shedding as being either 
PKC or p38 MAPK dependent, this was achieved through selective activation of 
the kinases using PMA and cantharidin respectively (209). The PKC dependent 
pathway relies on the presence of ERM/L-selectin interaction, while the p38 
MAPK pathway increases ADAM-17 activation and surface expression (209).  
 
1.10 Functional roles for L-selectin  
L-selectin is present on virtually all circulating leukocytes with the exception of 
activated B and T cells and effector memory T cells (269)(270)(271). Butcher and 
colleagues were the first the identify L-selectin as a CAM responsible for 
migration of lymphocytes from high endothelial venules into peripheral lymph 
nodes and Peyers patches (specific lymph nodes within the gut) (176). Since then, 
the role of L-selectin in leukocyte trafficking has been extended to recruitment in 
inflammation. L-selectin role in inflammation comes from early studies using L-
selectin-deficient mice challenged with different inflammatory stimuli. For 
example, impaired leukocyte recruitment was observed when sheep’s blood was 
injected into the footpad of L-selectin-deficient mice (272).  
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1.10.1 The role of L-selectin within the vessel lumen  
L-selectin catch-slip bonding (see section 1.2.2) produce tethers that will 
progress to rolling under high hydrodynamic shear force. L-selectin-dependent 
adhesion does not occur below 0.1 dynes/cm2 (273)(40)(274).Additionally, 
genetic modification, where the C terminus of L-selectin was truncated, abolished 
binding of the cytoskeletal binding partner -actinin, significantly reducing the 
duration of tethers(34).Of the three selectin molecules L-selectin mediates the 
fastest rolling velocity (~100m/second), in comparison P-selectin mediates 
rolling at a velocity of ~50m/second(32)(41)(32). L-selectin has been shown to 
mediate leukocyte rolling in vivo within the cremaster muscle and in vitro on 
cytokine activated endothelial cells (275)(276)(277)(35). Additionally, leukocytes 
are captured indirectly to the endothelium through secondary tethering (see 
section 1.2.1). In vitro, secondary tethers were abolished when L-selectin 
deficient neutrophils were perfused across E-selectin, and addition of a function 
blocking L-selectin antibody led to an 80% decrease in secondary capture from 
whole blood (278). L-selectin deficient mice have a dramatic effect on lymphocyte 
rolling reducing accumulation on the PLN HEV (279). 
1.10.2 The role of L-selectin beneath the endothelial monolayer and beyond  
For a long time, L-selectin function has been characterised solely in tethering and 
rolling. However, it is now emerging that L-selectin may play a role in regulating 
TEM and subsequent chemotaxis(212). In mouse models leukocyte infiltration 
into the peritoneum was significantly reduced in L-selectin deficient mice, or 
through the administration of L-selectin neutralising antibodies or a soluble 
recombinant L-selectin IgG chimera (20)(280). Using MEL-14 a function blocking 
antibody against L-selectin, it was shown that CD8+ T cells rely on L-selectin to 
migrate into virus infected tissues (281) L-selectin is also responsible for aiding 
leukocyte migration into skin graft (272)(282). Alongside this T reg cells deficient 
in L-selectin showed a 90% decrease in the PLN (283). Above, illustrates a wealth 
data characterising L-selectin as a “pro invasive” molecule. L-selectin’s role in 
chemotaxis has also been addressed, Hickey et al., saturated an agarose block 
with keratinocyte chemokine (KC) the block was positioned on the excised 
cremaster muscle, generating a diffusible gradient (284). The study demonstrated 
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that L-selectin lacking neutrophils had a profound decrease in neutrophil ability 
to migrate towards the agarose block (284).Similarly the path length in the L-
selectin null neutrophils was 40-50 % decreased in comparison to WT 
neutrophils upon cremaster superfusion with platelet activating factor (PAF) and 
KC(284) . Finally, studies in vivo and in vitro have demonstrated the role of L-
selectin shedding in migration and chemotaxis, discussed below. In vitro, 
genetically blocking L-selectin shedding in the monocyte cell line (THP-1), a cell 
line that cannot complete full transendothelial migration, led to dramatic 
increases in the number of transmigrated pseudopods formed, suggesting a 
polarity defect(212). Whilst in vivo, a mouse generated through replacement of 
the proximal cleavage domain with an analogous region of P-selectin and further 
crossed with an L-selectin null mouse, resulted in a “sheddase resistant” form of 
L-selectin, expressed only on T-cells (LP)(285). Upon engagement of the T cell 
receptor (TCR), WT cells shed their L-selectin, and lost their ability to re-enter the 
lymph node (LN), in LP mice however shedding did not occur and re-entry into 
the LN was possible (285).Here, it appears that the main function of L-selectin 
shedding is to prevent activated T-cells returning to the PLNs. The described 
studies above have identified a role for L-selectin in successful migration. Further 
to this, L-selectin’s involvement in chemotaxis has also been observed. This was 
investigated using another L-selectin “sheddase resistant” mice strain (L (E) same), 
generated through exchanging the cleavage region of L-selectin with a sequence 
from E-selectin(264). In L (E) same mice, leukocytes travelled no further then 50 
m away from the cremaster microvessel after KC perfusion. In comparison, WT 
mice counterpart leukocytes travelled a distance three fold greater 
(264).Additionally in vitro, when THP-1 cells were subjected to monocyte 
chemoattractant protein-1 (MCP-1) blocking L-selectin shedding was coupled 
with the prevention of front-back polarity (212).In summary, when L-selectin is 
lacking and if L-selectin is in its non-cleavable form both have profound 
influences in inhibiting polarity and directed migration.  
 
1.11 The role of L-selectin as a signalling receptor 
The section below demonstrates L-selectin’s ability to behave as a signalling 
molecule.  
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1.11.1 Integrin activation by L-selectin 
As described in section 1.2.3, integrins can be activated through chemokine and 
L-selectin signalling. In Jurkat T cells, L-selectin binding to the ligands GlyCAM-1 
and fucoidin promoted 1 integrin activation, this was assessed through 
fibronectin binding (214). Additionally, L-selectin also contributes to 2 integrin 
activation, recently work in primary neutrophils started to pinpoint molecular  
players of this signalling cascade(286). Here, L-selectin’s association with PSGL-1 
induced phosphorylation of the kinase Fgr (286). FcR and DNAX-activating 
protein-12 (DAP-12) are phosphorylated by Fgr to recruit spleen tyrosine kinase 
(SyK), which subsequently phosphorylates Bruton’s tyrosine kinase (Btk). Btk 
regulates p38 MAPK resulting in extension of LFA-1 (2 integrin) into its high 
affinity binding form, to allow ICAM-1 binding (287). Along side this, mAb 
crosslinking of L-selectin encouraged 2 integrin/L-selectin co-localisation, 
additionally, L-selectin cross-linking induced leukocyte binding to albumin coated 
microspheres (used to test for MAC-1 driven adhesion) (288). The potentiation of 
leukocyte adhesion of MAC-1 and LFA-1 to ICAM-1 has been attributed to L-
selectin cross-linking in the presence of IL-8 (289). Cross-linking of L-selectin has 
been directly associated with p38 MAPK activation(288). In fact, p38 MAPK 
phosphorylates after 1 minute post L-selectin cross-linking (288).  
1.11.2 Regulation of chemokine receptors and chemotaxis 
Antibody-mediated cross-linking of L-selectin with LAM1-3 promoted an increase 
in surface expression of the chemokine receptor, CXCR4, on human peripheral 
blood lymphocytes (290). Lymphocyte incubated with the L-selectin ligands 
fucoidan and sulfatide, also significantly increased the levels of surface CXCR4 
(291) and in both cases CXCR4 was mobilized to the surface from intracellular 
stores. Interestingly, this response appeared to be subtype specific as sulfatide 
ligation increased CXCR4 expression in CD4+ T cells but not CD8+ T cells or B 
cells. Coupled with aiding CXCR4 surface mobilization ligand bound L-selectin 
additionally prevented the CXCR4 from undergoing receptor internalization (see 
section 1.4.1).  Exposing these T cells to high levels (500ng/mL) of SDF-1 also 
known as CXCL12 (CXCR4 ligand) for 1 hour resulted in CXCR4 internalisation. 
This phenomenon could be reversed upon L-selectin ligand binding. The 
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functional consequences for the prolonged exposure to SDF-1 and retention of 
surface expression of CXCR4 were increased actin polymerization producing 
leukocyte firm adhesion. Suggesting that signalling derived from both SDF-1 
/CXCR4 interaction and L-selectin cross-linking worked in a synergistic manner 
to increase migration(290)(291).Furthermore L-selectin’s up regulation of 
chemokine receptor CXCR4 was considered to be unique, as expression of other 
chemokine receptors (CCR5 and CCR7) did not have the same outcome. On a 
molecular level L-selectin dependent CXCR4 up regulation was due to tyrosine 
phosphorylation, proven through pre-treating the cells with tyrosine phosphatase 
inhibitors. A further study demonstrated that ligand interaction with L-selectin 
resulted in enhanced chemotaxis of B cells (~70%) and T cells (~30%) towards 
secondary lymphoid tissue chemokine (SLC)(292). The mechanism behind this L-
selectin mediated response to SLC remains unclear; it is unlikely due to the up-
regulation of the corresponding receptor (CCR7) as no differences in surface level 
expression was observed before and after L-selectin ligand-induced clustering 
(292). However, L-selectin mediated chemotaxis towards SLC could be blocked 
using inhibitors for PKC, p38 MAPK and Syk kinases.  This would suggest that L-
selectin signalling acts synergistically with CCR7 to mediate chemotaxis. This data 
is in line with previous findings that L-selectin cross-linking, produces a 
downstream signalling cascade, which leads to an increase in MAPK activity(288). 
Taken together, these experiments clearly suggest L-selectin is not only a CAM but 
also a signalling molecule.  
1.12 The role of L-selectin in regulating TEM and polarity in monocytes 
Work by the Ivetic lab (myself included) used human primary monocytes to 
specifically identify L-selectin was shed during TEM(212). This study confirms L-
selectin is regulated differently dependent on species, in mice L-selectin 
expression is retained post emigration(293). Introducing either C-terminally 
green fluorescent protein (GFP) tagged WT L-selectin (WT GFP) or sheddase 
resistant L-selectin (MN GFP) molecules into the monocyte cell line THP-1 the 
subcellular distribution could be observed. Perfusion of the two cell lines across a 
TNF--activated HUVEC monolayer revealed that of the monocytes caught in mid 
transendothelial migration (mTEM) the MN GFP cells displayed significantly 
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higher numbers of transmigrated pseudopods per cell.  L-selectin distribution in 
these transmigrated pseudopods was monitored, WT L-selectin were 
preferentially observed in clusters, these clusters were not apparent in MN GFP 
cells (212). Clustering was attributed to L-selectin ligands based within the 
interstitium (verisan, biglycan and collagen XVIII) (240)(242). Additionally, the 
interaction of CaM and L-selectin was investigated in THP-1 cells caught in mTEM. 
FRET studies imply that once the serine residue S364 becomes phosphorylated 
(examined through the use of a serine mutant S364D) CaM is displaced. In 
evolution S364 is conserved in both mice and humans, which possibly reflects the 
importance of S364 phosphorylation. Beneath the endothelium, primary 
monocytes were tracked, pharmacologically blocking L-selectin shedding 
decreased the cells “straightness of migration” or directionality.  Together, the 
work illustrated both spatially and temporally when L-selectin shedding occurred 
and eloquently demonstrated that blocking L-selectin shedding influences 
front/back polarity and directional migration persistence. The paper proposes 
that L-selectin ligand clustering is a prerequisite for L-selectin shedding, shed L-
selectin can now display distinct signalling to limit or retract multiple protrusions 
(212).Below is a model illustrating the key findings identified within this paper 
(figure 1.12).  
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Figure 1.12: Schematic model representing a novel function for L-selectin in regulating 
pseudopod number in the THP-1 cell line 
In the WT GFP cell line model: During TEM L-selectin in the transmigrated pseudopods becomes 
clustered via ECM ligand binding. Clustering leads to L-selectin phosphorylation at S364 and 
calmodulin displacement, which ultimately causes L-selectin shedding. Shed L-selectin displays 
unique signalling which limits/retracts multiple protrusions. The monocyte is now polarised. In 
the MN GFP cell line model: During TEM MN L-selectin in the transmigrated pseudopods doesn’t 
become clustered via ECM ligand binding. Preventing L-selectin shedding leads to multiple 
protrusions. Calmodulin and MN interaction was not actively investigated in this study so 
calmodulin is not represented in the model. Image created through key findings from (212).  
 
1.13 The role of L-selectin in neutrophil effector functions 
L-selectin has been acknowledged in the literature for indirect roles in NETosis 
and degranulation. Recently, neutrophils have be shown to undergo NETosis 
through signalling initiated by salival mucins decorated with Sialyl Lewis (x)the 
necessary binding partner for L-selectin (294). Pre-incubating neutrophils with 
anti-L-selectin antibodies before incubating the cells with mucin rich saliva 
prevented NET formation. This study confirms that the signalling mediated from 
the Sialyl Lewis (x) and L-selectin interaction is crucial for NET formation (294). 
In further work, P-selectin transduced in to murine neutrophils promoted 
NETosis though PSGL-1 binding (295). Neutrophils have also been shown to be 
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more sensitive to degranulation of secondary, tertiary and secretory vesicles after 
L-selectin cross-linking (288) (296). For a more detailed discussion exploring 
how L-selectin governs neutrophil effector function see section 6.4. 
1.14 The role of L-selectin in disease  
L-selectin plays a major role in driving chronic inflammation progression. L-
selectin monoclonal antibodies have been shown to reduce the number of 
infiltrating neutrophils in a mouse model of peritonitis, and protect against a 
hyper-inflammatory response in parasitic infections (272). In an endotoxaemic 
model of inflammation, where lipopolysaccharide (LPS) is injected systemically 
into mice, L-selectin deficient mice showed 9-fold higher survival rates than their 
wild type littermate controls (272). Using a mouse model of cutaneous 
inflammation, skin graft rejection was significantly delayed in L-selectin-deficient 
mice compared to that of WT mice (272). The findings above demonstrate that the 
absence of or functional inhibition of L-selectin provides a protective role in 
inflammation. The above studies have been carried out in various animal models, 
but how this work translates to human models remains elusive.  
 
In humans, L-selectin has been implicated as a possible therapeutic target for 
atherosclerosis, although this is controversial. Two prominent studies carried out 
in the same lab produced conflicting roles for L-selectin in atherosclerosis 
progression. Eriksson et al., demonstrated using a murine model that L-selectin 
dependent secondary tethering accounted for 20-50 % of all leukocytes captured 
at atherosclerotic lesions(25). Imaging of advanced plaques identified a network 
of microvessels permeating the lesions, which appeared to serve as entry points 
for leukocytes to enter the lesion (25).Here, the role of L-selectin in leukocyte 
capture ultimately leads to plaque growth (297). Conflictingly, a double knockout 
mouse model (apoliopoprotein E (ApoE) -/-  and L sel -/-) showed that when fed a 
high cholesterol diet for 6 weeks aortic lesions increased 2 fold, compared to a 
ApoE-/- control (298). Apo E is responsible for the catabolism of triglyceride rich 
lipo-proteins. Confusingly this result suggests that L-selectin plays a protective 
role in atherosclerosis. Taken together there is a clear link between L-selectin and 
atherosclerosis, however, there appears to be no one model to fits all answers. 
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The role of L-selectin could vary dependent on what vessel is being studied or the 
stage of atherosclerosis progression.  
 
L-selectin and its ligands are continually being assessed as potential targets for  
anti-inflammatory therapies. Currently, to my knowledge there is no 
commercalised therapy that manipulates or blocks the function of L-selectin 
(299)(300). Clinical trails, using L-selectin as a target have so far been 
unsuccessful. Clinical trials blocking L-selectin failed to improve psoriatic lesions, 
while another presently in phase II, named Aselizumab, was associated with 
higher rates of infection and leukopenia compared to the control placebo group 
(301)(302). Together, these failures may be due to the redundancy within the 
selectin family; simply blocking one may not be enough. However there are other 
studies were the outcome does not look as bleak. The introduction of recombinant 
fusion protein, PSGL-1 linked to IgG-Fc, blocks leukocyte adhesion, the drug 
YSPSL is currently in trials to assess renal allograft rejection (303). Another 
exciting in vivo murine study transiently expresses L-selectin into a 
cardiomyocyte precursor cell (304). These cells home more effectively than non 
transfected cells to damaged tissue in the heart after myocardial infarction and 
initiate regeneration (304).  
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1.15 Current methods to study L-selectin  
The molecular tools to study L-selectin 
To date there has been a multitude of molecular technologies employed to study 
L-selectin. Genetic manipulation is conducted in vivo and in vitro to either  
visualise the cellular distribution of the molecule or to prevent a specific 
function/interaction or delete the molecule completely. Genetically rendering the 
L-selectin sheddase resistant has obvious advantages over mAb studies, where 
function-blocking antibodies may block L-selectin ligand binding, but also 
introduce L-selectin clustering which initiates downstream signalling. 
Additionally, L-selectin shedding can be blocked pharmacologically through the 
use of metalloproteinase inhibitors, but as discussed later in the text this poses 
caveats.    
The experimental tools to study L-selectin 
In vivo, L-selectin and other molecules involved in the adhesion cascade are 
studied using intravital microscopy of organs within the mouse.  This technique 
has obvious advantages, allowing complete visualisation of the adhesion cascade. 
However, no detailed information of the subcellular location of L-selectin and its 
relative binding partners can be gained. In vitro, experimental methods include 
Transwell assays and parallel plate flow chambers. The Transwell assay functions 
by establishing a concentration difference between the upper and lower wells, 
which are separated by a microporous filter. Simply, cells that are added to the 
upper well “sense” the chemokine in the lower well and migrate through the 
porous membrane. This assay has no direct imaging window and cells push 
through an inert membrane. The parallel plate flow chamber relies on the 
perfusion of leukocytes over an EC monolayer at physiological shear stress 
through negative pressure generated by a syringe pump, however this assay does 
not look beyond transendothelial migration so 3D migration and chemotaxis 
















1.16 Original hypothesis  
The role of L-selectin shedding in human monocytes has been recently reported 
to occur during transendothelial migration (TEM) (212). It is therefore proposed 
that L-selectin shedding may occur in human neutrophils during TEM. It is also 
postulated that preventing L-selectin shedding may result in defects in polarity-
dependent events for example during chemotaxis. 
1.17 Aims of the project  
In order to test the hypothesis several aims were established.  
1.  Use primary human neutrophils and generate HL-60 cell lines 
expressing WT and mutant forms of L-selectin-GFP to address the role 
of L-selectin shedding in TEM and chemotaxis. 
2. Design and fabricate microfluidic devices to monitor chemotaxis in 2D 
and 3D scaffolds. 
3. Determine a role for serine phosphorylation of the L-selectin tail 
(through generating cytoplasmic serine mutant cell lines) in regulating 
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2. Materials and methods  
2.1 Cell culture medium, buffers, reagents and chemical formulations  
 
 


















4x Protein Loading buffer Made in house  200mM Tris-HCL pH6.8, 8% 
SDS (v/v), 20% glycerol 
(v/v), 0.4% bromphenol-




buffered saline modified 




0.8% sodium chloride (w/v), 
<0.1% potassium chloride 
(w/v), <0.2%monosodium 
phosphate (w/v), <0.1 
potassium phosphate (w/v), 











Milk blocking buffer Supermarket  5% dry milk powder (w,v), 
in TBS with 0.1% (v/v) NP-
40.  
RT 
Tris-buffered saline (TBS) 
solution  
Made in house  150mM NaCL /15mM tris-
HCL, pH 7.4 in ddH20. 
RT 






Calyculin A  Sigma - 
Aldrich, 
Germany 
20M in DMSO  -20C 
Cantharadin  Sigma - 
Aldrich, 
Germany 
12.5mM in DMSO -20C 





1mM in DMSO  -20C 







1mM in DMSO -20C 
Celltracker TM Deep red Life 
technologies 
1mM in DMSO -20C 
Dimethylsulphoxide (DMSO; 






Glutaraldehyde  GPR TM N/A 4C 




Isopropanol Fisher Scientific, 
U.S.A. 
N/A RT 
Acetone Fisher Scientific, 
U.S.A. 
N/A RT 
Methanol Fisher Scientific, 
U.S.A. 
N/A RT 
Nonidet P-40 substitute (NP-
40) 




Novex NuPAGE  Bis-Tris 
4-12% gradient gels, 10 well, 
thickness 1.0 or 1.5 mm  
Invitrogen, 
U.K. 
Composition as stated by 
manufactures  
RT 
PageRuler TM Plus prestained 




Paraformaldehyde (PFA) BDH laboratory 
Supplies, U.K. 
8% (w/v) in PBS -20C 
Poly-L-lysine (PLL) Sigma - 
Aldrich, 
Germany 
0.1% (w/v) manufactures 
solution 
4C 
















32.5 mM in DMSO -20C 
Recombinant Human 
Monocyte chemoattractant 
protein 1 (MCP-1)/CCL2 
R&D systems 100 g/mL -20C 
Recombinant Human Tumor 
Necrosis factor alpha (TNF-) 
R&D systems 100 g/mL -20C 
Sodium Chloride (NaCl) Sigma - 
Aldrich, 
Germany 
1M in ddH20 RT 
Recombinant Human protein 





100 g/mL -20C 
Recombinant Human protein 
CXC motif chemokine ligand 
1, Gro  
R&D systems 100 g/mL -20C 
N-formyl-Met-Leu-Phe Sigma - 
Aldrich, 
Germany 
10 mM in DMSO  -20C 
Retinoic acid  Sigma - 
Aldrich, 
Germany 
10 mM in DMSO  -20C 




2 mM in DMSO -20C 
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SB 202190 Sigma - 
Aldrich, 
Germany 
3 mM in DMSO  -20C 
Sylgard184 Silicon 
elastomer kit, 2-part kit 
containing elastomer base 
and curing agent. 
Dow corning Use at a 10:1 (v/v) elastomer 
base: curing agent 
RT, as separate 
components.  
Microposit TM EC solvent II DOW Used as prepared by 
manufacture’s instruction. 
RT 
Microchem Negative epoxy 
resist SU-8 2000 series, 2005, 
2025 and 2050.  
Microchem N/A 4C for long term 
storage, 24 hours 
prior to 
experimentation 






N/A  4C 
Zymosan A (s.cerevisiae) Bio 
particles , Alexa Fluor 
594. 
Thermofisher 20 mg/mL in Human Serum 
Albumin, (HSA).  
4C 
Dextran, Alexa Fluor 488, 
10,000 mw  
Life 
technologies  
1 mg/mL in PBS -20C 




1 mg/mL in PBS -20C 
Dextran, Alexa Fluor 




1mg/mL in PBS -20C 
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Prepared in HBSS RT 
HBSS (Hank’s buffered salt 
solution) without calcium 




 Manufactures formulation RT 
 
 
Sodium Citrate  Phoenix Pharma 
Ltd. 
Used as prepared by 
manufactures 
4C 
FC receptor block  MACS Miltenyi 
Biotec  
Use at 1/100  4C 
Cell culture Fibronectin Sigma - 
Aldrich, 
Germany 
1mg/mL in PBS 4C 








Penicillin/Streptomycin Sigma - 
Aldrich, 
Germany 
10,000 Units penicillin and 
10,000 g/mL streptomycin  
-20C 
Matrigel Corning 18-21mg/mL  4C 
Puromycin  Sigma - 
Aldrich, 
Germany 
10 mg/mL in ddH20 4C 
G418 (Geneticin) Sigma - 10 mg/mL in ddH20 4C 
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Table 2.1: A tabulated list of chemicals, buffer formulations and cell culture resources used within this PhD project.
Aldrich, 
Germany 
RPMI (Roswell Park 
Memorial Institute) 1640 
Gibco 
Invitrogen, U.K 
Manufactures formulation 4C 
Trypsin – EDTA solution Sigma - 
Aldrich, 
Germany 
0.5g/l porcine trypsin and 
0.2g/l EDTA.4Na in Hank’s 
balanced salt solution with 
phenol red.  
-20C 
Rat tail collagen  Cell matrix, 
Nitta gelatin inc, 
Japan.  
Preparations in v/v ratios  
4:2:1:1 (collagen , 5xDMEM, 
reconstitution buffer, HL-60 
media (RPMI with 10% v/v 
FCS and 1%v/v Pen/Strep)) 
4C 
5X DMEM  PAA, Colbe, 
Germany 
1mg in ddH20 4C 
Reconstitution buffer for rat 
tail collagen  
Made in house  2.2g NaHCO3 in 100mL of 
0.05N NaOH and 200mM 
Hepes.  
4C 
EGM-2 Media Bulletkit  Lonza Walkersville Endothellial 
growth medium 
supplemented with hEGF, 
Hydrocortisone, FBS (fetal 
bovine serum), GA-1000 
(gentamicin, Amphotericin-
B),VEGF, hFGF-B, R3-IGF-1, 
Ascorbic acid, Heparin.  
4C 
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2.2 Antibodies  
 
Antibody Antigen Origin Mono(M)/ 
Poly(p) 
clonal  
Isotope  Stock 
conc.  
(g/mL) 
Source  Dilution 
Primary Antibodies 
Anti- GFP GFP Rat M IgG2a 1000 Chromotek 
WB 
1:1000 







Rabbit  M IgG - Cell signalling 
technology IF 1:400 
Dreg-56 L-
selectin 







Mouse  M 








Mouse  M IgG1 200 Santa cruz 





Goat M IgG1 200 Santa cruz 
biotechnology FACS 
1:200 
Anti-FPR1 FRP1 Rabbit 
P IgG 1000 
Sigma life 
sciences  WB 
1:500 
















Rabbit P IgG - Cell signalling 
technologies WB 
1:1000 
Anti -CXCR2  CD182 Mouse  M IgG1 200 Biolegend 
FC 1:250 






N/A Mouse M IgG1 100 Biolegend 
FC 
1:200 
IgG1 N/A Mouse  M IgG1 200 Santa cruz 
biotechnology FC 
1:200 
IgG1- PE N/A Rat M IgG1 




Table 2.2: Table of Primary Antibodies used within this thesis.  
 
 
Antibody  Antigen  Origin  Source  Dilution 



























































































Table 2.3: A Tabulated list of the secondary antibodies used within this thesis. 
 


















2.3 Cells and cell culture  
All cells were cultured at 37C, 5% carbon dioxide, under humidifying conditions 
and in compatible sterile plastic ware. 
2.3.1 HL-60 cells (Human promyelocytic leukaemia cells) 
HL-60 cells were purchased from American Type Culture Collection (ATCC).   HL-
60 cells stably overexpressing the chemokine membrane receptor CXCR2 were a 
generous gift from the Richmond Lab, Vanderbilt University, U.S.A. Cells were 
maintained in HL-60 media (RPMI-1640 (GIBCO®, Invitrogen) medium 
supplemented with 10% (v/v) FCS, 1% (v/v) antibiotics 
(penicillin/streptomycin)). Cells were seeded at a density of 0.3x106 cells/mL and 
split every 3-4 days upon reaching a density of 1x106 cells/mL. The cell line 
largely resembles promyelocytes, a granulocyte precursor. HL-60 cells can be 
induced to differentiate to either a neutrophil-like or monocyte-like phenotype, 
depending on the reagent used. Compounds such as retinoic acid and DMSO cause 
neutrophil-like differentiation, whereas vitamin D and GM-CSF promote a 
monocyte-like differentiation(305). For all experimentation conducted within this 
thesis HL-60 cells were terminally differentiated using 1.3% (v/v) DMSO, 
producing neutrophil-like cells.  Fresh HL-60 media was supplemented with 1.3% 
(v/v) DMSO and cell density was adjusted to 0.5x106/mL. Cells were used for 
experimentation 4-5 days after incubation with DMSO. Cells proliferation 
dramatically slows upon differentiation and the cell typically decreases in size.  
All experimentation was carried out on differentiated HL-60 cells (4-5 days post 
DMSO treatment) unless stated otherwise.  
2.3.2 HEK 293T cells  (Human embryonic kidney cells) 
HEK 293T cells were a kind gift from Dr Yolanda Calle (University of Roehampton, 
London, UK). Cells were maintained in HL-60 media. Every 2-3 days media was 
replenished and cells were passaged by trypsinisation and “split” 1:3. In order to 
split cells, 3 mL of warmed trypsin (serine protease, Sigma-Aldrich) was added 





2.3.3 HUVEC cells  (Human umbilical vein endothelial cells) 
HUVEC were purchased from Lonza as a cryovial containing 0.5 x 106 cells from 
pooled donors. HUVEC were cultivated in endothelial growth media (EGMTM-2 
Lonza) supplemented with growth factors and antibiotics (EGMTM-2 Bullet kit, 
Lonza). Cells were expanded to a maximum of 6 passages. For expansion cells 
were grown on 14cm diameter dishes, pre-coated with 10g/mL fibronectin. 
Media was aspirated from confluent dishes and washed twice with sterile PBS. 
When confluent HUVEC were “split” as described above (section 2.3.2). Complete 
cell detachment was verified by light microscopy using an x4 objective, 8 mL fresh 
pre-warmed endothelial growth media was then added to neutralise the action of 
the trypsin. After centrifugation the cell pellet was re-suspended to achieve a 1:3 
dilution for further passage. Upon reaching the 6th passage, HUVEC were 
trypsinised, harvested and re-suspended in cryopreserving medium (section 
2.3.4). Cells were kept in 1 mL aliquots so that they could be thawed for a once-
only use. Typically, one cryovial could be used to coat 4x35mm diameter 
fibronectin coated coverslips (section 2.5.1). 
2.3.4 Cryopreservation of cells 
Cells grown for cryopreservation were amplified in log phase, harvested at 
approximately 10 million cells for each Corning ® Cryogenic vial. The pellet was 
re-suspended in 10% DMSO and 90% FCS (v/v) making a total volume of 1 mL, 
this was placed in one pre-chilled Corning ® Cryogenic vial. The vial was 
transported on dry ice to an -80 freezer for 24 hours then transferred to liquid 
nitrogen for long-term storage. Vials were rapidly thawed through submerging 
them in 37C water bath. The DMSO/cell suspension was then immediately 
diluted in 9 mL of pre-warmed culture media (to minimize the toxic effects of the 
DMSO) and the cells harvested by centrifugation. After centrifugation the pellet 







Deleted: to ensure integrity of cellular characteristics. 
Deleted: tyrpsinised
 81 
2.3.5 Isolation of Primary Neutrophils  
All primary neutrophils were isolated from healthy volunteers; a maximum of 50 
mL of blood was taken from the brachial vein. Trained medical professionals, 
working within the Cardiovascular Division, carried out the phlebotomy. The 
work complied with the regulations stipulated in the Human tissue act of 2004. 
Blood was drawn into a syringe preloaded with sodium citrate (Phoenix Pharma 
Ltd.); citrate ions chelate the calcium ions in the blood, forming calcium-citrate 
complexes. Removal of calcium disrupts the coagulation process. Blood was 
carefully layered on top of Histopaque-1077 (Sigma- Aldrich) in a 50 mL falcon 
tube. This was then centrifuged for 30 minutes at 1450 rpm (with no brake on the 
centrifuge). The Histopaque-1077 solution composed of polysucrose and sodium 
diatrizoate, gives a density of 1.077g/mL. After centrifugation polysucrose 
stimulates erythrocytes aggregation and consequential sedimentation, 
granulocytes become hypertonic, the decrease in cell volume prompts 
sedimentation (figure 2.1). Monocytes and other mononuclear cells remain at the 
plasma/Histopaque – 1077 interface, in a narrow fraction known as the buffy coat 
(figure 2.1). Top layers were carefully removed with a Pasteur pipette, making 
sure not to disrupt the erythrocyte/granulocyte rich pellet. The pellet was then 
mixed at a 1:1 (v/v) ratio with HBSS (free from calcium and magnesium). The new 
total volume was then added to an equal amount of 2% (w/v) dextran solution 
(filter sterilised through 0.22 m filter). To ensure thorough mixing the falcon 
tube was inverted several times, and left for 20-30 minutes at room temperature. 
Erythrocytes sediment through gravity, the opaque neutrophil rich layer was 
carefully removed. The aspirate was mixed in a 1:1 (v/v) of HBSS and spun for 5 
minutes at 1150 rpm. The pellet was  re-suspended with 3mL of deionised sterile 
water for 30 seconds to lyse any residual erythrocytes through osmotic shock. 
The falcon tube was then rapidly topped up with 50mL of HBSS and spun for a 
further 5 minutes at 1150rpm. The pellet was re-suspended at the desired 
neutrophil density in pre-warmed RMPI culture media. Experimentation with 























Figure 2.1: Schematic demonstrating the procedure used to isolate neutrophils from human 
blood. 
Blood was collected from a brachial vein of healthy volunteers. To avoid coagulation blood was 
collected in sodium citrate (already present in the syringe). The neutrophil isolation process is a 
staged process. First whole blood is layered onto Histopaque-1077, providing a dense barrier 
through which mononuclear cells cannot penetrate, but erythrocytes and granulocytes can. After 
centrifugation, whole blood is separated into distinct layers.  Further suspension of the pellet in 
2% dextran allows erythrocytes to sediment and granulocytes to remain in suspension. The upper 
fraction containing granulocytes is finally harvested by centrifugation and any residual 
erythrocytes are lysed by osmotic shock.  
 
2.4 Flow cytometry 
2.4.1 Instrument and Instrument parameter settings 
Samples were analysed using a FACS BD ACCURI C6 (BD biosciences). FITC and 
GFP signals were excited at 488nm and detected at 530nm. Data was acquired 
with the acquisition software CellQuestTMPro version 4.0.2 (BD biosciences).  In 
total a minimum of 20,000 events were collected per sample. All data was 
analysed using the FlowJo cytometry analysis software vX 0.7 (Tree Star,Inc). 
Initially live cell populations were gated using the forward (FSC-H) and side 
scatter (SSC-H) profiles to exclude dead cells and cellular debris. The gated 
population was then examined for the fluorescence intensity of antibody-labelled 
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2.4.2 Antibody labelling  
Indirect antibody labelling of surface protein levels was conducted, using a 
fluorescently tagged secondary antibody, which has specificity for the antibody 
species of both the isotype control and primary antibody being used. This indirect 
detection method has increased sensitivity due to signal amplification; multiple 
epitopes are available on the primary antibody. All cell labelling was conducted 
on ice in 1.5 mL Eppendorf tubes. Primary and secondary antibody incubations 
were performed on ice for 30 and 20 minutes, respectively. Neutrophils were 
labelled with the appropriate antibody in block solution containing 33% FCS 
(v/v) in PBS, to ensure blocking of non-specific interactions.  Between primary 
and secondary antibody incubations, the cells were subjected to two PBS washes 
to remove excess antibody. Prior to FACS analysis, cells were re-suspended in 3% 
FCS (v/v) in PBS within a 1.5 mL Eppendorf. For actual antibody concentration 
used see table 2.2 and table 2.3.  Briefly, 200,000 cells were isolated per replicate 
per sample; analysis was conducted on gated populations to remove cell debris 
and dead cells.  All FACS experimentation unless otherwise stated was conducted 
in triplicate-where three repeats on the same day represents N = 1, and an N = 3 
completes the data set for any given FACS experiment.  
2.4.3 Flow Jo analysis 
As information on every single cell is acquired digitally, gating of cell populations 
could be performed post-acquisition using the Flow Jo vX 0.7 analysis software. 
Cell gating was performed to include singlet live cells but remove: cell aggregates, 
dead cells, bubbles and cellular debris. This gating could be achieved within 
histograms showing forward and side scatter profiles. Non-fluorescently labelled 
cells were used to measure auto-fluorescence, which could then be subtracted 
from the fluorescence intensity measurements. Antibody isotype-matched 
controls were used to measure fluorescence detected from non-specific binding 
arising from the Fc region of the conjugated secondary antibody.  The 
fluorescence values from the above controls were used to threshold a positive 




gated sample. All experiments were performed in triplicate and data is 
represented as a mean +/- standard error of the mean (SEM).  
2.5 Parallel plate flow chamber  
Prior to perfusion assays, cells were re-suspended to an appropriate density in 
HL-60 media supplemented with 25mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES). The imaging platform for the perfusion 
assays has no in-built CO2 supply; therefore, Hepes acts to maintain the culture 
medium at physiological pH.  Experimentation was performed at 37°C and 
visualised using an Olympus IX81 time-lapse inverted fluorescence microscope 
connected to a Hamamatsu C10600 ORCA-R2 digital video camera. A silicon 
gasket was vacuum-sealed to the activated endothelium, either seeded in the 3D 
device or on a coverslip. A Harvard syringe pump (Harvard Apparatus®, U.S.A) 
was used to draw leukocytes across activated HUVEC monolayers at a fixed flow 
rate (0.25mL/min). Typically, cells were perfused at 1.24 dynes/cm2, which falls 
within a physiological shear stress of blood flow within post capillary venules. 
Volocity®, Imaging software Perkin Elmer, was used to control the acquisition 
rates, which was stored as digital data files. Figure 2.2 outlines the main features 
of the parallel plate flow chamber.   
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Figure 2.2:  Schematic depicting the parallel plate flow chamber set up. 
The images show the microscope set up, all assays were performed in plastic housing, (not 
shown), to maintain temperature control. A) The parallel plate flow chamber is attached via a 
vacuum seal to an endothelial monolayer; together this is placed onto an inverted fluorescence 
microscope.  A syringe pump draws leukocytes via negative pressure from a receptacle across the 
activated HUVEC. Unbound leukocytes alongside media are collected into a syringe. Time-lapse 
videos were recorded through a CCD (charge coupled device) camera with a video recorder 
connected to the computer. Volocity software (Perkin Elmer, USA) acquired movies throughout 
the experiment.  Bi) Schematic demonstrating connections found in the Perspex part of the 
parallel plate flow chamber-vacuum inlet and an inlet and outlet to allow the passage of 
leukocytes. Bii) An Image to demonstrate the assembly of the parallel plate flow chamber.
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2.5.1 Cell perfusion assays for binding dynamics  
Differentiated HL-60 cells or primary neutrophils were cultured at a density of 
0.5x106 cells/mL in HL-60 media (RMPI media, 10% (v/v) FCS, 1% 
penicillin/streptomycin) the night before the experiment. A total of 3mL of the 
cell suspension was delivered into the flow chamber, followed by media alone. 
The cells were perfused over TNF--activated HUVEC monolayer grown on 
fibronectin-coated 35 mm diameter sterile glass coverslips. In cases where L-
selectin shedding was pharmacologically blocked, primary neutrophils were pre-
treated with cell media supplemented with 10M TAPI-0 twenty minutes prior to 
perfusion. Media supplemented with 10M TAPI-0 was also used to condition the 
TNF-activated HUVEC monolayer for 5-10 min before each flow experiment. 
Image acquisition started from the moment the syringe pump was switched on. 
All recordings were performed using a 10x objective microscope. The dead 
volume of tubing from the cell suspension to the flow chamber was approximately 
0.5 mL. Given that the flow rate was set to 0.25 mL/min, the cells would begin to 
enter the flow chamber by 2 min and cell binding would typically be seen a few 
minutes after that.  To avoid bias in recording cell adhesion and transmigration 
events, a minimum of three fields of view was acquired for every flow assay 
conducted.  Typically, for every phase contrast and GFP channel, each field of view 
was acquired every 30 seconds. To monitor the leukocyte’s dynamic behaviour 
with activated endothelial monolayers, video stills at 6 minutes, 10 minutes and 
30 minutes were scored for stages of the adhesion cascade; binding, intraluminal 
crawling, mid-transendothelial migration (mTEM – where cells are captured in 
mid-transmigration) and full transendothelial migration (fTEM – where the 
process is complete).  The time taken for the entire adhesion cascade to be 
executed was also monitored and scored from the moment cells were captured to 
the activated HUVEC monolayer up until the cells entered the sub endothelial 
space. Conveniently, TEM is easy to observe by eye: leukocytes appear phase 
bright when above the endothelium and phase dark when within the sub 
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endothelial space. Volocity software (PerkinElmer,U.S.A) was used to analyse 
leukocyte transmigration events.  
Samples prepared for confocal analysis requires disassembly of the parallel plate 
flow chamber to retrieve of the 35 mm glass coverslip. The coverslip is then 
subsequently submerged into 4% PFA(W/V) made up in PBS. Retrieval of the 
coverslip is performed in less than a minute to avoid any radical changes in cell 
morphology. The coverslip is then permeabilised, blocked and stained for 
intracellular/extracellular markers. See section 2.8.2 for more detailed 
description on immunostaining for microscopy. Shorter perfusions (15 minutes) 
were conducted to optimise visualisation of cells engaged in mid-transendothelial 
interaction, and address the subcellular distribution of L-selectin.  
2.5.2 Cell tracking of fully transmigrated neutrophils  
To determine the speed and directionality, cells were manually tracked using the 
ImageJ (NIH) plugin, MTrackJ. The co-ordinates of the cell trajectories were input 
into a custom-made open source computer program-Diper. A more 
comprehensive documentation of the code can be found in the report by Gorelik 
et al (306). 
2.5.3 Cell perfusion of the 3D device 
The 3D devices were prepared as described in section 2.12 and subjected to 
activation for 12-16 hours with TNF-. Perfusion was conducted in HL-60 media, 
supplemented with 25mM Hepes (pH 7.3). Where HL-60 cells were co-perfused 
over activated endothelial monolayers, each cell line was uniquely stained with 
1M cell tracker dye (Cell Tracker). To stain, neutrophils were incubated in 
RPMI media only (no FCS) for 15 minutes at 37 C, after; cells were washed and 
re-suspended in appropriate media.  To avoid bias and prevent any adverse 
effects on cell behaviour, dyes were exchanged periodically between lines and 
experiments. Primary neutrophils were stained with 1M Cell Tracker Orange. 
In experiments where L-selectin shedding was pharmacologically inhibited, the 
neutrophils and HUVEC monolayer were pre-treated for 20 minutes with 10M 
TAPI-0. Each flow assay was performed for 2 hours per device, after which the 
devices were fixed with 4%(w/v) PFA in PBS, permeabilised and stained for 
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visualisation (see section 2.8.2) on an inverted spinning disk  (Yokagawa) 
confocal. 
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2.6 Protein Biochemistry 
2.6.1 Polyacrylamide gel electrophoresis of HL-60 cell lysates, using the Novex 
NuPAGE SDS-PAGE pre-cast gel system  
To generate whole cell lysates, 2 million HL-60 cells were pelleted for 5 minutes 
by centrifugation. The pellet was lysed in 200 L 2x protein loading buffer (see 
table 2.1), then transferred into a 1.5mL Eppendorf.  To decrease the viscosity of 
the sample (generated by nuclear lysis) and ensure accurate gel loading, the 
preparation was sonicated for a few pulses. Samples were subsequently placed in 
a heat block at 95 C for 5 minutes to complete protein denaturation. For static 
transmigration assays, HUVEC monolayers were grown to confluence in 
fibronectin coated 6 well plates and activated overnight in 10 ng/mL-1 TNF-. The 
added neutrophils were left to transmigrate for 45 minutes at 37C and 5% CO2. 
For each well, 200 L of 2x protein loading buffer was added and lysate harvested 
instantaneously using a cell scraper and then processed by sonication as 
described above.  The denatured protein samples were resolved by 
polyacrylamide gel electrophoresis on pre-cast Novex® NuPAGE® 4-12% Bis-
Tris gradient gels (Life Technologies, U.K.) in 1x MES buffer. To characterise the 
molecular weights of proteins, Novex® sharp pre-stained protein standard 
molecular weight markers (Life Technologies, U.K.) were used for all gels. 
Electrophoresis was performed at a voltage between 100-180 volts, and was 
stopped when the dye front reached the base of the gel casing.  
2.6.2 Western blotting  
Protein was transferred from the polyacrylamide gels to Nitrocellulose 
(Millipore®, U.K.) membrane; the membrane was pre-wet in transfer buffer, (see 
table 2.1). Transfer was carried out in a NuPAGE® transfer blot module 
(Invitrogen, U.K.) at 27 volts for 2 hours.  The membrane was then blocked for 1 
hour in 5% (w/v) milk (MARVEL) made up in TBS solution, known as blocking 
solution (see table 2.1). The membrane probed with the appropriate primary 




Deleted: containing Tris buffered saline solution, known 
as blocking solution. The membrane was then 
Formatted: Font: Bold, Italic
 90 
The following day the membranes were washed for 10 minutes with TBST (0.1% 
v/v tween-20) followed by three consecutive short 3 minute washes with TBS 
(see table 2.1). The membrane was further blocked for 1 hour before addition of 
the secondary antibody at a dilution of 1:15,000 again for 1 hour. Both these 
incubations were conducted at room temperature. Membranes were washed as 
described above before imaging.  
2.6.3 Densitometry analysis 
Nitrocellulose membranes labelled using LI-COR® compatible antibodies were 
scanned using the LI-COR® system; bands were analysed and quantified using 
Image Studio Software (Version 2.1, LI- COR® Biosciences, UK). Protein levels 
were determined based on their band intensities normalised to their respective 
loading control intensities, for example -actin. In the case of L-selectin shedding, 
the intensity of the membrane-retained fragment, or “stump”, was normalized 
against total L-selectin: bands corresponding to both full-length L-selectin and 
“stump”. This normalisation is represented by “stump”/(“stump”+Full length).  
2.7 Lentiviral transduction and generation of stable cell lines  
2.7.1 Lentiviral production 
Lentivirus particles encoding L-selectin were produced using the packaging cell 
line HEK 293T.  For the generation of lentiviral particles HEK 293T cells were 
transfected with three plasmids; psPAX2 (packaging), pMD2.G (envelope) and 
pHR’SIN (carrying the gene of interest).  Prior to transfection HEK 293T cells 
were grown to ~80% confluence in a sterile T175 flask. On the day of transfection 
30g psPAX2, 40g pHR’SIN and 10g pMD2.G were mixed together with 4mL of 
OPTIMEM(GIBCO®, Invitrogen). In a separate tube another 4mL of OPTIMEM was 
mixed with 1L of 10mM polyethylene imine (PEI). The contents of the two tubes 
were then combined and left to incubate at RT for 15 minutes. HEK 293T culture 
media was aspirated and replaced with 8mL of transfection media and incubated 
for 4 hours under normal culture conditions, after which the transfection media 
was then replaced with 14mL of warmed fresh HEK 293T culture media.  HEK 
293T cell media was carefully harvested at 48 and 72 hours post-infection. Note 
that after the first harvest, 14mL of fresh HEK 239T culture media was added 
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back to the flask. The supernatants from both harvests, containing the lentiviral 
particles, were pooled, filter sterilised (0.45m) and stored at -80C.  
 
To concentrate the virus particles, the supernatants were thawed and 
ultracentrifuged (Sorvell® Discovery) for 2 hours (4C , 19,990rpm ). From each 
13.2 mL polyallomer ultracentrifuge tube (Beckman Coulter) the supernatant was 
carefully discarded and the pellet re-suspended in 50L of HL-60 culture media. 
All re-suspended pellets were pooled and incubated on ice for 50 minutes to 
ensure complete suspension of virus particles, after which the suspension was 
aliquoted into smaller volumes ~20 L to prevent excessive freeze thaw cycles. 
Each aliquot was stored at -80 C until further use.  
2.7.2 Estimating lentiviral titres 
In order to establish the viral titre (number of virus particles per mL), THP-1 cells 
were grown in a 24-well plate, at a density of 2x105 cells/well at day 0. THP-1 
cells were counted and transduced by adding increasing dilutions of the 
concentrated lentivirus, (10-5– 10-1) to a total volume of 200l (per well) HL-60 
cell culture media.  On day 2 an additional 200l HL-60 cell culture media was 
added to each well. On day 4, cells were collected and GFP expression levels 
monitored through FACSCalibur flow cytometer (BD Biosciences).  The 
percentage of GFP positive cells was plotted against the lentiviral particle 
concentrate added.  This was then used to determine a concentration of lentivirus 
that infected no more than 25% of the THP-1 population within the well. This low 
infection percentage would lower the risk of multiple insertions within the 
genome.  
Titres and MOI were calculated according to the following equations:   
 
a)    T=((PXN)/(DXV)) 
b)    MOI= VT/N 
 
Where: (a) T = titre, P =number of GFP positive cells, D = dilution and V = volume,  
(b) MOI = multiplicity of infection, V = volume of lentivirus required, T= titre, N= 





Volume of concentrated virus used for the generation of a stable cell line was 
found on the basis of titre and desired multiplicity of infection (MOI).   
Below is a table highlighting the titres used within this thesis to generate the HL-
60 cell lines stably expressing L-selectin-GFP (table 2.4). These viruses, with the 
exception of MN SSAA GFP, had been previously made, and titres quantified, by a 
previous PhD student in the Ivetic lab - Karolina Rzeniewicz. I generated the MN 
SSAA GFP virus, as the viral stock had previously run out.  
 
 
Table 2.4: Virus titres and MOI used for cell line generation 
 
2.7.3 Lentiviral infection of HL-60 cells  
One day prior to transduction, HL-60 cells were passaged to a density of 0.5 x 106 
cells/mL, to ensure cells were in log phasic growth. The following day cells were 
enumerated and 1 million cells re-suspended to 0.5x106 cells/mL in HL-60 culture 
media, lentiviral particles were added. The volume of lentiviral particles to add 
was calculated using viral titre and desired multiplicity of infection. Transduced 
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cells were stored at 37C and 5% C02; cells were supplemented with fresh media 
24 hours after transduction, and then passaged as normal (section 2.3.1).  
2.7.4 FACS sorting  
All cells were sorted using a FACSAria II cell sorter housed within King’s College 
London’s Biomedical Research Centre. Cells were sorted to match the expression 
of their WT/control counterpart to ensure the tagged protein level remained 
similar for each cell line.  
2.8 Confocal microscopy  
2.8.1 Equipment 
Unless stated otherwise confocal images were acquired using the Leica TCS SP5 
confocal microscope (Leica Microsystems,Germany). GFP was excited at λ = 488 
nm with an Argon laser, whereas TRITC-phalloidin and AlexaFluor®633 were 
excited with Helium Neon lasers at λ = 543/568 and 633 nm, respectively. 
AlexaFluor®405 and DAPI (4',6-diamidino-2- phenylindole) were excited at λ = 
405 using a UV laser line. Images were acquired using LAS AF software (Leica 
Microsystems, Germany). Images were acquired at 1024 x 1024 pixels with a 16-
bit resolution at a frequency of 400Hz and 32 line averages.  
2.8.2 Cell fixation and labelling procedures  
For visualization of L-selectin in primary neutrophils or HL-60 cells, specimens 
were fixed in 4% PFA (w/v) in PBS for 20 minutes at RT and washed 3 times in 
PBS.  It is important to note that washes were conducted with extreme care with 
respect to the troughs in the 3D devices, as the fixed specimen was highly 
susceptible to disintegrate through harsh pipette action. Coverslips or 3D devices 
were incubated with 0.1 % (v/v) ice cold Nonident P-40 (NP40) 
(FlukaBioChemika) in PBS for 3 minutes to permeabilise the leukocytes and 
HUVEC plasma membranes. Coverslips and 3D devices were then subjected to 
three short PBS washes, then blocked in 33%(v/v) FCS in PBS for 30 minutes at 
RT. The appropriate primary antibody/ies concentration/s can be found in table 
2.2 and table 2.3. To visualise actin, either TRITC or FITC conjugated phalloidin 
was used at a dilution of 1:300 (table 2.1). Block solution (33%FCS in PBS) was 
supplemented with Fc receptor block (1:100 (v/v) dilution). Fc receptor block 
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ensures that the Fc region of an antibody does not react with Fc receptor on the 
neutrophil plasma membrane. Samples were stained overnight at 4 C. The 
following day coverslips or 3D devices were washed 3 times in PBS and incubated 
in the above blocking solution with the appropriate fluorescently conjugated 
secondary antibody. Again, secondary antibodies (see table 2.3 for correct 
concentration/s) were incubated in block solution containing 1:100 (v/v) Fc 
receptor block. Following an overnight incubation in the dark at 4C, samples 
were washed three times in PBS. Coverslips were mounted onto a microscope 
slide using the mountant DAKO, which preserves the fluorescent signals from the 
immunostaining process. In order to prevent collagen dehydration a square glass 
cover slip was placed on top of the trough to act as a lid, fluorescent mountant 
was used the seal the PDMS and glass interface. Both coverslips and 3D devices 
were stored at 4C prior to imaging, ensuring the stability/longevity of the 
samples.  
2.8.4 Analysis of GFP and LAM1-14 positive “spots”  
Neutrophils were perfused over TNF- activated HUVEC as described in section 
2.5.1. TRITC-phalloidin labelling enabled visualisation of HUVEC actin cables and 
VE-cadherin marked adjoining endothelial adherens junctions. Disruption of this 
junctional marker denotes a breach in the endothelial monolayer and signifies 
bona fide paracellular TEM, as opposed to transcellular TEM. Single z-plane 
images were acquired with a Leica TCS SP5 confocal microscope. Images were 
acquired using a 63X oil immersion objective. To ensure high quality images line 
averages of 32 and a line scan speed of 200Hz was used. L-selectin rich areas was 
defined through either the GFP signal or LAM1-14 antibody binding to L-selectin 
EGF domain. Analysis was performed using the Volocity (PerkinElmer), “find 
spots” tool.  HL-60 cells transduced with GFP alone was used to threshold spot 
area in HL-60 cells stably expressing L-selectin-GFP.  
2.8.5 Morphology analysis  
Images of fully transmigrated neutrophils acquired by confocal microscopy and 
stored in Leica-based Liff files were imported into the open licence software Fiji. 






ratio obtained. Cells were traced using the outline of the cell cortex (established 
by phalloidin labelling).  
Circularity ratio: 4 𝜋((𝜋𝑟2)/(2𝜋𝑟)2 ) 
 
This ratio is set between 1 and 0, where 1 is “a perfect circle”. As the value 
becomes closer to zero, the shape will increase disproportionally in one axis and 
result in irregular or elongated morphologies. For each cell line, fifteen cells were 
analysed for each experimental repeat, a total of three repeats were conducted for 
this analysis.  
2.8.6 Subcellular localisation of L-selectin  
 HL-60 cells chemotaxing on fibronectin-coated 2D substrates were analysed for 
the subcellular distribution of WT or mutant forms of L-selectin-GFP.  Images 
were captured using differential interference contrast (DIC) and 488nm 
excitation. A line 30-pixels wide was drawn through the front-back of a clearly 
polarised cell; using the line profiler in Fiji, DIC determined the front-back cellular 
extremities. Greyscale values along the line profile for the green channel 
(corresponding to the GFP signal) was obtained, and internally normalised for 
each cell. An in-house MATLAB code was written to “stretch” each data set to 
account for differences in cell length, which allows all data to become 
superimposed and accurately averaged. All line profiles were “stretched” to 100 
pixels in length, for example if a cell was 50 pixels in length through the front-
back line the code “stretches” the data to form 100 pixels while still maintaining 
the original GFP intensity profile. The code uses interpolation as it creates new 
data points in between existing data points.  
2.9 L-selectin shedding assays 
2.9.1 Monitoring L-selectin shedding from cell suspensions  
Primary Neutrophils and HL-60s were stimulated with PMA or various 
chemoattractants in 10% (v/v) FCS in Hanks buffered saline solution at 37C. For 
each experiment, 200,000 cells were incubated in HL-60 culture media 
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supplemented with one of the above stimuli, and left at 37C and 5% CO2 for 
30minutes. Cells were then centrifuged, the supernatant aspirated and placed on 
ice. Cells were then prepared for FACs as described in section 2.4.2. Experiments 
were conducted on three days, each day carried out in triplicate to ensure 
accuracy.  
2.9.2 Monitoring L-selectin shedding in neutrophil/HUVEC co-cultures 
Confluent HUVEC monolayers were grown in 6 well plates and activated with 
10ng/ml TNF-. Cells (2x106 million) were added to each plate and incubated for 
45 minutes. Each plate was gently washed with pre-warmed cell media to remove 
any unbound leukocytes. Extracts were harvested and resolved on 
polyacrylamide gels for Western blot analysis (section 2.6).   
2.10 Micropipette chemotaxis assays  
Micropipette assays were employed to monitor chemotaxis and cellular 
behaviour of leukocytes challenged with a single gradient of chemoattractant 
(figure 2.3). Glass-bottomed dishes (5 cm in diameter) were coated with 5 g/mL 
of fibronectin (diluted in PBS) and left to incubate for 1 hour at 37 °C. Excess 
fibronectin was removed through two rounds of aspiration and PBS washes. 
Before the addition of cells, dishes were further incubated in imaging media (PBS 
containing calcium and magnesium supplemented with 1% FBS, penicillin/ 
streptomycin, 1 mg/mL BSA) to block nonspecific binding of cells to the glass 
bottoms. Cells were seeded at a density of 1 × 106 cells/mL in warm imaging 
media and left to adhere for 30 min at 37 °C. Excess unbound cells were removed 
before imaging. All experiments were conducted at 37 °C and performed within 1 
hour. Micropipettes were manufactured in-house. Borosilicate glass capillaries 
with an inner diameter of 0.5 mm were pulled using a P-97 Flaming/Brown 
micropipette puller (Sutter Instrument Company). Pipettes were pulled using the 
following parameters: heat = 500, pull = 500, velocity = 30, and time = 250. The 
micropipette was attached to a pressure system (Narishige IM300 microinjector 
(0.7 psi)). Avoiding air bubbles, the pipette tip was filled with the desired 
chemoattractant diluted in imaging media supplemented with a 10kDa TRITC-
dextran tracer to observe gradient formation. Note that the average molecular 


















Figure 2.3:  The micropipette set-up 
The sample, in an open top glass dish is placed into a heated stage unit; a pressurised needle 
housing the glass capillary micropipette chemoattractant-filled tip is placed into the glass dish. 
The tip can be manipulated in X, Y and Z-axes with both coarse and fine movements. Cell migration 
behaviour is captured by the use of an inverted microscope objective lens. 
 
2.11 Microfluidic 2D device  
The design and fabrication (photolithography and soft lithography) are discussed 
in detailed in section 4.1.2.   
2.11.1 Gradient generation  
Gradients were established using the Fluigent system (MFCS-8C). The 
microfluidic flow rate controller allows a stable and continuous free flow from 8 
independently controlled outlets, which uses positive pressures ranging from 0 to 
1000mbar. Fluigent allows control over multiples inlets simultaneously, a great 
advantage over the syringe pump. Gradients were visualised using fluorescently 




 2.11.2 Cell seeding  
The device was filled with 30g/mL fibronectin for HL-60 cell seeding. The 
fibronectin in the device was incubated for 1 hour at 37C. PBS was then flushed 
through to remove excess fibronectin. Particular attention was paid to remove all 
bubbles from the microchannels. Cells were seeded through the open inlet and 
unbound cells left through the opposite outlet; cells were left to adhere for 20 
minutes at 37C. During this time all inlets and outlets are sealed to prevent 
internal fluid movement. For information on cell streaming to correctly position 
cells in the middle of the main channel see section 4.1.4.  
 
2.12 Microfluidic 3D device  
The design and fabrication (photolithography and soft lithography) are discussed 
in detailed in section 4.2.2. 
2.12.1 Collagen imaging  
Rat tail type 1A collagen (Cellmatrix, Nitta gelatin Inc, Japan) was reconstituted on 
ice to prevent premature gel polymerisation in the following (v/v) proportions: 4 
parts collagen; 2 parts 5X DMEM (PAA, Colbe, Germany); 1 part sterile 
reconstitution buffer made up to a total of 120mL (2.2gNaHCO3 (0.2M) in 100mL 
of 0.05N NaOH and 200mM Hepes) and 1 part HL-60 culture media, this 
formulation would provide a protein concentration of 2.5 mg/mL.  Culture media 
volume was adjusted in optimisation experiments when varying the total collagen 
concentration see section4.2.4.  The reconstituted collagen solution was 
deposited within the PDMS bespoke cut trough and left within a humidified sterile 
environment at 37C to polymerise for 30 minutes. Successful collagen 
polymerisation was assessed through light microscopy through the presence of 
collagen fibres.  To assess collagen fibre heterogeneity and collagen depth within 
the 3D device reflective confocal imaging was adopted, first reported by the lab of 
Voytik-Harbin (307). Briefly, the microscope parameter settings are readjusted so 
the emission spectrum is lowered to around the same wavelength range as its 










2.12.2 HUVEC seeding 
Although PDMS has major advantages, e.g. similar reflective index to glass and 
biocompatibility, it does have some disadvantages; it is hydrophobic and has low 
adhesive properties for cell attachment.  To overcome this the glass (bottom of 
the 3D device was pre-coated with poly-L-lysine (PLL) treatment for 20 minutes 
after which the polymer polydimethylsiloxane (PDMS) was subjected to oxygen 
plasma for 2 minutes.  The troughs were then pre-chilled on ice, after which 30L 
of reconstituted collagen (section 2.12.1) was carefully placed into the centre of 
the trough and a tilting motion was used to gently cover all the glass surface area. 
The device was then placed into a 14 cm dish, which was placed into a cell culture 
incubator for 45 minutes.  To minimise a collagen meniscus being formed, a 
hydrophobic pen outlined the PDMS edges of trough prior to collagen addition. 
Once set, the collagen was inspected visually and devices with concave or convex 
menisci, or devices where the collagen had pulled away from the sides of the 
PDMS trough were discarded. Where successful collagen polymerisation was 
achieved, HUVEC were thawed and immediately seeded on to the collagen bed. 
Approximately half a million cells were added to each (2.3 cm x 0.5 cm) 
rectangular trough; a confluent monolayer was achieved 24 hours post-seeding. 
Prior to any flow assay, HUVEC were stimulated overnight with 10 ng/ml TNF-.  
2.12.3 Optimisation procedure for gradient formation in the 3D device 
Gradients were generated using a 10,000 Da fluorescently labelled dextran. The 
movement of this polysaccharide through the microfluidic channels and the 
polymerised collagen scaffold mimics the diffusion of most chemokines, which are 
of comparable molecular weights (8-10kDa). Gradients were established using a 
Harvard syringe pump. To visualise the establishment of diffusion gradient across 
the collagen scaffold over time, a single Z line scan was taken every minute. The Z 
line scan was imaged using an inverted scanning confocal microscope (FV1000 
confocal head-Olympus) with a 10x objective lens.  Diffusion gradients were left 
to establish for 1 hour and imaging was acquired in a heated chamber set at 37 C. 
Gradients were analysed using the line profiler plugin in the image analysis 




over 30 pixels.  More information regarding gradient generation and analysis can 
be found in section 4.2.7.  
2.12.4 Static transmigration assays using 3D devices 
Rectangular troughs were cut from cured PDMS, and plasma bonded to cleaned 
glass coverslips, 5 cm in diameter.  For every trough, 50L of Rat-tail collagen 
type 1A was dispensed and allowed to polymerise for 30 minutes at 37C. Once 
set, the collagen acted as a solid support for the establishment of activated HUVEC 
monolayers. All leukocytes were labelled with 1M CellTracker (Molecular 
Probes, Life Technologies) for 10 minutes at 37C in RPMI containing no FCS only 
25mM Hepes(pH 7.3) Labelled cells were harvested by centrifugation and re-
suspended at 0.5 x106 cells/mL in culture medium. 0.5 x106 cells were added per 
trough and left for 1 or 4 hours, after which the assay was stopped, washed and 
preserved by fixation in 4% paraformaldehyde (made up in PBS). In TAPI-0-
treated experiments, neutrophils were pre-incubated for 20 minutes with 10M 
TAPI-0 prior to cell labelling. In these assays the HUVEC were also treated with 
10M TAPI-0 20 minutes prior to neutrophil addition. TAPI-0 also remained 
present within the culture medium at 10 M for the duration of the experiment.  
When HL-60 cells were co-introduced on an activated endothelium, each cell line 
was uniquely stained with cell tracker dyes. To avoid bias and overcome any 
adverse effect of dye loading on cell behaviour, dyes were exchanged sequentially 
between lines and experiments. 
2.12.5 Measuring leukocyte invasion post-transmigration 
In order to measure the extent of invasion post-transmigration, 
paraformaldehyde-fixed 3D devices (described in chapter 5 ) were imaged using 
an inverted spinning disk confocal (Yokagawa). A 30x objective was used and 
fields of view were selected on the basis of an intact endothelial monolayer and 
proximity to the chemoattractant source. Laser excitement at 488nm, 543nm and 
633nm was used to specifically discriminate between cell lines that were co-
perfused. Multiple fields of view were imaged per trough (n=1). FITC-phalloidin 
staining was used to identify HUVEC monolayers, which possess characteristically 
large cable-like stress fibres. A total of 200 x 1 micron-thick Z-slices were taken 





collagen trough was manually enumerated, using a 16-colour heat map (Fiji); 
leukocytes in focus become labelled with a representative “hotter” colour. 
Neutrophils were enumerated in 10m steps, downward from the HUVEC 
monolayer. For a more detailed description of the post acquisition analysis see 
chapter 5. 
2.13 Statistical analysis   
All quantified data was evaluated using the statistical analysis package GraphPad 
Prism. Significance was determined using unpaired Student t-tests, Mann 
Whitney tests and one-way ANOVA followed by either Dunnett’s or Tukey’s post 
test. Data was deemed significant when p<0.05. Both the unpaired Student t test 
and one-way ANOVA are parametric tests; these statistical models assume that 
data follows a probability distribution with a fixed set of parameters. T tests were 
used to compare means from two samples, while the one-way ANOVA with 
appropriate post test was used to compare means from more than two samples. 
Unlike Student t-test the Mann Whitney test does not assume a normal 


























3. Establishing a cellular model to understand the importance 
of L-selectin shedding in regulating neutrophil migratory 
behaviour. 
 
3.1 Biological rationale  
Recently, L-selectin shedding has been shown to occur specifically during TEM in 
primary human monocytes(212). Blocking L-selectin shedding induced dramatic 
effects on cell polarity and chemotaxis (see section1.12).  The primary aim of this 
chapter was to determine if L-selectin shedding occurred during primary human 
neutrophils TEM, and, if so, does blocking L-selectin shedding alter cell polarity 
and migration during either transendothelial migration or chemotaxis within the 
subendothelial space. 
 
This study employed the use of primary neutrophils and HL-60 neutrophil-like 
cell lines. To investigate L-selectin shedding in primary neutrophils, cells were 
incubated with 10 M TAPI-0 (which is: TNF- protease inhibitor) a known 
inhibitor of ADAM17, previously shown to block L-selectin shedding in 
monocytes. The cell line chosen for this study is an immortalised cell line, HL-60, 
derived from human promyelocytic leukaemia cells. HL-60 cells are routinely 
used in leukocyte research, importantly in migration assays (308)(309). Crucially, 
DMSO differentiated HL-60 cells do not express any detectable levels of 
endogenous L-selectin. This fact allows direct comparisons between cell lines 
expressing WT and mutant forms of L-selectin. In order to mimic all stages of the 
leukocyte adhesion cascade it was paramount that the leukocyte underwent full 
transendothelial migration, this was achieved through overexpression of 
chemokine C-X-C receptor 2 (CXCR2) in the HL-60 cells. With primary 
neutrophils, L-selectin could not be engineered as a GFP fusion and so was 
visualised using the mAb LAM1-14. LAM1-14 detects L-selectin at the EGF-like 
domain a region that is above the cleavage site, meaning that only the full-length 
form can be detected.  
 





Four L-selectin constructs, (WT, MN, MNSSAA and MNSSDD) were virally 
transduced into the HL-60 cells.  All these L-selectin molecules were C-terminally 
tagged with GFP to allow real time visualisation of the molecule. Given the relative 
size of GFP (238 amino acids) compared to the shed form (cytoplasmic 
tail+transmembrane domain alone) of L-selectin (17 amino acids), previous 
studies were carried out to establish the tag exhibited no adverse effects on L-
selectin expression form and function(212). These control experiments were 
conducted in THP1 cells by Karolina Rzeniewicz a past PhD student (212). The 
genetic “sheddase resistant” mutant of L-selectin was generated through an eight 
amino acid deletion, (MIKEGDYN) below the proximal cleavage site, rendering 
the site unrecognisable to cleavage enzymes. This mutation shall be termed MN 
for simplicity.  To verify L-selectin’s contribution towards any observed 
phenotypes, cells were transduced with GFP alone for direct comparison.  
 
To dissect the molecular mechanisms governing the phenotypes observed from 
blocking L-selectin shedding, sheddase resistant cells (MN) harbouring 
substitution mutations in both the serine residues of the cytoplasmic tail were 
generated. Here, the serines, (S364, S367), were converted to either alanines (A) 
or aspartates (D), to mimic serines in a permanently phospho-dead or phospho-
active form, respectively.  
Finally, L-selectin shedding was assessed in response to either end-stage or 
intermediary chemoattractants.  
3.2 Results  
3.2.1 Primary human neutrophils undergo L-selectin shedding during 
transendothelial migration (TEM) 
Previous reports have stated that neutrophils undergo L-selectin shedding during 
the firm adhesion phase of the multi-step adhesion cascade. The Ivetic lab 
recently showed that L-selectin shedding in CD14-positive primary human 
monocytes underwent L-selectin shedding specifically during TEM and not before 
(212). To determine if this phenomenon also applies to primary human 






-activated HUVEC monolayers for 30 minutes. In parallel experiments where L-
selectin shedding was blocked, neutrophils were pre-incubated with 10 M TAPI-
0. This inhibitor was supplemented in the perfusion media throughout the flow 
assay to ensure that its effect lasted during the entire perfusion experiment. After 
each flow assay, all specimens were fixed in 4% paraformaldehyde and analysed 
by laser scanning confocal microscopy. In experiments where the carrier, 
dimethyl sulfoxide (DMSO), was used, neutrophils that underwent full (or 
complete) TEM (fTEM) were virtually all L-selectin negative (figure 3.1).  This 
observation was reversed when flow experiments were supplemented with TAPI-
0 (figure 3.1). To ensure that the endothelial monolayer was intact in all 
experiments, junctional staining of F-actin and VE-cadherin was used to detect 
actin cables and endothelial junctions, respectively.  
Figure 3.1: L-selectin shedding occurs during transendothelial migration 
Primary human neutrophils were perfused over TNF-activated HUVEC for 30 min. Flow assays 
were supplemented with either 10 M TAPI-0 (to block L-selectin shedding) or DMSO carrier 
alone. Specimens were fixed with 4% (w/v) PFA, permeabilised and stained with LAM1-14-488, 
TRITC-phalloidin and VE-Cadherin-633 to visualise L-selectin, F-actin and endothelial junctions, 
respectively. Instrument parameter settings remained unchanged during acquisitions. Confocal 
images were acquired with a 63x oil immersion lens. Scale bar = 24m. Red arrows indicate cells 
that have undergone complete TEM, e.g. fTEM cells.  
 
To quantify the fluorescent signal corresponding to L-selectin signal at the plasma 
membrane, a line profile was drawn along the longest axis of the cell, (figure 3.2 
A). The phalloidin signal was used as a guide for the plasma membrane to 
accurately define the beginning and ending of the cell. This was particularly 
important in the situation where TAPI-0 was not used and the L-selectin signal 























was minimal. Fluorescence intensities from the peripheral LAM1-14 signal were 
outputted as greyscale values (figure 3.2 B).  
 
Greyscale is an image that represents black and white shades, producing a 
combination of levels, 0=black and 255=white, the range between is a continuous 
spectrum of grey shades. Thus the higher the greyscale value the higher the 
fluorescence signal intensity. To directly compare greyscale values between cells, 
imaging parameters and microscope setting remained constant. Greyscale values 
for the first three and last three pixels in the line profile for each cell were taken 
as the plasma membrane (PM) (figure3.2 A&B). Care was taken to only include 
cells, which had undergone complete transmigration; this was achieved through 
taking confocal z-slices 1m above and below the endothelium. Fully 
transmigrated cells were only in focus below the endothelium.  
 
A total of 80 cells were counted for each condition, TAPI-0 treated cells registered 
a mean greyscale value at the PM of 115.3 +/- 4.18, while DMSO control cells had 
a mean grey scale value of 14.22 +/- 0.90 (figure 3.2 B).  The percentage of cells 
with a positive L-selectin signal at the PM in fTEM was enumerated: 10.03% +/- 
3.303 and 95.31% +/-2.259 for DMSO treated and TAPI-0 treated cells, 
respectively (figure 3.2 C). Given that ~10% of the fTEM DMSO-treated 
neutrophils remained L-selectin positive suggests that the isolation was not 100% 
pure; basophil and eosinophil contaminations could explain the remaining DMSO 
treated L-selectin positive fTEM cell (figure 3.2 C). 
 
To elucidate whether L-selectin is shed prior, during, or after TEM, primary 
neutrophils were continuously perfused over TNF- activated HUVEC for 15 
minutes, to capture a higher percentage of cells in mid-TEM (referred to as 
mTEM). Perfusion assays were performed as described in, (section 2.5.1) and 
samples were prepared for confocal microscopy as described in (section 2.8.2). 
Again, line profile analysis was conducted to quantify the signal corresponding to 
L-selectin, as described above.  Line profiles were performed on non-
transmigrated and transmigrated parts of the same DMSO treated cell caught in 
mTEM, these cells were compared against TAPI-0 treated fTEM cells (figure 3.3). 
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Again, to allow direct comparisons of greyscale values microscope parameters 
and setting were kept constant. 
 
 
Figure 3.2: Quantifying L-selectin shedding in transmigrated neutrophils 
A) A schematic to represent L-selectin signal distribution at the plasma membrane within a DMSO 
or TAPI-0 treated cell of the same dimensions. Line profiles where the L-selectin signal is 
internally normalised for each cell. A line profile is taken along the front-rear axis of the cell and 
the plasma membrane is defined as the intensity values for the first three and last three pixels of 
the line. B) Averaged greyscale value at the plasma membrane (PM), each value at the plasma 
membrane represents 3 pixels averaged. A total of 80 cells were analysed per condition. Error 
bars represent standard error of the mean, TAPI-0; 115 +/- 4.18, DMSO; 14.22 +/- 0.90. The 
statistical test conducted was a two-tailed unpaired t-test, **** p<0.0001. C) Percentage of 
transmigrated cell with L-selectin present at the PM. A total of 80 cells were analysed per 
condition. Error bars represent standard error of the mean. Student t test was conducted, **** 
p<0.0001. Three separate experiments conducted.  
 
Mean greyscale values for the transmigrated (“Bottom”), 116.7 +/- 4.606, and 
non-transmigrated (“Top”), 84.31 +/- 4.36, parts of the neutrophil suggests that L-
selectin shedding is triggered either: (i) upon neutrophil contact with receptors 
on the endothelial abluminal plasma membrane or (ii) ECM components (e.g. 
Biglycan) (figure 3.3 Bii). No significant difference in greyscale value was 
observed between the non-transmigrated parts of DMSO-treated neutrophils and 
TAPI-0-treated neutrophils that had undergone fTEM. This data strongly suggests 




























































































































































































































that little to no shedding occurs when neutrophils adhere to the apical aspect of 
the endothelium (figure 3.3 C).  In other words, this data strongly supports the 
notion that L-selectin shedding occurs within the sub-endothelial space of 
transmigrating neutrophils.  
 
Figure 3.3: L-selectin shedding is initiated in pseudopods entering the sub endothelial  
space 
Neutrophils were perfused over TNF-activated HUVEC for 15 min and subsequently fixed in 4% 
PFA to capture neutrophils in mTEM. A) Specimens were permeabilised and stained with LAM1-
14-488, TRITC-phalloidin and VE-Cadherin-633 to visualise full-length L-selectin, F-actin and 
endothelial junctions, respectively. Red arrow denotes where the continuity of the VE-cadherin 
signal has been breached, and represents bonafide TEM. Scale bar is 3m. Confocal images were 
acquired with a 63x oil immersion lens.  Bi) Schematic represents neutrophils  undergoing mTEM 
or fTEM. Line profiles (represented as black dotted lines) were drawn across the longest axis of 
the cross-sectional area of the cell. Bii) Quantification of greyscale values at the plasma membrane 
(PM) that correspond to the LAM1-14 L-selectin signal, where each value at the plasma membrane 
represents 3 averaged pixels. A total of 132, 112 and 96 cells were analysed for “top”, “bottom” 
and “fTEM” respectively. Error bar represents SEM.Top; 116.7 +/- 4.60, Bottom; 84.31 +/- 4.36 
and fTEM; 57.88 +/- 3.06. Statistical test; one-way ANOVA followed by Tukey’s multiple 
comparison test, **** p<0.0001, ** p <0.01. C) Quantification of signals corresponding to L-selectin 
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were compared between non-transmigrated DMSO-treated neutrophils and TAPI-0-treated 
neutrophils that had undergone fTEM. Averaged greyscale values corresponding to L-selectin at 
the plasma membrane (PM). Each value at the plasma membrane represents 3 pixels averaged. A 
total of 132 and 80 cells were analysed for DMSO (Top) and TAPI-0 (fTEM), respectively. Error 
bars represent standard error of the mean, TAPI-0; 115 +/- 4.18. Top; 116.7 +/- 4.60. Student t–
test was conducted, no statistical significance. Three separate experiments conducted on different 
days.  
 
3.2.2 Behavioural analysis of primary neutrophils perfused over TNF- activated 
HUVEC.  
 A previous study revealed that blocking L-selectin shedding with 30 M of the 
sheddase inhibitor, Ro 31-9790 had no effect on neutrophil adhesion and TEM 
(310). To interrogate the dynamic behaviour of primary human neutrophils 
perfused over TNF-activated HUVEC, and to determine if blocking L-selectin 
shedding influenced changes in cell behaviour, cells were subjected to 30 minutes 
of flow using the parallel plate flow chamber (see section 2.5.1). In short, a bolus 
(a single high density wave) of neutrophils was perfused over activated HUVEC 
for three minutes and perfusion with just media alone continued for a further 27 
minutes. In each field of view the percentage of neutrophils bound or fully 
transmigrated (fTEM) was quantified from the total number of recruited cells 
(TRC). Assessment of binding, crawling, mTEM and fTEM was monitored over a 
series of time points: 6 minutes, 10 minutes and 30 minutes. Once captured from 
flow, neutrophils typically remained bound before embarking TEM. In other 
words, little “crawling” behaviour was observed.  Figure 3.4, shows an image 
series of a neutrophil undergoing fTEM from capture. Fully transmigrated cells 
could be easily identified by their phase-dark appearance in the bright-field 
channel (figure 3.4). Interestingly, once neutrophils had undergone fTEM, they 
appeared to aggregate into “clusters”. This did not appear to be because 
neutrophils would preferentially transmigrate through “hotspots”. In support of 
this, as mentioned before, neutrophils would engage in very little crawling on top 
of the endothelial monolayer. 
 
Among all the time points analysed TAPI-0 pre-treatment of neutrophils led to no 
significant difference in the percentage of TEM at all three time points. At ten and 
30 minutes it appears that blocking L-selectin shedding marginally increases the 
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(figure 3.5). 
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“invasive potential” of neutrophils across activated endothelial cells, perhaps due 




Figure 3.4: Phase contrast image series of neutrophils accumulating into “clusters” within 
the sub endothelial space. 
Primary human neutrophils were perfused across a TNF--activated HUVEC. Phase contrast time-
lapse microscopy reveals that neutrophils bound to the apical aspect of the endothelium appear 
“phase-bright” (red circle) and those that have undergone fTEM appear “phase-dark” (blue circle). 
Over time, it was noticed that fTEM neutrophils would aggregate into “clusters” (broken blue 


































Figure 3.5: Addressing the impact of blocking L-selectin shedding on neutrophil TEM 
behaviour 
Primary neutrophils were perfused over TNF-activated HUVEC as a bolus for 3 minutes, followed 
by 27 minutes of culture media alone. Neutrophils were pre-treated with 10M TAPI-0 or DMSO 
carrier (control). Dynamics were recorded by time-lapse bright-field microscopy (10 x inverted 
objective lens) over the 30-minute period. Bound or fTEM neutrophils were scored at 6, 10 and 30 
minute time points as a percentage of the total cells recruited (TRC) in any given field of view 
(FOV). Experiments were conducted in triplicate with 3 FOV per repeat. A total of 343 and 321 
cells were scored for the TAPI-0 and DMSO condition, respectively. Error bars represent SEM and 
statistical significance was assessed through unpaired Student t-test, comparing different cell 
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3.2.3 Speed of neutrophil transmigration across TNF-activated HUVEC and within 
the sub endothelial space 
To address this aspect more closely, primary human neutrophils were monitored 
from the moment of capture up until fTEM.  The average rate (in minutes) of TEM 
was astonishingly fast: 2.21 +/- 0.11 and 2.11+/- 0.10 in DMSO and TAPI-0 
treated cells respectively, indicating that preventing L-selectin shedding does not 
regulate the actual TEM times (figure 3.6 A).  
 
To determine if blocking L-selectin shedding impacts neutrophil locomotion 
beneath the endothelium, fTEM neutrophils were manually tracked so that their 
average speeds could be quantified. Directionality and speed was deciphered 
using a free access excel macro, DIPER (306). To ensure speed did not bias the 
directionality ratio, cells were all tracked for a fifteen minute time period. 
Directionality ratio or straightness ratio; is defined as the straight distance 
between the start and end point of a cell’s journey, divided by the length of the 
actual journey. A cell with a high directional persistence of migration will have a 
directionality ratio close to 1, while an undirected cell will have a directionality 
ratio close to 0.  
 
As mentioned before, fTEM neutrophils migrating within the sub endothelial 
space aggregated to form large clusters of cells, between 5-30 cells large, (figure 
3.4). Within these clusters, TAPI-0 treated cells appeared disoriented, switching 
front–back polarity rapidly, which is reflected in the directionality scores. 
Although clusters of neutrophils have been observed in vivo (termed “neutrophil 
swarming”) it is not clear what is driving the phenomenon in these flow chamber 
assays (311). TAPI-0 treatment affected cell speed; averaged cell speed was 1.57 
m/min +/- 0.02, compared to DMSO treated cell, 1.92m/min +/- 0.03 (figure 
3.6 B). Directionality was significantly impaired in TAPI-0 treated cells; with 
average directionality ratio for DMSO and TAPI-0 treated cells was 0.197 +/- 0.01 
and 0.15+/- 0.01,respectively (figure 3.6 C). 
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Figure 3.6: Blocking L-selectin shedding negatively impacts cell speed and directionality in 
fTEM neutrophils 
A) Primary human neutrophils were perfused over a TNF--activated HUVEC and recorded using 
a 10x inverted objective lens. To avoid bias, three fields of view were selected before perfusion of 
neutrophils, which were conducted in triplicate on separate days. The rate of TEM was calculated 
as the time taken from initial capture to fTEM.  At least 80 cells were scored for each condition. 
Student t-test carried out. B&C) Over 250 fTEM cells were tracked for 15 minutes for each 
condition over three separate experiments. B) Student t-test, **** p<0.0001 C): Mann- Whitney 
test, **p<0.01  
3.2.4 Monitoring the impact of blocking L-selectin shedding on neutrophil 
morphology within the sub endothelial space 
Cell polarity is an essential prerequisite for neutrophil effector responses. In 
other words, if neutrophils cannot reach their target sites, they are unlikely to 
execute their effector functions such as: degranulation, phagocytosis and NETosis. 
As mentioned previously, directionality was dramatically hindered when cells 
were exposed to TAPI-0. These results match what is seen in primary human 
monocytes (212). To determine if blocking L-selectin shedding in neutrophils also 
impacted cell morphology, primary human neutrophils were perfused over TNF-




Specimens were stained for phalloidin to stain the actin-based cytoskeleton. Thin 
(0.75 micron) optical z-sections were acquired by confocal microscopy and the 
perimeter of neutrophils was traced using a free-hand line tool from Fiji 
(freeware post-acquisition analysis tool), using the actin cortex as a marker for 
the cell periphery (figure 3.7 A).  No differences in cell area were observed in 
DMSO and TAPI-0 treated cells with respective cell areas of: 198 m2 +/- 3.64 and 
200 m2 +/- 3.77, suggesting blocking L-selectin does not effect cell spreading 
(figure 3.7 B). To compare cell polarisation, the circularity ratio was quantified 
(see section 2.8.5). Note that the closer to 1 the circularity ratio is, the more 
circular the object. Typically, TAPI-0-treated neutrophils possessed “rougher” 
undulating cell edges, and were elongated in shape with no obvious “front” or 
“back” (see upper panel in (figure 3.7 A). Quantification of the circulatory ratio 
was significantly different between groups: 0.66 +/- 0.01 for TAPI-0-treated cells 
and 0.72 +/- 0.01 for DMSO-treated cells (figure 3.7 C). This data further confirms 
that blocking L-selectin shedding in neutrophils impacts their polarity once 










Figure 3.7: Impact of blocking L-selectin shedding on the cross-sectional area and 
circularity ratio fTEM neutrophils.  
Primary neutrophils were perfused over a TNF--activated HUVEC for 30 minutes and 
subsequently fixed in 4% PFA treatment. The specimen was stained with phalloidin to visualise F-
actin. Single z-plane images were acquired by confocal microscopy and cell size parameters 
measured by using the free hand drawing tool, Fiji. A) Cells were individually traced, using the 
phalloidin signal as a marker of its cellular boundary. B&C) 65 cells were scored for each 
condition. Error bars represent standard error of the mean. An unpaired Students t-test 
conducted. * p <0.05.  Scale bar is 24m. 
 
3.2.5 Monitoring the sub-cellular distribution of L-selectin in fTEM primary 
neutrophils  
It is possible that the defects in neutrophil directionality and polarity that are 
impacted by TAPI-0 treatment could be due to altered sub-cellular distribution of 
L-selectin. Confocal microscopy was therefore used to monitor the subcellular 
distribution corresponding to LAM1-14 staining. It should be noted that LAM1-14 
detects L-selectin at the EGF-like domain, meaning that only the full-length form 
is detected in this approach. PFA-fixed samples were processed as described in 
section 2.8.2 and stained with LAM1-14-488 and TRITC phalloidin. L-selectin 
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“spots” were seen in fTEM cells in both TAPI-0 and DMSO treated cells (figure 3.8 
A). Spots were determined by using a size thresholding tool in Fiji, excluding 
spots smaller than 0.1m; below this size differentiation between a spot and 
background noise could not be obtained. The number of spots per cell and spot 
area were enumerated. No statistical differences in spot number or size could be 
detected between the treatment groups (figure 3.8 B&C). The function of the 
spots could not be elucidated through this assay. L-selectin is known to have 
multiple ligands within the sub-endothelium, binding to which could promote L-
selectin clustering and subsequent spot formation. Indeed, the heparan sulphate 
proteoglycan, biglycan, has been recently shown to be enriched in the basolateral 
aspect of the endothelium and drive L-selectin clustering in the pseudopods of 





Figure 3.8:  Organisation of L-selectin “spots” in fTEM neutrophils is not affected by TAPI-0. 
A) Primary neutrophils were perfused over a TNF- activated HUVEC, for 30 minutes, fixed in 4% 
PFA. F-actin was stained with TRITC-phalloidin and LAM1-14-488.  Single z-plane images were 
acquired by confocal microscopy; spots were isolated using the “find spot” tool in Volocity. B &C) 
Between 12-15 cells were scored for each condition, monitored over 3 repeats. Unpaired Student 
t-test was conducted, but no statistical significance found.  Scale bar is 3m. Error bars represent 
























































































































3.2.6 Generation of an HL-60 cell line to study the contribution of L-selectin 
shedding in regulating neutrophil migratory behavior 
A major aim of this section was to generate a cell line that was genetically 
tractable, which is impossible to undertake in primary human neutrophils. 
However, it was important to understand beforehand how primary human 
neutrophil migratory behaviour is affected in the context of blocking L-selectin 
shedding. Primary neutrophils, although informative, have limitations in what 
they can be subjected to. All of the studies above have so far used the sheddase 
inhibitor, TAPI-0, which does not exclusively block L-selectin shedding. The 
sheddase that TAPI-0 targets at 10 M, ADAM17, has many other substrates (e.g. 
TNF and the  subunit of the integrin LFA-1)(312)(313)(314). It is therefore 
difficult to assign any of the phenotypes that have shown significance between the 
TAPI-0 and DMSO treatment groups as being exclusively due to the blockade of L-
selectin shedding. To ratify the phenotypes observed in primary human 
neutrophils it was important to generate a human neutrophil cell line, in which 
molecular mechanisms could be probed at the genetic level. Importantly, L-
selectin is not expressed in HL-60 cells unless transiently stimulated with retinoic 
acid (personal communication: Dr. Alun Brown, KCL). This made investigating the 
contribution of mutant forms of L-selectin easy to compare with WT. In previous 
work from the Ivetic group, tagging L-selectin with Green Fluorescent Protein 
(GFP) did not affect L-selectin-dependent adhesion, shedding and interaction with 
ERM and calmodulin – two known binding partners of L-selectin(315)(212).To 
this end HL-60 cells were transduced with lentiviral constructs, containing either 
GFP alone (as a control), WT L-selectin-GFP, or a non-cleavable form of L-selectin 
called MN–GFP. MN refers to the 8 amino acids that have been deleted between 
the cleavage site and the amino acid closest to the extracellular face of the plasma 
membrane (NH2-MIKEGDYN-COOH). For a detailed description of generation of 
lentiviral particles and the MOI used for each cell line, see section 2.7.The newly 
generated cell lines were FACs sorted to ensure protein levels were matched 
between cell lines, and to also remove contaminating non-fluorescent cells.  After 
sorting, GFP-positive cells were above 98% for all cell lines, which were 




 Quantification of GFP intensities for WT L-selectin-GFP and MN L-selectin-GFP 
cell lines were comparable: 19274 (A.U) and 21082(A.U.), with no significant 
differences (figure 3.9). However, HL60 cells expressing GFP alone cells 
expressed over a 3-fold increase in fluorescence intensity: 72521(A.U) (figure 
3.9). The HL-60 cell lines WT L-selectin–GFP, MN L-selectin–GFP and GFP alone 

















Figure 3.9:  Fluorescence intensity measurements of GFP in HL-60 cell lines 
Post-sorting, HL-60 cells expressing WT, MN or GFP were subjected to flow cytometry to monitor 
GFP intensity values. Each cell line was investigated on three separate occasions. A) 
Representative histogram. B) Quantification, one-way ANOVA, followed by Tukey’s multiply 
comparisons test. *** p<0.001, **p<0.01.  
 
3.2.7 Differentiation of HL-60 cells with DMSO 
To terminally differentiate HL-60 cells into a neutrophil like phenotype, 1.3% 
(v/v) DMSO was added to HL-60 media for 4-5 days prior to experimentation. 
Differentiated cells are phenotypically unique to their undifferentiated 
counterparts being smaller and less spherical. The scatter plots in figure 3.10 
reveals that differentiated cells are much smaller in size, corresponding to a 






















































































































































































































































































do not express endogenous L-selectin, this was confirmed in cells prior to 
lentiviral transduction through flow cytometry (figure 3.11 A&Ai). Additionally, 
DMSO-induced differentiation does not promote endogenous expression of L-
selectin (figure 3.11 A&Ai). 
 
 As experiments were conducted on day 4 and day 5 of differentiation it was 
important that in this 24-hour window L-selectin surface levels were not 
significantly different.  For this WT (L-selectin GFP) cells were differentiated for 
either 4 or 5 days with 1.3% (v/v) DMSO. L-selectin levels were confirmed via 
flow cytometry. Importantly, there was no significant difference between surface 
levels at days 4 or 5 (figure 3.11 B&Bi). Interestingly, when compared to non-
differentiated cells, DMSO treatment induced ~35% (an average between day 4 
and day5) drop in L-selectin expression levels. It is likely that as cells 













Figure 3.10:  GFP levels in the HL-60 cell lines 
HL-60 cells either undifferentiated or DMSO differentiated were subjected to flow-cytometry. 
Forward light scatter (FSC) along the X-axis is proportional to the cell area or cell size, while the 
side light scatter (SSC) along the Y-axis is proportional to cell granularity. Oval gate represents the 













Figure 3.11:  The impact of DMSO treatment on L-selectin-GFP expression in HL60 cells  
A) Untransduced differentiated HL-60 cells were labelled with either DREG-56 followed by an 
Alexafluor633 secondary antibody or appropriate isotype control. Endogenous L-selectin levels 
were normalised against the isotype control. Data in graph represents three independent 
experiments, each conducted in triplicate. Student t-test was performed. Ai) Histograms show 
relative expression levels of endogenous L-selectin.  B) WT cells were differentiated for 0, 4 and 5 
days in 1.3 %(v/v) DMSO. L-selectin levels were monitored with DREG-56 conjugated with 
phycoerythrin (PE).  Percentage surface expression was quantified through removal of isotype 
median fluorescent values then normalised against median fluorescent values for day 0. Data in 
graph represents three independent experiments, each conducted in triplicate.  One-way ANOVA, 
followed by Tukey’s multiple comparisons test. **** p<0.0001 ***p<0.001. Bi) Histograms show 
relative expression levels of L-selectin-GFP.  
 
3.2.8 Blocking L-selectin shedding reduces fMLP chemotaxis 
Previous work in THP-1 monocyte cell lines expressing either WT L-selectin-GFP 
or MN L-selectin-GFP revealed that blocking the shedding of L-selectin 
dramatically impacted the polarisation towards chemotactic gradient of 
monocyte chemoattractant protein-1 (MCP-1 or CCL2) (212). Much work has 
been published in HL-60 cell chemotaxis towards the end-stage chemoattractant, 
fMLP. As HL-60 cells cannot chemotax effectively towards CCL2, they were 
challenged with fMLP in micropipette assays (see section 2.10). Fluorescent 
FITC-dextran (10kDa) supplemented into the chemoattractant media allowed the 
fMLP gradients to be approximated (figure 3.12).  Cells were imaged and tracked 
using the manual tracking software MTrackJ (Fiji) for ten minutes, with an image 


























































































being taken every 20 seconds (figure 3.12). The micropipette was centred into 
the FOV, and all adhered cells within the FOV were tracked (figure 3.13). For each 
cell track, directionality was assessed at each time point. At time 0 the straight 
distance between the micropipette tip and the cell was recorded, (D0i), at each 
twenty-second interval the new distance (Di) was divided by D0i. A cell migrating 
directionally towards the pipette tip will over time display a reduced Di/D0i ratio, 
whereas a cell randomly migrating or undergoing chemorepulsion will display 
over time a Di/D0i ratio close to 1 or a Di/D0i ratio higher than one, respectively 
(figure 3.14 A). The individual Di/D0i ratios for cells within each cell line were 
averaged to display the generalised behaviours towards the 200nM fMLP source 
within the ten-minute period, (figure 3.14 B). Quantifying directionality at the 
final minute (tenth minute) showed that both WT and GFP cells migrated 
directionally to the micropipette tip, while MN cells showed a significantly 
reduced ability to migrate to the source of fMLP, (figure 3.14 Bi). At this time 
point the Di/D0i ratio for WT, GFP and MN was 0.69 +/- 0.02, 0.57+/- 0.05 and 
0.88 +/- 0.03, respectively. Taken together, blocking L-selectin shedding 







        
   
          
  121            























Figure 3.12: Micropipette assay  
Assays were conducted using an FV-1000 scanning laser confocal microscope (Olympus), inverted 20x objective, A) Top row image series showing cells 
chemotaxing over time. Middle row - cells were manually tracked using MTrackJ and traces are shown in different colours to represent unique tracks. 
Bottom row - fluorescent dextran within the expelled micropipette media models the chemoattractant gradient; yellow asterisk denotes position of 































Figure 3.13: Blocking shedding of L-selectin inhibits chemotaxis towards fMLP 
HL-60 cells adhered to fibronectin-coated glass bottomed dishes. WT, MN or GFP cells were challenged with 200nM fMLP.  Each ten-minute experiment 
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Figure 3.14: Blocking shedding of L-selectin inhibits chemotaxis towards fMLP 
WT, GFP and MN cells were allowed to adhere to fibronectin-coated glass-bottomed dishes and 
were then challenged with 200nM fMLP released from a pressurized micropipette tip. A) 
Schematic describing the straight distance measured at time 0 (D0i) and the new distance 
measured at a time (i) time point (Di ). B) Averaged Di/D0i ratio for each cell line, a total of 88, 116 
and 112 cells were analysed for GFP, WT and MN, respectively. Bi) The Di/D0i ratio represented 
for the final minute of the chemotaxis experiment (10th minute), a total of 88, 116 and 112 cells 
were analysed for GFP, WT and MN in at least 8 independent experiments.  Statistical analysis, 
one-way ANOVA followed by Tukey’s multiple comparisons test. ****p<0.0001.  
 
Upon chemotaxis, L-selectin-GFP underwent a dramatic re-localisation; 
concentrating at the uropod (figure 3.15). A similar phenomenon was reported, 
but in neutrophils rolling on either purified E-selectin or on IL-1 activated 
HUVEC monolayer. Under these conditions, L-selectin was enriched at the rear of 
the cell, and this was followed by the relocation of ADAM17 to a similar part of the 
neutrophil(265). By grouping L-selectin to the rear of the cell, along with ADAM-
17 the authors proposed that transmigration would ensue upon shedding of L-
selectin(265).   
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Figure 3.15. L-selectin subcellular localisation during chemotaxis 
Cells were observed using an FV-1000 scanning laser confocal microscope (Olympus), 20x 
objective, using DIC and 488-laser excitation. Representative images for each cell line, WT, MN 
and GFP depicting GFP signal localization.  
 
In order to assess whether enrichment of L-selectin-GFP at the uropod was 
similar between WT and MN cells, line profiles, 30 pixels wide, were drawn 
through the longitudinal axis of polarised cells (figure 3.16 Ai). The polarised 
cells were on a fibronectin substrate. GFP fluorescence intensities were internally 
normalised in each cell with respect to the pixel with the highest GFP intensity, 
F1/F0. Prior to this background fluorescence intensities (Fb) were also removed. 
Line profile intensities were then stretched to conform to a uniform length of 100 
pixels (figure 3.16 A&Ai).  GFP fluorescent intensities were taken at the mid (40-
60 pixel location) and rear (70-90 pixel location) of the longitudinal axis and 
quantified (figure 3.16). Cells transduced with GFP alone were used to control for 
cell volume changes in the 2D assay, as the GFP signal is cytoplasmic.  There was 
no significant difference between the fluorescent signals corresponding to the 
mid-body and rear of GFP cells (figure 3.16 B).  However, both WT and MN cells 
displayed significantly higher distribution of GFP signal to the rear compared to 
their respective mid regions, (figure 3.16 B).  Additionally, both WT and MN had 
significantly higher levels at the rear to GFP cells (figure 3.16 C). Interestingly, 












profoundly different, suggesting that blocking L-selectin shedding does not alter 
the distribution of L-selectin in polarised cells. Indicating that the localisation of 













































































































Figure 3.16   L-selectin is localised at the uropod 
GFP fluorescence intensities were monitored using the Fiji line profile tool. Ai) Line profiles were 
taken from 80 polarised cells in the front-back axis, for each cell line A) Data from all GFP 
fluorescence intensity line profiles were stretched using a bespoke Matlab code, generating a 
uniform cell length of 100 pixels. Individual line profiles were normalised and background 
fluorescence removed.  B) Direct comparisons of fluorescence intensities of the mid and rear 
regions within each cell. Unpaired Student t-test, ****p<0.0001 C) Fluorescence intensities at the 
rear of each cell are compared between cell lines. Statistical analysis, One–way ANOVA, followed 
by Turkeys post test ****p<0.0001.  
 
3.2.9 CXCR2 is essential for HL-60 TEM 
 
To generate a valid cellular model of neutrophils, it was vital that the HL-60 cells 
could undergo fTEM. To test this, WT cells were perfused over TNF--activated 
HUVEC monolayers. Over a 30-minute period of perfusion, very few fTEM events 
were recorded (see figure 3.19). However, of the HL-60 cells that adhered to 
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HUVEC under flow, they were observed to actively crawl along the apical aspect of 
the endothelium. This observation implied that HL-60 cells were lacking a vital 
component of a “TEM-sensing” cue.  
 
TNF- activation of endothelial monolayers induces the expression of the cell 
adhesion molecules E- and P-selectin, alongside expression of the chemokine 
Interleukin-8 (IL-8 or CXCL8) (316) . IL-8 has been shown to act as an important 
driver of neutrophil TEM (317)(318)(319), by acting on the receptor CXCR2. As 
CXCR2 is absolutely required for TEM, HL-60 cells were tested by flow cytometry 
for the presence of this receptor. Surprisingly, little to no CXCR2 was detected on 
the surface of HL-60 cells and could explain the inability of these cells to undergo 
TEM. In order to test this hypothesis, HL-60 cells expressing CXCR2 were 
obtained from Prof. Anne Richmond’s Lab, Vanderbitt University, Tennessee, 
U.S.A. In addition, HL-60 cells expressing a signalling-defective form of CXCR2 – 
called CXCR2 ILAA – were also obtained as negative control cells. Briefly, two 
amino acid substitution mutations, I323A and L324A, which fall within the LLKIL 
motif of CXCR2, produced a 50% drop in ligand induced receptor internalisation 
and abolished chemotaxis towards IL-8 gradients (320)(321). For clarity in 
nomenclature, these new cell lines will be termed hereon as: CXCR2 WT and 
CXCR2 ILAA.  
 
To confirm the newly acquired HL-60 cells were expressing CXCR2 at the plasma 
membrane, median fluorescence intensity values were acquired through flow 
cytometry. For a detailed description of sample preparation and analysis see 
section 2.4.Median fluorescence intensity values were normalised with respect to 
HL-60 cells. Quantification revealed a 33.5 +/- 2.39 fold increase of CXCR2 
expression in CXCR2 WT cells, and a 16.8 +/- 1.25 fold increase of CXCR2 in 
CXCR2 ILAA (figure 3.17) compared to HL-60 previously used. CXCR2 expression 
is therefore two-fold higher than CXCR2 ILAA (figure 3.17).
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Figure 3.17: Relative expression levels of CXCR2 in the different HL-60 cell lines 
The HL-60 cells: CXCR2 WT, CXCR2 ILAA or no overexpression (HL-60) was labelled with anti-
CXCR2 or an appropriate isotype-matched control antibody. Secondary antibodies were APC 
conjugated. Surface expression was measured by flow cytometry. A) Histograms show expression 
levels of CXCR2.  B) Comparison of CXCR2 expression between the cell lines, which is presented as 
fold increase. Results were obtained from median fluorescence intensities, after subtraction of the 
IgG isotype control values and then normalised against the endogenous levels of CXCR2 in HL-60.  
Data in graph represents mean +/- SEM. No statistical tests could be performed as the data 
represents two independent experiments, each performed in triplicate and three times on 
separate days.  
 
To assess if overexpression of CXCR2 increased the percentage of TEM, perfusion 
experiments were conducted as described in section 2.5.1. As in section 3.2.2, 
HL-60-HUVEC interaction was monitored at 6 minutes, 10 minutes and 30 
minutes during the course of the perfusion experiments. Cells were scored as 
being: bound, crawling, mid-transendothelial migration (mTEM) and full 
transendothelial migration (fTEM) (figure 3.18). A striking difference in TEM was 
detected as early as 6 minutes in HL-60 CXCR2 WT cells: 12.5 % +/- 4.01 
compared to 0% of HL-60 cells undergoing fTEM (figure 3.19 A).  At the final time 
point, 30 minutes, the majority of the recruited HL-60 cells were crawling, 83.4% 




















































contrast, only 4.58% +/- 1.23 of CXCR2 WT were crawling and 61.3% +/- 4.88 had 
undergone fTEM (figure 3.19 C). Repeating flow experiments in CXCR2 ILAA cells 
revealed the importance of expressing functional CXCR2 in HL60-cells. At 30 
minutes only 11.2% +/- 3.92 of CXCR2 ILAA cells underwent fTEM (figure 3.19 
D). It is believed that the dramatic reduction in fTEM of CXCR2 ILAA may be 
reflective in the 50% drop of surface expression compared to the WT form, but 
this cannot fully explain the 5-fold increase in fTEM in HL-60 cells expressing 
CXCR2 WT.  
 
Figure 3.18: Stills from a time-lapse movie showing HL-60 cells crawling along the apical 
aspect of TNF-activated HUVEC. 
HL-60 cells underwent transendothelial migration in stages; bound, mid-transendothelial 
migration (mTEM), luminal crawling, and full transendothelial migration (fTEM). Red scale bar is 
50 m. White scale bar is 30m. Red asterisk denotes cells crawling for approximately 5 minutes 













Figure 3.19: The importance of CXCR2 expression on HL-60 TEM behaviour. 
HL-60, CXCR2 WT and CXCR2 ILAA cells were perfused over TNF--activated HUVEC monolayers 
for a total of 30 minutes. Cells were scored as; bound, crawling (along the apical aspect of the 
endothelium), mTEM or fTEM. Interactions were scored at 6, 10 and 30 minutes and recorded as a 
percentage of the total recruited cells (TRC) in any given field of view (FOV). Experiments were 
conducted in triplicate with 3 FOV per repeat. A total of 327, 376, 369 cells were scored for HL-60, 
CXCR2 WT and CXCR2 ILAA, respectively. Error bars represent standard error of the mean. 
Statistical significant was assessed through unpaired Student t-test, comparing the different cell 
lines at each separate stages of the adhesion cascade. **p<0.01, ***p<0.001 and ****p<0.0001.  
 
3.2.10 Expression of CXCR2 does not prevent chemotaxis towards fMLP 
Although CXCR2 and FPR1/2 have been shown to signal through PI3K/Akt and 
p38 MAPK pathways, respectively, for the purposes of this study it was essential 
to test that the CXCR2 WT cells responded to both end-stage and intermediate-
stage chemoattractants (e.g. IL-8 and fMLP). Ultimately, the intention of this thesis 
is to challenge HL-60 cells and primary human neutrophils with conflicting 
intermediate-stage and end-stage chemoattractants within 3D collagen scaffolds 
(see chapter 5).  
 
Each cell line was plated onto a fibronectin coated glass-bottomed dishes, and 
then challenged with either 200nM fMLP or 100ng/mL  IL-8 in micropipette 
assays, see section 2.10 for a more detailed set up description. First the 
percentage of migrating and non-migrating cells (also termed bound) was scored 
to confirm that there was no difference in the populations of cells that had 
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undergone DMSO induced differentiation. For both cell lines (CXCR2 WT and 
CXCR2 ILAA) there was no significant difference in the percentage of randomly 
migrating cells in response to either IL-8 or fMLP (figure 3.20 A & figure 3.21 A). 
Additionally, neither cell lines displayed significant differences in cell speeds 
when migrating cells were scored (irrespective of cell direction) (figure 3.20 B & 
figure 3.21 B). Interestingly, fMLP promoted significantly higher cell speeds than 
IL-8 in both cell lines (figure 3.21 D). Heit et al, demonstrated in neutrophils that 
fMLP driven chemotaxis was p38 MAPK dependent while IL-8 driven chemotaxis 
was PI3K dependent, this could be responsible for the different cell speeds 
observed when subjected to IL-8 and fMLP (111). Alternatively, cell response to 
chemoattractants could be due to the “steepness” of the gradient produced, which 
in turn will depend on the diffusion of the chemoattractant. The diffusion of a 
smaller molecule will be more rapid. IL-8 size is  ~11kDa while fMLP is ~437Da, 
therefore fMLP will produce a swallower gradient. Several groups using the 
model organism Dictyostelium demonstrated chemotaxis towards a steep 
gradient of cyclic adenosine monophosphate (cAMP) was PI3K dependent. 
(322)(323) However, in the same organism Andrew et al., demonstrated in the 
presence of a shallow cAMP gradient PI3K was not required for migration. 
Suggesting that chemotaxis occurs via a variety of mechanisms, and a 
chemoattractant gradient may be an important determinant (324). Importantly, 
directed migration towards IL-8 was only impaired in CXCR2 ILAA cells, and both 
lines migrated efficiently towards the micropipette tip dispensing fMLP (figure 
3.20 & figure 3.21). Directed migration was analysed through the Di/D0i ratio, 
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Figure 3.20: Chemotaxis towards IL-8 
CXCR2 WT or CXCR2 ILAA cells were left to adhere to a fibronectin coated glass bottom dish and 
were then challenged with 100ng/mL IL-8.  Each ten-minute experiment was observed using an 
FV-1000 scanning laser confocal microscope (Olympus), 20x objective. All cells within the field of 
view (FOV) were scored. A) The cells were scored for their ability to migrate, (assessed through 
uropod contraction and uropod movement of >6m). Migrating cells within the FOV were 
manually tracked and speed, (B) and directional information obtained, (C). Directionality was 
defined by the Di/D0i ratio, see section 3.2.8. Ci) Directionality was statistically assessed using the 
final minute, (10th). In total 89 and 101 migrating cells were tracked for CXCR2 WT and CXCR2 
ILAA, respectively. Statistical analysis was conducted through unpaired Student t-test, 




















































Figure 3.21:  Chemotaxis towards fMLP 
HL-60 cells were left to adhere to a fibronectin coated glass bottom dish. CXCR2 WT or CXCR2 
ILAA cells were challenged with 200nM fMLP.  Each ten-minute experimentation was observed 
using a FV-1000 scanning laser confocal microscope (Olympus), 20x objective. All cells within the 
field of view  (FOV) were scored. A) The cells were scored for their ability to migrate, (assessed 
through uropod contraction and uropod movement of >6m). Migrating cells within the FOV were 
manually tracked and speed, B) and directional information obtained, C). Directionality was 
defined by the Di/D0i ratio, see section 3.2.8.Ci) Directionality was statistically assessed using the 
final minute, (10th) In total 92 and 98 migrating cells were tracked for CXCR2 WT and CXCR2 ILAA, 
respectively. Statistical analysis was conducted through unpaired Student t-test. D) Comparison of 
the cell speeds with respect to the chemoattractant stimuli, unpaired Student t-test used. **** 
p<0.0001. Experiments were conducted three times on three independent occasions. 
 
To conclude the increased expression (~33.5 fold increase) of CXCR2 dramatically 
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inhibit chemotaxis towards fMLP. Therefore L-selectin constructs were 
introduced into the CXCR2 WT cells. From now on all new cell lines, unless stated 
otherwise will be overexpressing CXCR2 WT. HL-60 cell lines with no 
overexpression of CXCR2 will no longer be used for experiments in this thesis. .  
3.2.11 Engineering WT L-selectin and mutants into HL-60 cells expressing functional 
CXCR2. 
Based on the high proportion of fTEM events observed in HL-60 cells stably 
expressing CXCR2, the main objective for this section of the study was to 
introduce WT and mutant forms of L-selectin-GFP using approaches previously 
described in section 2.7. To simplify the definition of cell lines from hereon, all 
the cells used beyond this point will be stably expressing CXCR2. For simplicity 
the new cell lines all overexpressing CXCR2 WT are renamed: WT L-selectin–GFP 
cell line will be referred to as WT; ∆MN-GFP as ∆MN, ∆MN SSAA-GFP as ∆MN 
SSAA, ∆MN SSDD-GFP as ∆MN SSDD and GFP remains unchanged. The new cell 
lines MN SSAA-GFP and MN SSDD-GFP will be discussed in more detail later in 
this chapter. The GFP alone cell line, controls for the action of lentiviral stress on 
the cell. See table 2.4 for details on MOI.  To ensure that their protein expression 
was similar to prevent bias cells were FACS sorted. L-selectin levels were 
compared by flow cytometry in all the L-selectin-GFP constructs (figure 3.22). All 
cell lines expressing WT and mutant forms of L-selectin-GFP constructs displayed 
no significant differences in expression levels between one another. This is 
important for future experimentation to accurately attribute phenotypes to 
mutations of L-selectin, rather than variations in protein levels.  
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Figure 3.22: Comparison of WT and mutant L-selectin-GFP fluorescence intensity values in 
HL-60 cells stably over expressing CXCR2 
After FACs sorting HL-60 cells stably expressing WT, MN, MN SSAA and MN SSDD were 
subjected to flow cytometry to monitor their relative GFP fluorescence intensities. Each cell line 
was investigated on three separate occasions. A) Histogram of superimposed FACS profiles. B) 
Quantification of fluorescence intensities based on the GFP tag, one-way ANOVA, followed by 
Tukey’s multiple comparisons test. Error bar represents standard error of the mean.  
 
In order to establish if these newly developed HL-60 cell lines reflect primary 
neutrophil behaviour, the HL-60 cells were subjected to assays that interrogate: 
TEM behaviour, TEM rates, and the directionality and morphology of fTEM cells.  
 
To first interrogate TEM behaviour; WT, ∆MN and GFP cells were perfused over 
TNF-activated HUVEC as described before. The most striking observation was at 
the 30-minute time point; WT and ∆MN had significantly higher percentages of 
fTEM, compared to GFP alone cells (figure 3.23). The percentage of fTEM at 30 
minutes was 64.8% +/- 2.78, 63.9% +/- 2.67 and 52.4% +/- 2.81 for WT, MN and 
GFP respectively (figure 3.23). In accordance with this observation, a 
significantly higher proportion of GFP cells were undergoing mTEM at 10 min and 
30 min compared to WT and MN cells.  These results suggest that the expression 
of L-selectin-GFP in HL-60 cells drives the invasive potential in neutrophils, 
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Figure 3.23: Monitoring HL-60 TEM behaviour and the contribution of L-selectin shedding 
to this mechanism 
 WT,MN and GFP cells were subjected to 30-minute perfusion over TNF--activated HUVEC 
monolayer. Cells were scored at 6 minute, 10 minute and 30 minutes intervals, interactions 
between the leukocyte and the endothelium was described as either: bound, crawling, mTEM or 
fTEM. Total recruited cells were enumerated per each field of view (FOV). Experiments were 
conducted in triplicate with 3 FOV per repeat. A total of 254, 288,291 cells were scored for WT, 
MN and GFP, respectively. Error bars represent standard error of the mean. Statistical significant 
was assessed through one-way ANOVA followed by Tukey’s post test, different cells lines were 
compared with respect to a stage of the adhesion cascade. * p<0.05 **p<0.01.  
 
To investigate whether blocking L-selectin shedding altered the rate of TEM, as 
described before, HL-60 cells were timed from their initial capture from flow up 
until fTEM. There was no significant difference between the cell lines rate of TEM, 
with all cell lines taking between 4.6-5.8 minutes (figure 3.24 A). HL-60 TEM rate 
is over 2.19-2.76 times slower than observed for primary neutrophils. This 
difference is likely due to two reasons; firstly a percentage of HL-60 cells 
 136 
underwent crawling prior to TEM, and secondly, the average HL-60 diameter is 
~11m while primary neutrophils have a smaller diameter, ~7m. Additionally, 
primary neutrophils have a multi-lobed nucleus giving a higher degree of 
deformability to “squeeze” faster through cell junctions.  
 
Once cells had undergone fTEM, they were manually tracked as previously 
described in section 2.5.2. WT cells were significantly more directionality than 
both the GFP and MN cells (figure 3.24 B). The directionality ratios were: 
0.61+/- 0.02, 0.49+/- 0.03 and 0.43 +/- 0.02, for WT, MN and GFP, respectively. 
Conversely the speed of the GFP cells was  significantly faster compared to the 
other two cell lines, (figure 3.24C). Interestingly, clustering of fTEM HL-60 cells 
was not observed and may suggest defective mechanisms in swarming.  
 
Figure 3.24: HL-60 dynamics beneath the endothelium 
WT, MN and GFP were perfused over TNF--activated HUVEC and recorded under phase 
contrast (10x objective lens) with an inverted time-lapse microscope. (A) The rate of TEM was 
calculated from the time taken from initial capture to complete TEM.  80 cells were scored for each 
condition. One-way ANOVA carried out.  (B&C): Over 250 fTEM cells were tracked for 15 minutes 
for each condition over three separate experiments. B: Mann-Whitney test,  **** p<0.0001, ** p 
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The fTEM cell morphologies; cell area and circularity (described in section 3.2.4) 
phenocopied observations seen in primary neutrophils: MN had lower 
circularity ratio than WT (figure 3.25 A&B).  MN cells were elongated with 
indistinguishable front/back polarity, while WT cells appeared to have a rounded 
uropod. Interestingly, the cross-sectional cell area was smaller in GFP cells than 
WT or MN cells (figure 3.25 C). The cell area was; 241.3 m2 +/- 7.6, 244 m2 
+/- 8.2 and 194.4 m2 +/- 4.3 for WT, MN and GFP, respectively. Change in cell 
area is a direct consequence of cell spreading; L-selectin has never before been 
seen to effect cell spreading. However, it is known that many ligands for L-selectin 
can be found in the ECM, e.g Biglycan (241)(325).  High-density ligand binding 
leads to clustering of L-selectin. Subsequently, L-selectin clustering through 
GlyCAM-1 ligand binding or enforced monoclonal antibody (mAb) cross-linking 
has lead to 1 integrin activation (214). 1 integrins are responsible for binding 
fibronectin, the substrate pre-coated on the glass coverslips(326). Taken together, 
it is plausible that once the L-selectin positive cells have undergone fTEM, L-
selectin binding to available ligands within the ECM, leads to clustering and L-
selectin dependent 1 integrin up regulation/activation which successively leads 


































































Figure 3.25:  Characterisation of HL-60 circularity and cross-sectional area of fTEM HL-60 
cells  
WT, MN and GFP were perfused for 30 minutes over TNF--activated HUVEC and subsequently 
fixed in 4% PFA treatment. Following permeabilisation, F-actin was stained with TRITC-
phalloidin.  Thin optical (0.75  micron) z-plane images were acquired by confocal microscopy and 
cell size parameters measured by using the free hand drawing tool, Fiji. A) Cells were individually 
traced, using the phalloidin signal as a marker. B&C) 55 cells were scored for each condition. A 
one-way ANOVA conducted. **** p<0.0001, ** p =0.01.  Scale bar is 13m.  
3.2.12 L-selectin-GFP is deposited from the uropod as HL-60 cells complete TEM 
During perfusion assays, it was observed that WT and MN cells undergoing fTEM 
detached fragments of their uropods. As these “uropod spots” were GFP-positive, 
it strongly suggested that they were enriched in L-selectin (figure 3.26).  The 
frequencies of uropod spots deposited were scored in fTEM HL-60 cells only. Cells 
did not deposit more than one uropod spot. Frequency is scored between 0-1, 
with 0 being 0% percentage of the fTEM population depositing uropod spots, 
while 1 is equivalent to 100% of the fTEM population depositing uropod spots. 
Enumeration revealed that the frequency of uropod deposition was  0.41 +/- 0.04 
in WT, 0.34 +/- 0.03 in MN and 0.01 +/- 0.01 in GFP cells (figure 3.27). 
Therefore, as exogenous expression of WT or MN L-selectin, but not GFP alone, 
increased the likelihood of the deposition of uropod spots; it strongly suggests the 
phenomenon is specific to L-selectin expression.  
 
 
Deleted: n unpaired Students t-test conducted
Deleted: Scoring of HL-60 cells undergoing fTEM 
revealed that these uropod spots occurred with a 






Figure 3.26: Deposition of uropod spots during TEM 
Transmigrating HL-60 cells deposited uropod spots only when WT L-selectin-GFP or MN L-
selectin-GFP was expressed. WT L-selectin-GFP cells are shown in this figure.  Uropod spots were 
observed by inverted fluorescence time-lapse microscopy, using a 10x dry lens objective.  Phase 
contrast, GFP and merged channels are shown in time series from left to right. Scale bar is 60m. 
























































Figure 3.27: Frequency of uropod spots formed in HL-60 cell lines.  
WT, MN and GFP cells were perfused over TNF--activated HUVEC, as described in section 2.5.1. 
The frequency of uropod spots deposited by fTEM HL-60 cells increased significantly if either WT 
or MN L-selectin was expressed. At least 3 independent flow assays were conducted per cell line, 
each with 3 FOV.  A total of 190, 213, 183 cells were scored for WT, MN and GFP respectively.  A 
one-way ANOVA followed by Tukey’s multiple comparison was conducted. **** P <0.0001. Mean 
and +/- SEM are shown.  
 
3.2.13 Understanding the role of the L-selectin cytoplasmic tail in contributing to 
the phenotypic changes observed in MN cells 
The cytoplasmic tail of L-selectin is composed of a 17 amino acids, two of which 
are serine residues at positions S364 and S367 (RRLKKGKKSKRSMNDPY). 
Phosphorylation of S364 and S367 was shown to be mediated by PKC isozymes 
alpha, theta and iota(226). Activation of classic PKC isoforms with PMA is known 
to promote robust shedding of L-selectin, and mutation of S364 to alanine 
(S364A) significantly reduces the shedding response. This suggests that the serine 
residues within the L-selectin tail undergo dramatic changes in phosphorylation 
and dephosphorylation – some of which act to promote the shedding of L-selectin 
(section 1.7). Additionally, phosphorylation of the L-selectin tail also occurs in 
response to stimulation with the chemoattractants fMLP and IL-8 (327).  
 
Calmodulin (CaM) has been shown to negatively regulate L-selectin shedding 
(328) (329). Recently, phosphorylation of S364 was shown to promote the 
dissociation of CaM from L-selectin and culminates in L-selectin shedding (212). 
The serine S364, but not serine S367, is conserved in both mice and humans, 
suggesting conserved evolutionary mechanisms at this site. Although MN L-
selectin cannot be cleaved, it is highly likely that the phenotype presented in HL-





































60 cells expressing this mutant form of L-selectin is driven by altered 
phosphorylation of S364 and S367 as previously shown in THP-1 cells. This in 
turn could impact on downstream signalling events. To address this question in 
more detail, two cell lines were generated to express MN L-selectin with non-
phosphorylatable alanines (A) or phospho-mimicking aspartates (D) at positions 
S364 and S367. The serine mutant MN cell lines were generated as described in 
section 2.7, and termed MN SSAA and MN SSDD for simplicity. Cell sorting, 
followed by flow cytometry, was used to ensure the cell lines (WT and MN) had 
similar expression levels of L-selectin-GFP (figure 3.22). Quantification revealed 
no significant differences between in L-selectin surface expression levels in all L-
selectin-GFP cell lines.  
 
In order to establish a possible role that phosphorylation of the S364 and S367 
serines have in MN, MN SSAA and MN SSDD cells were subjected to the same 
experiments as previously documented for primary human neutrophils and for 
the GFP, WT and MN HL-60 cell lines. The frequency of fTEM events, rate of TEM, 
directionality of fTEM cells, and the morphology of fTEM cells were all elucidated 
and compared directly to the MN cell line. As described in section 2.5.1 the MN 
SSAA and MN SSDD were perfused over TNF--activated HUVEC monolayers for 
30 minutes to firstly quantify the frequency of fTEM events.  As before, videos 
were acquired and analysed at the 6 minute, 10 minute and 30 minutes time 
points. Statistically significant differences in TEM behaviour were observed 
between MN, MN SSAA and MN SSDD cells. Firstly, MN SSAA and MN SSDD 
both displayed significantly more crawling behaviour compared to MN cells  at 
all three time points (figure 3.28). The average percentage crawling at 10 
minutes was 24.30 %+/- 2.43, 29.4% +/- 4.72, 7.8% +/- 1.66 for MN SSAA, MN 
SSDD and MN, respectively (figure 3.28 B). Cell crawling on the apical aspect of 
the endothelium was apparent in HL-60 cells lacking CXCR2 expression (see 
figure 3.19). To determine that crawling observed in MN SSAA and MN SSDD 
cells was not a hallmark of surface CXCR2 expression loss flow cytometry was 
used to re-measure surface levels of CXCR2 between cell lines. CXCR2 surface 
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MN SSDD cells portrayed a lower percentage of fTEM events, 47.9%  +/- 2.75 
which was significantly different to both MN 63.7% +/- 2.70, and MN SSAA 
66% +/- 2.46 fTEM events (figure 3.28 C). Interestingly, the percentage of fTEM 




Figure 3.28: Defining the contribution of S364 and S367 in regulating TEM behaviour in HL-
60 cells expressing MN L-selectin-GFP 
MN SSAA, MN SSDD and MN were subjected to a 30-minute perfusion over TNF--activated 
HUVEC monolayers. Cells were scored at 6 minute, 10 minute and 30 minutes intervals, and TEM 






































































































































































































































































































































































the total number of recruited cells (TRC), which was performed over 3 independent experiments. 
Experiments were conducted in triplicate with 3 FOV per repeat. A total of 272, 298, 235 cells 
were scored for MN SSAA, MN SSDD and MN, respectively. Error bars represent SEM. 
Statistical significant was assessed through one-way ANOVA followed by Tukey’s post test, cell 
lines were compared with respect to the stage of the adhesion cascade. * p<0.05 **p<0.01. 
***p<0.001 ****p<0.0001. 
 
Next, the TEM rates were assessed more closely between cell lines, which may 
help understand some of the phenotypic differences observed in (figure 3.28). 
The increased crawling behaviour of MN SSDD likely reflected the increased 
time taken for TEM, averaging ~ 8 minutes. In contrast, the time taken for  MN 
SSAA averaged ~6 minutes (figure 3.29 A). Both of these TEM rates were 
significantly higher than MN cells, suggesting that altering the phosphorylation 
status of the L-selectin tail significantly impacts TEM behaviour. Or, in other 
words, the cytoplasmic tail of MN L-selectin is under continued dynamic change 
of serine phosphorylation/dephosphorylation.  
 
Next, the speed and directionality of fTEM HL-60 cells were analysed within the 
sub endothelial space. Both MN SSDD (0.39m/min +/- 0.00) and MN 
SSAA(0.32m/min +/- 0.00)  cell speeds were significantly reduced compared to 
MN (0.47m/min +/-0.01)(figure 3.29 B). Interestingly, differences in the  
directionality ratio and circularity ratio of fTEM MN SSAA and MN cells were 
not significant (figure 3.29 C and figure 3.30). The circularity ratio of MN SSAA 
and MN cells was 0.39+/- 0.01 and 0.41+/-0.10, respectively. The directionality 
ratio of MN SSAA and MN cells was 0.52 +/- 0.01 and 0.49+/- 0.02, 
respectively. Together, this suggests that removal of phosphates at the serines 
S364 and S367 could contribute to the cell polarity defects and unsuccessful 
directional migration observed in MN cells. However, in MN SSDD cells, fTEM 
cellular behaviour was significantly different to MN SSAA and MN cells, with a 
directionality and circularity ratio of 0.39+/-0.02 and 0.36+/-0.01, respectively. 
This implies that if the cytoplasmic tail is permanently phosphorylated this 
negatively alters cell morphology, (more so than MN) producing a more 
elongated cell underneath the endothelium and a less directed travel (figure 3.29 
C & figure 3.30). Cell area remains unchanged between the cell lines (figure 3. 30 
C). The study implies that blocking dynamic phosphorylation of the serine’s does 
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not alter cell spreading. In summary, blocking dynamic phosphorylation 
encourages cell crawling. Once beneath the endothelium, MN behaviour is close 
to MN SSAA, indicating MN within this stage of the adhesion cascade possibly 
remains largely un-phosphorylated. Interestingly, the amount of “uropod spots” 
produced decreased in MN SSAA, yet MN SSDD resembled WT and MN cells in 
the frequency of “uropod spot” deposition, supporting the idea that 
phosphorylation can change dramatically, perhaps dependent on L-selectin ligand 
interactions (figure 3.31). 
 
 
Figure 3.29: Monitoring migratory behaviour of fTEM HL-60 cells within the sub endothelial 
space 
MN SSAA, MN SSDD and MN cells were perfused over TNF- activated HUVEC and recorded 
under phase contrast (10x objective lens) using an inverted time-lapse microscope. A) The rate of 
TEM was calculated from the time taken from initial capture to fTEM.  At least 80 cells were scored 
for each condition. One-way ANOVA  conducted for the statistical analysis. B&C: Over 250 fTEM 
cells were tracked for 15 minutes for each condition over three separate experiments. B: one-way 
ANOVA, **** p<0.0001 C: Mann-Whitney test, *** p <0.001 * p <0.05. Figures display the mean and 
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Figure 3.30: Assessment of cell morphology in fTEM HL-60 cells within the sub endothelial 
space 
MN SSAA, MN SSDD and MN cells were perfused for 30 minutes over TNF--activated HUVEC 
monolayers. Specimens were fixed in 4% PFA, and permeabilised so that the F-actin was 
cytoskeleton could be visualised using TRITC-phalloidin.  Single z-plane images were acquired by 
confocal microscopy and cell size parameters measured by using the free hand drawing tool, Fiji. 
A) Cells were individually traced, using the phalloidin signal as a marker. B&C) 55 cells were 
scored for each condition. A one-way ANOVA was conducted, * p <0.01.  Scale bar is 13m. Figures 















Figure 3.31 Frequency of uropod spots deposited by fTEM HL-60 cells  
MN SSAA, MN SSDD and MN were perfused over TNF--activated HUVEC monolayers, as 
described in section 2.5.1. The frequency of uropod spot deposition from all fTEM cells was 
scored over a 30-minute period. Data are representative of 3 independent experiments, conducted 
in triplicate per day (each assay contains 3 FOV).  A total of 197, 203, 193 cells were scored for 
MN SSAA, MN SSDD and MN, respectively.  One-way ANOVA followed by Tukey’s multiple 
comparison was conducted. ** p <0.01. *p<0.05 .Mean and +/- SEM are shown.  























































































3.2.14 Chemoattractant stimulated shedding of L-selectin in primary neutrophils 
Neutrophils are continually challenged with conflicting chemoattractants derived 
from intermediary and end-stage sources: e.g. IL-8 and fMLP, respectively. 
Although L-selectin shedding typically follows cell stimulation, its response to 
different types of chemoattractants has not been well studied.  To better 
understand the extent of L-selectin shedding in response different types of 
chemoattractants, primary neutrophils were isolated from healthy volunteers and 
exposed to a given chemoattractant in suspension for 30 minutes at 37C, after 
which cells were prepared for flow cytometry (see section 2.4 for details). 
Neutrophils were also challenged with DMSO or 100nM PMA for 30 minutes, as 
respective negative and positive controls for shedding. Quantification revealed 
significant differences in surface levels of L-selectin in fMLP-stimulated 
neutrophils compared to the DMSO carrier treatment. However, based on the 
concentration range of fMLP used, no dose response in respect of L-selectin 
shedding was observed (figure 3.32 A&B). Additionally, IL-8 stimulation 
promoted L-selectin shedding, which did appear to slightly change across the 
range of concentrations used in the assay (figure 3.32 C&D). Finally, no L-selectin 
shedding was observed when primary human neutrophils were challenged with 
100ng/ml - 1g/ml of Gro- (figure 3.24 E&F). In fact, the L-selectin surface 
expression increased slightly in response to Gro- challenge, perhaps due to 
prevention of either basal shedding or increased mobilisation of L-selectin to the 
plasma membrane, or both. In conclusion, L-selectin shedding is remarkable 
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Figure 3.32: fMLP induces L-selectin shedding in primary neutrophils  
Primary neutrophils were stimulated for 30 minutes with increasing concentration of either fMLP 
(A&B), IL-8(C&D), Gro-(E&F). DMSO treatment defined a non-shed control, while treatment with 
100nM PMA defined a positive shed control. L-selectin was labelled using a PE-conjugated DREG-
56. B&D&F) Representative histograms: depicting the surface expression of L-selectin after the 
specific treatments.  Percentage surface L-selectin expression was calculated from median 
fluorescence values, after removal of IgG isotype control value, and normalisation to the DMSO 
non-shed control. Each data bar represents 3 health volunteer donor samples, the experiment was 
conducted in triplicate, bar graph represents mean +/- SEM. Statistical analysis; One –way ANOVA 
with Dunnett’s comparative testing. **** p<0.0001, **p<0.01 and *p<0.05. 
 
3.2.15 fMLP induces phosphorylation of p38 MAPK in primary neutrophils 
L-selectin shedding can occur via two alternate kinase-dependent pathways; PKC 
or p38 MAPK, see section 1.9.2. The p38 MAPK-dependent pathway involves 
activation of TACE by phosphorylation of its cytoplasmic tail, which leads to 
increased mobilisation of TACE to the plasma membrane (209). As fMLP was 
previously shown to activate p38 MAPK it was important to determine if this 
finding could be reproduced in this project (330). Briefly, primary neutrophils 
were stimulated for 30 minutes in 200nM fMLP (a concentration that is known to 
robustly promote L-selectin shedding, (figure 3.32 A&B). Immediately after 
stimulation, lysates were generated and resolved on polyacrylamide gels so that 
changes in phospho-p38 MAPK could be detected in Western blots. Due to the 
similarity of molecular weights of phospho-p38 MAPK (43kDa) and p38 MAPK 
(40kDa), cell lysates were resolved on separate polyacrylamide gels and 
subsequently Western blotted on separate membranes. To normalise any changes 
in protein levels, p38 MAPK and phospho-p38 MAPK were normalised against -
actin within each Western blot. As shown in figure 3.33, stimulation of 
neutrophils with fMLP induced a significant increase in phospho-p38 MAPK levels 
(78.56% +/- 2.55) compared to cells challenged with just DMSO carrier (35.69% 
+/- 5.49). These data suggest that, following fMLP stimulation, p38 MAPK is 








Figure 3.33: Stimulation of primary human neutrophils with fMLP activates p38 MAPK  
Primary neutrophils were isolated from healthy donors and stimulated for 30 minutes with 
200nM fMLP or a DMSO carrier. After stimulation, cells were lysed and whole cell lysates were 
resolved on polyacrylamide gels before being transferred to nitrocellulose filters for Western 
blotting. Phospho-p38MAPK, (A) and p38 MAPK, (C), were probed for on separate membranes. 
Proteins were identified using LI-COR compatible antibodies. B&D) Fold change was quantified by 
densitometric changes in protein bands corresponding to p38 MAPK and phospho-p38 MAPK, 
following normalisation against -actin levels. E) Relative percentages of p38 MAPK and phospho-



































































































































3.2.16 PMA stimulates L-selectin shedding in WT but not MN cell lines 
To confirm WT cells could undergo bonafide L-selectin shedding, and, conversely, 
that MN cells do not in order to definitively mimic the abilities of the DMSO and 
TAPI-0 treated primary neutrophils respectively. Each cell line was stimulated 
with 100 nM PMA as this is a potent PKC activator, PKC has been reported to 
induce L-selectin shedding in multiple leukocytes subtypes(202). Cell lines were 
incubated in PMA for 30 minutes and flow cytometry was used to measure the 
remaining surface L-selectin. In the presence of DMSO, L-selectin surface levels 
remained at 100% (-PMA), but decreased dramatically to 2.3% +/- 2.3 in the 
presence of 100 nM PMA (figure 3.34). Importantly, surface levels of MN L-















Figure 3.34: PMA stimulation of HL-60 cells expressing WT and MN L-selectin 
HL-60 cells stably expressing WT and MN L-selectin cells were incubated with 100nM PMA for 
30 minutes at 37oC. Cells were labelled with PE-conjugated DREG-56 antibody and L-selectin 
expression levels analysed by flow cytometry. A) Representative histograms depicting the surface 
expression of L-selectin after DMSO (-) or PMA (+) treatment.  B) For each cell line, percentage L-
selectin expression was calculated from median fluorescence values after subtraction of the IgG 
isotype-matched control values and normalisation to DMSO control. Experiments were conducted 







































Shedding of L-selectin with 100nM PMA, peaked at 5 minutes, as shown through 
Western blot analysis (figure 3.35). Interestingly, at 15 minutes the intensity of 
the cleaved/ stump band (35kDa) decreased suggesting the molecule turn over 
rate (figure 3.35). There is also a band at 25kDa MW, which doesn’t fluctuate in 
density over time.  The band corresponds to the molecular weight of GFP (27kDa), 
it is possible that is a product of degradation, or alternatively, the GFP protein 





















Figure 3.35:  Time course of PMA-induced shedding of L-selectin by Western blotting  
HL-60 cells stably expressing WT L-selectin-GFP were stimulated with 100nM PMA for time 
periods of 0, 1, 5, 15 and 30 minutes. After stimulation, cells were lysed and whole cell lysates 
were resolved on polyacrylamide gels before transfer onto nitrocellulose filters for analysis by 
Western blot. A) Western blots were probed with anti-GFP antibodies to detect both the full-
length and the cleaved forms (stump) of L-selectin. B) Proteins were identified using LI-COR 
compatible secondary antibodies. Full-length and stump levels were normalised against the total 
full length and stump fractions at the corresponding time point. No statistical analysis was 
conducted as this data represents an N = 1.  A.U=Arbitrary units.  
 
3.2.17 Activation of the p38 MAPK-dependent pathway in WT cells 
A previous study reported by Killock and Ivetic demonstrated that cell 
stimulation with PMA or the PP1/PP2A inhibitors: cantharidin and calyculin A 






































































respectively promoted L-selectin shedding via PKC or p38 MAPK (209). Therefore 
to confirm L-selectin-GFP could be cleaved in WT cells via p38 MAPK, cells were 
treated with either 250 M of cantharidin or 25nM of calyculin A for 30 minutes. 
Shedding was assessed through flow cytometry. L-selectin levels were 
dramatically reduced in response cantharidin and calyculin A, with only 7.2 % +/- 


















Figure 3.36: WT L-selectin-GFP is shed in response to stimulation with cantharidin or 
calyculin A 
WT cells were incubated for 30 minutes with either 250M cantharidin or 25nM calyculin A. A 
DMSO carrier treatment was used as control and values normalised to 100% surface expression. 
Treatment with 100nM PMA was used as a positive control. L-selectin was labelled using a PE-
conjugated DREG-56. Surface expression was measured by flow cytometry as described in section 
2.4. A) Overlaid histograms depicting the surface expression of L-selectin after challenging WT 
cells with various treatments. B) Percentage surface L-selectin expression was calculated from 
median fluorescence values, after removal of IgG isotype control value, and normalisation to the 
DMSO carrier control. Experiments were conducted three times each in triplicate, bar graph 
represents mean +/- SEM. Statistical analysis; one–way ANOVA with Tukey’s comparative testing. 





























































3.2.18 Monitoring L-selectin shedding in WT HL-60 cells undergoing TEM 
Earlier in this results chapter, L-selectin shedding was shown to occur in primary 
human neutrophils undergoing TEM. Performing similar assays using HL-60 cells 
is more difficult, as the L-selectin is tagged to the C-terminus with GFP. 
Additionally, the LAM1-14 monoclonal antibody used in figure 3.1 is not 
commercially available and is in very limited supply (obtained through a 
materials transfer agreement with Prof. Thomas. F. Tedder – Duke University, 
USA). To quantify the extent to which L-selectin-GFP is cleaved during TEM of HL-
60 cells, WT cells were subjected to static TEM assays; see section 2.9.2 for more 
details. In short, WT or MN cells were co-cultured with TNF--activated HUVEC 
monolayers for 45 minutes. After removal of unbound leukocytes, whole cell 
lysates were made from the remaining leukocytes/HUVEC co-culture, and L-
selectin-GFP was detected by Western blot.  As GFP is associated with both the 
full-length and cleaved forms of L-selectin, this approach allowed the extent of L-
selectin shedding to be quantified. Quantification through densitometry 
measurements of anti-GFP bands, corresponding to full-length and cleaved forms 
of L-selectin, revealed there was a significant difference in shedding WT and MN 
cells. The percentage of “stump” with respect to total L-selectin level (see below 
for formula) generated in WT cells was 12.6 % +/-2.10, while MN cells had 
approximately 6-fold less: 2.11% +/- 0.3 (figure 3.37 A&B). To determine if the 
activated HUVEC monolayer played a significant contribution in the shedding 
process, WT cells were incubated for 45 minutes in cell culture media and lysed to 
monitor the extent of L-selectin-GFP shedding by Western blot. Quantification of 
densitometry revealed there was a significant difference in the % stump 
/(stump+ full length) WT cells co-cultured with HUVEC and those suspended in 
cell culture media (figure 3.37 C&D). The percentage of stump levels for TEM WT 
cells was 12.6%+/-2.10, while percentage stump levels for WT cells in suspension 
was only 4.15%+/- 0.30.  The data implies that TEM of HL-60 cells also triggers L-
selectin shedding; mimicking the behaviours observed in primary human 






Figure 3.37:  Monitoring L-selectin shedding in WT cells subjected to static TEM assays 
WT or MN were co-cultured with TNF--activated HUVEC monolayers for 45 minutes at 37C 
(see  section 2.9.2 for details). After removing unbound cells, the remaining monolayer was lysed 
and the proportion of WT or MN L-selectin-GFP was monitored by Western blotting (A). In a 
separate assay (C), cells expressing WT cell suspensions were lysed after incubation in media for 
45 min. B&D) Densitometric analysis of bands corresponding to full-length and cleaved forms of L-
selectin-GFP. The ratios of full length and cleaved/stump levels for each sample assessed the 
percentage of shedding in each condition/cell line. Three separate cell lysates carried out on three 
separate occasions complete a data set. Statistical analysis conducted, unpaired Student t –test,  ** 
p<0.01. A.U=Arbitrary units. 
 
3.2.19 fMLP does not promote L-selectin shedding in HL-60 cells 
Although the phosphatase inhibitors Calyculin A and cantharidin can indirectly 
activate p38 MAPK, this mechanism bypasses any signalling to p38 MAPK that 
might occur naturally, e.g. downstream signalling of FPR1/2 (fMLP receptors) 
post fMLP stimulation. To understand whether HL-60 cells responded to fMLP in 
a similar manner to primary neutrophils (see figure 3.32 B) WT cells were 
stimulated with a range of fMLP concentrations (10nM- 1M) for 30 minutes at 
37C. Cells were subsequently monitored for L-selectin surface expression by flow 
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significant difference in surface expression of L-selectin between fMLP and DMSO 
controls (figure 3.38). This was surprising given the dramatic shedding seen 
when primary neutrophils were subjected to fMLP, and the extent to which both 
cantharidin and calyculin A could promote shedding in HL-60 cells (figure 3.36).  
 
As stimulation of primary neutrophils with fMLP induced robust phosphorylation 
of p38 MAPK in primary human neutrophils (figure 3.33), it was important to 
understand if fMLP could induce the same response in HL-60 cells.  WT cells were 
stimulated for 30 minutes with either 200nM fMLP or 250 M cantharidin. As 
Cantharidin triggers robust p38 MAPK phosphorylation in HL-60 cells (figure 
3.39), this was used as a positive control. No difference between the DMSO and 
fMLP groups was detected, yielding values of: 2.43% +/-0.74 and 1.71% +/- 0.68, 
respectively (figure 3.39). In contrast, a significantly higher increase in phospho-
p38 MAPK was induced with cantharidin: 38.9% +/-5.52 (figure 3.39). Taken 
together, one can conclude that defective signalling pathway between FPR1/2 and 
p38 MAPK has been unearthed, which can be bypassed by the use of PP1/PP2A 
phosphatase inhibitors. It is important to note, DMSO treated primary neutrophil 
have ~38% of p38 MAPK in a phosphorylated state (figure 3.33), while WT HL-
60 cells only have ~3% of p38 MAPK in its phosphorylated state (figure 3.39). 
This clearly illustrates differences in behaviour (basal kinase activity) between 
the cell line and primary cells.  
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Figure 3.38: L-selectin-GFP is not shed from HL-60 cells stimulated with fMLP  
WT cells were stimulated for 30 minutes with a range of fMLP concentrations and flow cytometry 
was used to monitor the remaining L-selectin at the cell surface. DMSO treatment acted as a 
negative control, while treatment with 100nM PMA was used as a positive control. L-selectin was 
detected with PE-conjugated DREG-56. A) Histograms depicting the surface expression of L-
selectin after the specific treatments. B) Percentage surface L-selectin expression was calculated 
from median fluorescence values, after removal of IgG isotype control value, and normalisation to 
the DMSO non-shed control. Experiments were conducted three times, each in triplicate. Bar 
indicates statistical significance and represents mean +/- SEM. Statistical analysis; one–way 








































































Figure 3.39: Stimulation of HL-60 cells with fMLP induces p38 MAPK phosphorylation 
WT cells were stimulated for 30 minutes with DMSO, 200nM fMLP or 250M Cantharidin. After 
stimulation, whole cell lysates were generated and phospho-p38 MAPK levels were determined by 
Western blotting. Phospho-p38MAPK, (A) and p38 MAPK, (C), were probed for on separate 
membranes. Proteins were identified using LI-COR compatible antibodies. B&D) Fold change was 
determined by densitometric analysis of protein bands corresponding to p38 MAPK and phospho-
p38 MAPK, after normalisation to -actin. E) Percentage of phospho-p38 MAPK was compared 
between treatment groups. Statistical analysis, one-way ANOVA followed by Turkeys multiple 
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3.2.20 Regulation of FPR1/2 receptor expression in WT and MN HL-60 cells 
Earlier in this chapter, chemotaxis of HL-60 cells towards fMLP was shown to be 
hindered in MN cells, but not WT cells (section 3.2.8). This observation suggests 
defective chemoattractant sensing, only when L-selectin shedding is blocked. This 
finding corroborates with an earlier report, where rendering L-selectin non-
cleavable in vivo profoundly impacts chemotaxis towards the intermediary 
chemoattractant, KC (a mouse CXCR1 agonist, called Gro- in humans). One 
possibility in the defective chemotactic ability of MN cells towards fMLP 
gradients in micropipette assays could be because of defective FPR1/2 
expression. Homo sapiens express three  paralogues of the formyl peptide 
receptor; FPR1, FPR2 and FPR3.  All three genes are located adjacently on 
chromsome 19. Neutrophils express only FPR1 and FPR2, which share a 69% 
sequence homology, FPR1 is the high affinity receptor for fMLP (Kd~10nM), while 
FPR2 is the low affinity receptor for fMLP (Kd~1M)(331) (332).  
 
To monitor surface levels of FPR1 and FPR2, WT, MN and GFP cells were 
exposed to 200nM fMLP for 20 minutes, then prepared as described in section 2.4 
for flow cytometry. Quantification of median fluorescence intensities (MFI) values 
revealed that WT cells expressed significantly higher levels of FPR1 and FPR2 






Figure 3.40: Formyl-peptide receptors surface expression is increased in WT HL-60 cells 
WT, MN or GFP cells were stimulated for 20 minutes with 200nM fMLP. Cells were prepared for 
flow cytometry through primary labelling with either anti-FPR1 or anti-FPR2; secondary 
antibodies were conjugated with AlexaFluor 633. In parallel isotype controls were conducted. 
Ai&Bi) Representative histograms depicting the surface expression of FPR1 (Ai) and FPR2 (Bi), 
after fMLP treatment. Aii&Bii) Percentage surface expression was calculated from median 
fluorescence intensity (MFI) values, normalised against their respective isotype controls. 
Experiments were conducted three times each in triplicate, bar graph represents mean +/- SEM. 
Statistical analysis; one–way ANOVA with Tukey’s comparative testing. ** p<0.01, *p<0.05.  
 
Western blotting was next used to determine if the difference in surface 
expression was due to: (i) overall decrease in protein expression or (ii) defective 
receptor trafficking to the plasma membrane. Briefly, each cell lines was 
stimulated, for twenty minutes at 37oC with 200nM fMLP, and whole cell lysates 
probed for FPR1/2 expression by Western blotting. Importantly, the normalised 
levels of FPR1 and FPR2 were not significantly different in either of the three cell 
lines (figure 3.41). This strongly implies that expression of WT, but not MN, L-











































































































































Figure 3.41: Total protein levels of FPR1 and 2 are not altered between WT, MN and GFP 
cells 
WT, MN or GFP cells were stimulated for 20 minutes with 200nM fMLP and whole cell lysates 
were resolved on polyacrylamide gels, transferred to nitrocellulose filters and probed by Western 
blotting. A single Western blot of FPR1 is represented in (Ai), and densitometric analysis was 
performed on at least 3 independent Western blots (A ii). Total protein levels were normalised to 
-actin for both receptors. Similar procedures applied for the detection and quantification of 































































































































































3.3 Discussion  
The main aim of this chapter was to determine if the shedding of L-selectin in 
neutrophils occurs specifically during TEM, which was recently reported in 
primary human monocytes(212) .This indeed was the case, which then led to the 
establishment of a cellular model that could be used to genetically dissect some of 
the pathways that might be critical in controlling this process. As this project is 
heavily weighted towards studying L-selectin shedding, the use of sheddase 
inhibitors (such as TAPI-0) is an extremely useful tool when working with non-
genetically tractable cells, such as primary human neutrophils. However, the 
specificity of such small molecule inhibitors are often limiting as they can have 
uncharacterised off-target effects. This is why a great effort has been invested in 
establishing a cellular model. 
 
Generating cell lines to faithfully reproduce neutrophil behaviour is equally 
fraught with limitations, as cell lines are typically highly proliferative with 
doubling times reaching 1-2 days. The nature of increased proliferation is likely to 
impact the type of kinases and phosphatases that are active during cellular 
processes such as TEM, which may not be equally active in primary human 
neutrophils. This chapter has therefore generated and characterised HL-60 cell 
lines that express GFP alone or the non-cleavable MN to act as suitable controls 
for understanding HL-60 cells that express WT L-selectin-GFP. 
3.3.1 L-selectin shedding during TEM and beyond: similarities and differences in 
monocytes and neutrophils 
This study has shown that, as in monocytes, L-selectin is cleaved from neutrophils 
specifically undergoing TEM. There are however a number of fundamental 
similarities and differences with primary human monocytes, which will be 
described in smaller sections below: 
3.3.1.1 The role of p38 MAPK and L-selectin shedding during TEM 
It is clear from the work documented in this chapter that L-selectin shedding is 
activated specifically in response to TEM, and not before. This observation applies 
to both primary human neutrophils (figure 3.1) and HL-60 cell lines (figure3.37). 
Importantly, these observations corroborate well with what has been reported in 
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monocytes and suggests a conserved mechanism between different leukocyte 
subsets. Currently, it is not known which kinase (PKC, p38 MAPK or both) triggers 
L-selectin shedding during TEM. However, it appears that the extent to which L-
selectin is shed during TEM is very different between primary human neutrophils 
and HL-60 cells. It is likely that the difference in the degree of phosphorylation of 
p38 MAPK is responsible for the disparity in L-selectin shedding. In support of 
this, stimulating primary human neutrophil suspensions with fMLP leads to 
robust L-selectin shedding (figure 3.32), which is not detectable when HL-60 
cells are challenged in the same way. However, when HL-60 cells are incubated 
with cantharidin or calyculin A, both activators of p38 MAPK, L-selectin shedding 
is robust. Further work using inhibitors of p38 MAPK, MEK/ERK and PKC, as 
shown by Killock and Ivetic (209) should be implemented in this study to better 
understand the role these kinases play in promoting L-selectin shedding during 
TEM. As endothelial cells will also come into contact with these inhibitors, one 
should be aware that this approach might not provide a fully conclusive result.  
3.3.1.2 Blocking L-selectin shedding and its impact on chemotaxis and cell polarity  
Based on the data outlined in figure 3.13 and figure 3.14, it is clear that HL-60 
cells expressing MN L-selectin do not  polarise or chemotax towards fMLP 
gradients as effectively. Similar phenotypic observations have been published in 
monocyte-like THP-1 cells, which fail to polarise efficiently towards micropipettes 
dispensing MCP-1 when MN, but not when WT L-selectin is expressed (212).As 
MCP-1 is an intermediary chemoattractant and fMLP is an end-stage 
chemoattractant, this would suggest that blocking L-selectin shedding could 
indeed impact chemotaxis irrespective of the chemoattractant. It also suggests 
that blocking L-selectin shedding impacts chemotaxis in different leukocyte 
subsets. However, nothing is known about how this happens at a mechanistic 
level. 
 
Blocking L-selectin shedding in primary human monocytes and neutrophils 
affects cell polarity within the sub endothelial space, but in rather different ways. 
Figure 3.7 shows that TAPI-0-treated primary human neutrophils present an 
elongated phenotype, which is similar to primary human monocytes treated with 
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TAPI-0 (monocyte treated with TAPI-0 displayed a significantly increased longest 
axis compared to control cells).  Interestingly, HL-60 cells expressing MN L-
selectin can phenocopy the bipolar phenotype, suggesting that the effects of TAPI-
0 in neutrophils could be specifically targeting L-selectin shedding. In contrast to 
neutrophils, monocytes have been shown to present a “multi-protrusion” 
phenotype. Although the molecular mechanism underlying differences in 
monocyte and neutrophil polarity have not been investigated in any detail, it 
indicates two possibilities: (i) the cytoskeletal machinery regulating migration is 
“hard-wired” differently in monocytes and neutrophils, (ii) blocking L-selectin 
shedding in monocytes and neutrophils impacts different aspect of cytoskeletal 
regulation, resulting in different polarity phenotypes. 
3.3.1.3 The contribution of S364 and S367 in driving phenotypic differences in WT 
and MN cells 
The serine residues within the tail of L-selectin are known to regulate the binding 
of calmodulin(212). It is known that mutation of S346 to alanine or aspartate not 
only decreases CaM binding to L-selectin, but also L-selectin shedding. Therefore 
it is likely that the ERM proteins, which also interact with the L-selectin tail, are 
similarly affected by L-selectin serine phosphorylation, but this is currently 
speculation. Nonetheless, altering the capacity of these serine residues to be 
phosphorylated by mutating them to non-phosphorylatable alanines or phospho-
mimicking aspartates has revealed some interesting phenotypic differences. 
Single alanine/aspartate mutants of L-selectin at S364 or S367 may pinpoint 
more accurately which residue is more important. As serine S364 is conserved 
between mice and humans, it is likely that this residue plays a dominant role in 
regulating signal transduction events. 
3.3.2 L-selectin enrichment at the cell rear  
L-selectin was found to localise at the uropod of the cell, upon chemotaxis on a 
fibronectin substrate and immediately prior to TEM. During TEM this uropod 
enrichment of L-selectin often corresponded with detachment of uropod 
microparticles. Preventing L-selectin shedding did not alter the frequency of the 
uropod spot formation. MN SSAA significantly reduced the amount of uropod 










localised to the uropod is predominantly phosphorylated.  The uropod may be a 
location of serine phosphorylation or have a lower concentration of serine 
phosphatases. Interesting, no uropod spots were observed in GFP alone-
transduced HL-60 cells, indicating that uropod spots could be composed 
exclusively of cell membrane. To confirm this is not the case, GFP cells could be 
stained with a membrane dye and re-measured for uropod spots. The function of 
these uropod spots remains elusive, they could act to temporarily seal the 
endothelial junctions after a TEM event has occurred, or could act as signalling 
molecules to indicate sites permissive for transmigration. To investigate these 
hypothesis’, junctional permeability could be monitored using fluorescent 
dextrans, and multiple waves of leukocyte perfusions could indicate if TEM occurs 
more frequently at the deposition site of these uropod spots. 
3.3.3 L-selectin clustering in fTEM primary neutrophils  
Previous observations in the human monocytic cell line THP-1, where WT L-
selectin GFP was expressed, demonstrated that L-selectin organised into punctate 
spots specifically within the transmigrated pseudopods. The spots were 
hypothesised to form as a consequence of ligand induced L-selectin clustering, 
likely through the proteoglycans vinculin and biglycan, known ligands of L-
selectin, and present beneath the basal surface of the endothelium. L-selectin 
clustering was severely reduced in THP-1 cells when L-selectin shedding was 
genetically blocked (212).To this end full-length L-selectin “spot” organisation 
was observed and quantified in fully transmigrated primary neutrophils. 
Strikingly, no significant difference in spot size and number of spots per cell were 
observed between DMSO and TAPI-0 treated cells. The antibody LAM1-14 
detected L-selectin, however, this antibody recognises only the extracellular 
domain, and thus does not highlight the behaviour of the cleaved stump. 
Additionally, cells were permeabilised prior to immunostaining, therefore it 
cannot be exclusively ruled out that the spots are intracellular. The cause of these 
“spots” are currently unknown, however they could occur as a consequence of = i) 
molecule trafficking, ii) membrane organisation or iii) in response to ligand 
clustering. Each will be briefly discussed below:  
As a consequence of molecular trafficking 
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The spots observed could be a result of L-selectin turnover, internalisation for 
degradation or trafficking to the membrane. Investigating co-localisation of L-
selectin with endosomal markers, such as CD63, EEA1 and RAb1, could be 
conducted in future studies to fully elucidate the exact function of this L-selectin 
enrichment (333) (334) (335).  
As a consequence of membrane organisation 
As the spots were only observed in fTEM primary neutrophils the spots could be a 
result of membrane reorganisation post TEM. In neutrophils L-selectin has a 
bimodal distribution (~51% +/- 7 found in lipid rafts and ~33% +/- 7 found in 
none raft fractions) (336). TEM might encourage movement of L-selectin into 
lipid rafts. Lipid rafts are thought to be regions of L-selectin shedding as these 
rafts have a 2-3-fold elevation of the negatively charged phosphatidylserine 
compared to the plasma membrane. Here, the basic rich cytoplasmic tail of L-
selectin may strongly interact with the highly anionic rich inner leaflet of the lipid 
raft plasma membrane, preventing calmodulin interaction and thus encouraging 
L-selectin shedding (337),(338),(339).Additionally, ADAM-17 is found in lipid 
rafts, further supporting the notion that L-selectin is shed within these membrane 
domains. To address this hypothesis, the cell lines WT and MN could be used 
and stained with LAM1-14. Here, co-localisation between the C-terminally fused 
GFP and N terminally bound LAM1-14 signal will indicate whether the shed form 
of L-selectin residues in similar clusters. Investigating co-localisation of L-selectin 
with known lipid raft associated proteins for example flotillins may also confirm 
whether the L-selectin clustered signal is within a lipid raft.  
As a consequence of ligand clustering 
L-selectin clustering could be a prerequisite for shedding. Several studies have 
shown that mAb cross-linking induced L-selectin clustering has resulted in L-
selectin shedding (340)(341)(342). Furthermore, densely arranged sulphated 
ligands, similar to ECM sulphated proteoglycans have been shown to cluster and 
ultimately shed L-selectin (343)(344). 
3.3.4 Final thoughts  
Finally, all cell migratory behaviours post transendothelial migration have been 
monitored in the sub endothelial space. This two-dimensional space between 
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endothelial monolayer and glass cover-slip substrate is ~1 micron in height, and 
constricts the neutrophils in a manner non-reflective of the heterogeneous 
flexible ECM fibre meshworks. The following results chapters is concerned with 
generating and optimised a device to monitor the entire leukocyte adhesion 
























4. Generating microfluidic devices to monitor neutrophil 
migration in complex environments 
4.1. Generation of a 2D device to monitor leukocyte behaviour when responding to 
conflicting gradients of chemoattractants  
4.1.1.  Biological rationale behind the design of the 2D device 
Understanding how a leukocyte decides which signal to follow within a tissue is 
complex and little is known about the “guidance hand-over” between 
intermediary and end-target chemoattractants occurs. Therefore, to interrogate 
how leukocytes respond when challenged to both an end-target and intermediary 
chemoattractant simultaneously a reductionist approach was required. The first 
section of this chapter is concerned with designing and generating a microfluidic 
device to view how leukocytes respond to conflicting chemotactic cues. The 
device is a modification of gradient generating devices (345)(346)(347). The 
design and optimisation stages will be discussed in detail below.  For simplicity, 
the device will now be referred to as the “2D device” because migration takes 
place only in 2D.  
4.1.2 Designing and generating the 2D device  
Briefly, the device (figure 4.1 A) is composed of a central 300m wide main 
channel. Running parallel, on either side of this main channel, are side channels. 
The side channels are connected to the main channel through a series of smaller 
perpendicular microchannels (figure 4.1 A). The device has 7 openings numbered 
1-7 (figure 4.1). The openings will be referred to later in the text as inlets or 
outlets for the passage of cell culture media, in certain cases carrying cells or 
chemoattractants. The openings 1-4 are inlets for the introduction of media while 
the openings 5-7 are outlets for the removal of media.  
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Figure 4.1: Schematical representation  of the 2D device.  
A) Ariel view of the 2D device with appropriate dimensions. Numberings identify inlets (1,2,3,4) 
and outlets (5,6,7). B) Cross sectional view of the 2D device within the red-hatched lines, the 
dimensions here indicate the relative heights of the main and side channels (both 60m) 
compared to the small microchannels (2m).  
 
Prior to fabrication, the design (figure 4.1) was drawn to scale using AutoCAD, 
and printed onto two black emulsion masks at 40,000 dots per inch (dpi) 
(JDphotodata). The masks were printed in inverted contrast where all the 
features of the device (channels and inlets) were transparent; allowing light to 















Figure 4.2: Black emulsion masks for the 2D device  
A) 1st Layer: small microchannels. Scale bar is 120 m. B) 2nd Layer: main and side channels with 
corresponding inlets and outlets. Scale bar on both images is 1cm. Each black emulsion mask has 
four devices. The central rectangles are identical in position in both the 1st and 2nd layers of the 
black emulsion masks -these features are alignment marks.  
 
Once checking for geometric and printing errors within the black emulsion masks 
was complete, the initial stage of the device fabrication could commence. The 2D 
device was constructed using a staged approach, summarised in the following 
schematic figures (figure 4.3 &figure 4.4).  In summary, the first stage (figure 
4.3) uses ultraviolet (U.V) light to crosslink a photosensitive resist in the desired 
pattern onto a silicon wafer. This process is termed photolithography. The second 
stage (figure 4.4) uses the previously generated patterned silicon wafer to act as 
a master mould to cast inverted replicated stamps. These replica stamps are cast 
using an elastomeric material, Polydimethylsiloxane (PDMS). This second stage of 
the device design is termed soft lithography.  
 
All photolithography work was carried out in a class 1000 (ISO 6) cleanroom at 
the London Centre of Nanotechnology (LCN). Temperatures, timings and spin 
speeds were all optimised using guidance from the photoresist manufacturer 
Microchem.  
 
To start the fabrication process a 3-inch circular silicon wafer (WRS materials) 




dehydrated for 20 minutes at 200℃ to remove any residual alcohol (figure 4.3 
stage 1). Once dry, an epoxy-based negative photoresist, SU8 2002 (Microchem), 
was spin coated onto the wafer, this spin coating results in the first layer of 
device, producing the 2m high microchannels.  The thickness of the layer of 
photoresist on the wafer is determined by resist type, spin speed and spin 
duration. Later, (see below) a second layer of photoresist is applied to the wafer; 
this results in features of 60m height.  To apply the SU8 2002 the wafer was 
spun at 3000 rpm for 1 minute to obtain a 2m thickness. This thickness 
determines the size of the first set of features (microchannels) imprinted onto the 
wafer (figure 4.3 stage 2).  The coated wafer was baked for 1 minute at 95℃ to 
remove solvent from the photoresist, in turn increasing the viscosity (figure 4.3 
stage 3). The wafer was then aligned with the black emulsion mask directly above 
the wafer. Aligning both the emulsion mask and the pre-coated wafer was carried 
out using a Karl Suss MJB3 mask aligner. The wafer was then exposed to U.V for 4 
seconds at 20 mJ/cm2.  The U.V light travels through the “clear” regions of the 1st 
emulsion mask (figure 4.2 A) to hit the photoresist. U.V exposure cross-links the 
photoresist making it adherent to the silicon wafer (figure 4.3 stage 4). Post 
exposure baking of the wafer was then conducted for 2 minutes at 95℃ (figure 
4.3 stage 5). Uncross-linked SU8 2002 photoresist was chemically removed from 
the wafer through incubation with Microposit EC solvent-11 for 1 minute (figure 
4.3 stage 6).  The cross-linked microchannel features remain present on the 
silicon wafer.  
 
To generate the main and side channels a second round of photolithography was 
employed onto the patterned wafer described above. The wafer was spin coated 
with a second SU8 photoresist (SU8 2025) and re-spun at 1500 rpm to obtain a 
60µm thickness (figure 4.3 stage 7). The more viscous a photoresist, the thicker 
the coating produced onto the silicon wafer. SU8 2025 photoresist was used for 
this second spin due to its increased viscosity compared to SU8 2002. The coated 
wafer was baked (pre-exposure) for 2 minutes at 65℃ and 7 minutes at 95C 
(figure 4.3 stage 8). The second black emulsion mask (figure 4.2 B) was 
positioned above the silicon wafer using the Karl Suss MJB3 mask aligner, the 






reflected the thicker resist layer.  Prior to exposure, alignment marks previously 
created onto the wafer (figure 4.2) from the previous exposure were used to 
align the two layers of features to ensure that the small microchannels would 
correctly connect with the side and main channels (figure 4.3 stage 9). Post-
exposure bake time was 1 minute at 65℃ and 6 minutes at 95C (figure 4.3 stage 
10). The wafer was then developed in Microposit EC solvent-11 for 5 minutes 
(figure 4.3 stage 11). Finally, to preserve the longevity of the features patterned 
on the wafer, the patterned wafer was hard baked at 180C for 5 minutes and 
inspected using light microscopy to ensure all the features were accurate and well 
developed (figure 4.3 stage 12). The final product from this stage of the 
fabrication process was a silicon wafer patterned with both 2µm high features 





Figure 4.3:  Schematic representing the 12 stages of the photolithography process for the 
2D device fabrication 
1) The silicon wafer is cleaned. 2) The silicon wafer is spin-coated with a SU8 2002 photoresist to 
produce an even layer 2m thick. 3) The silicon wafer is baked. 4) Silicon wafer is aligned with the 





























the black emulsion mask generating permanent features on the wafer, this occurs through U.V 
dependent cross-linking of the photoresist. 5) The silicon wafer is baked. 6) Chemical 
development to remove uncross-linked photoresist. 7) The silicon wafer is spin-coated with a SU8 
2025 photoresist to produce a 60m thick layer. 8) Silicon wafer is baked. 9) Align a second black 
emulsion mask and expose to U.V. 10) Bake. 11) Chemical development. 12) Visual inspection.  
 
The patterned wafer is placed into a petri dish to act as a master mould. PDMS is 
poured on top of the silicon wafer. PDMS is a polymer made by mixing elastomer 
and curing agent in a 10:1 ratio of elastomer: curing agent. PDMS is frequently 
used to generate biological devices, as the polymer is biocompatible and optically 
transparent. The PDMS is cured for a minimum of 2 hours at 60℃ (figure 4.4 A). 
Once set, PDMS devices are released from the master mould. Inlet and outlet holes 
are bored using a 0.75mm diameter biopsy punch, to excise cylindrical PDMS 
from the PDMS stamp. The PDMS device is irreversibly bonded feature side down 
to a cleaned 5cm diameter glass. To bond, oxygen plasma is passed over the 
surfaces of both the PDMS and glass coverslip and immediately placed together. 
Oxygen plasma converts the silicon bonded methyl groups on the PDMS surface to 
silanol terminations (SiOH) and the oxygen plasma oxidises the glass coverslip. 
Together the functionalised PDMS and glass adhere covalently by producing Si-O-
Si bonds. To ensure a strong PDMS to glass bond formation, the 2D device is left at 
60C overnight. The following day, the inlets and outlets are then fitted with tygon 
tubing (figure 4.4 B) to allow for the introduction of fluids for 2D device priming 
(see section 4.1.3) and ready for the introduction of cells into the main channel 
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Figure 4.4:  Schematic representing the soft lithography and 2D device assembly process.  
A) PDMS is poured onto the patterned silicon wafer, which acts as a master mould. The PDMS is 
left to polymerise, once set the PDMS can be cut free. B) Inlets and outlets are generated using a 
biopsy punch. The PDMS is irreversibly bonded to a glass coverslip, feature side down to generate 
the channels. Tubing is then introduced. C) Cells and fluids can be introduced from the inlets into 
the device.  
 
4.1.3 Quality control testing of a chemoattractant gradient  
Chemotaxis of leukocytes within the 2D device is strictly dependent on the correct 
establishment of a diffusion gradient. Basic linear gradients are generated in the 
main channel - the location where the leukocytes are seeded. To generate 
gradients in the main channel, chemoattractants are introduced into the side 
channel inlets under low pressure (between 9-13 mbar).  Under this low 
pressure, fluid velocity is low, and the fluids travel in laminar flow.  Laminar flow 
describes fluids flowing in parallel, where different fluids mix solely through 
lateral diffusion at the interface.  For fluid to enter the main channel it must move 
from the side channels to the microchannels, the height difference between the 
microchannels (2µm) and the side and main channels (60µm) restricts fluid 
movement. During a chemotaxis experiment the inlet and outlet corresponding to 
the main channel is sealed. Therefore, the movement of fluid from the 
microchannel and into the main channel is governed by diffusion and the little 
internal convection that is present. To monitor gradient formation, medium 
supplemented with fluorescently labelled dextrans was introduced into the side 
channel inlets (1,2&4) (figure 4.1). Each inlet introduced a uniquely labelled 
dextran; FITC-dextran, TRITC–dextran and Alexa647-dextran. To accurately 
model diffusion of the physiologically relevant chemokines, the molecular weights 
of all dextrans were 10kDa as this reflected the average weight of a chemokine 
(~8-11kDa). Additionally, to maintain consistent comparative fluorescence 
intensities throughout different 2D devices, dextrans were used at a working 
concentration of 0.1mg/mL and microscope settings and parameters were kept 
constant.  
 
The ultimate aim of the 2D device was to initially expose cells to only one 
chemoattractant (either an end-target or intermediary), and then confront cells to 
a second chemoattractant gradient from the opposite direction. To this end, cell 
Deleted: is 
 174 
behaviour can be monitored in response to a single signal; this behaviour can 
then be directly compared (looking at the same cell population) when 
immediately presented with a choice of chemical cues (figure 4.5). 
 
 
Figure 4.5:  Schematic of chemoattractant competition experiment 
A) Leukocytes are seeded within the main channel and subjected to the first chemical cue - 
chemoattractant A. B) A second chemical cue is introduced – chemoattractant B. Leukocytes 
within the main channel are now subjected to two opposing gradients. For simplicity, the 
microchannels are not represented in this schematic; this is a representative depiction of the 
middle section of the 2D device, omitting inlets and outlets.  
 
To achieve the setups demonstrated in figure 4.5 A&B, inlets 1,2 and 4 were 
individually pressurised using a Fluigent system (MFCS-8C). The Fluigent system 
is a pressure driven flow controller, which is capable of individually controlling 8 
unique pressure values. The MFCS-8C instrument works through positive 
pressure at a value range of 0-1000mbar. To create the set up in figure 4.5 A each 
of the three inlets were pressurised: Inlet 4 (10.5mbar) and inlet 1 (9mbar) 
introduce different chemoattractants, while inlet 2 (10mbar) introduces cell 
culture media only. Initially cells within the main channel sense only the 
chemoattractant gradient supplied from inlet 4 due to the bifurcation channel 
(figure 4.5 A & figure 4.6 A). The bifurcation channel (a forked channel where 
two separate liquids are introduced from two separate inlets and converge into 
one side channel) allows the fluids introduced from inlet 1 and 2 to run in parallel 
laminar flow in the side channel. The cell culture media introduced from inlet 2 
shields the cells from the chemoattractant supplied from inlet 1 (figure 4.6 C).  To 














is stopped, and inlets are re-pressurised. I will refer to this step as a pressure 
switch as it typically can be achieved in a few milliseconds. The new pressure 
values are as follows: Inlet 1 (13mbar), Inlet 2 (0mbar) and Inlet 4 (10.5 mbar). 
Again, the rapid change in fluid pressure is achieved through the use of the 
Fluigent system. One minute after the re-pressurising of the inlets, a 
chemoattractant gradient produced from inlet 1 is visible in the main channel 
(figure 4.6 B & figure 4.7). Importantly, this pressure switch does not alter the 
pre-existing gradient formed within the main channel from inlet 4 (figure 4.6 B & 
figure 4.7). The leukocytes are now exposed to two opposing chemoattractant 
gradients (figure 4.5.B). Pressure values for each inlet were determined 
empirically.  
 
Gradient formation within the device was monitored live using an inverted 
fluorescence microscope. Two separate fields of view (FOV) were taken along the 
main channel. The two FOV were positioned ~50m and ~250m from the start 
of the main channel, respectively. It was important to include both of the side 
channels in the FOV to calculate initial fluorescence intensity for each dextran, 
prior to dextran dilution within the main channel. This initial fluorescence value 
will normalise fluorescence intensity values in the main channel, to gauge the 
relative concentration of chemoattractant.  Fluid movement coming from each 
inlet (1,2&4) could be identified through their unique fluorescence wavelength. 
Fluid from inlet 1 contained FITC-dextran, inlet 2 contained Alexa 647-dextran 
and inlet 4 contained TRITC-dextran. These were visualised using excitation at 
the following wavelength: 488nm, 543nm and 633nm, respectively. Images were 
acquired every minute using a 10x objective for a total duration of 45 minutes. 
The pressure switch occurred at the 23rd minute of experimentation (figure 4.7).  
 
To analyse gradient formation over time, post acquisition analysis was performed 
in the middle of the two FOV for each device using Fiji. A total of four devices were 
used to characterise the gradient behaviour. To determine fluorescence intensity 
values, a line profile was drawn across the width (transverse section) of the main 
channel in both FOVs. Intensity values, from the line profile were recorded over 
time separately for each wavelength. Line profiles were averaged over a 30-pixel 
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width to reduce noise. For each fluorescent dextran, fluorescence intensity values 
from each line profile at each time point were internally normalised, (F1/F0). 
Here, F0 is the fluorescence intensity within the side channel, prior to dextran 
diffusion.  Fluorescence normalisation controlled for slight differences in laser 
intensities between experiments. All fluorescence intensities were subjected to 
background fluorescence removal (Fb) (figure 4.7). Background fluorescence 
occurs through auto fluorescence of sample (e.g. from the 2D device or media), or 
from noise from the excitation light. Background fluorescence was measured for 
each unique fluorescent dextran using the appropriate laser excitation when no 
fluorescent dextran was present within the 2D device. Figure 4.7 show that two 
opposing gradients can be reproducibly generated at the two FOVs. The gradients 
also remain stable for a period greater than 20 minutes, an appropriate time scale 





Figure 4.6: Diffusion within the 2D device  
Confocal microscopy monitored the movement of each of the three dextrans into the main channel 
from the side channels. A&B) Numbers on top left hand side of image denote inlet specific dextran. 
A) A Confocal image before the pressure switch: inlets were pressurised as follows:  9mbar for 
inlet 1 (FITC-dextran), 10 mbar for inlet 2 (Alexa647-dextran), and 10.5mbar for inlet 4 (TRITC-
dextran). B) A Confocal image after the pressure switch: inlets were pressurised as follows: 13 
mbar for inlet 1 (FITC-dextran), 0 mbar for inlet 2 (Alexa647-dextran) and 10.5mbar for inlet 4 
(TRITC-dextran). C) Confocal still demonstrating the bifurcation channel, here fluids are 
introduced from inlet1 and inlet 2, and the liquids converge into the same channel however both 
liquids flow side by side.  Scale bar is 300m.  Switch occurs after 23 minutes of dextran 
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Figure 4.7: Fluorescence intensity line profile through the main  
Gradients profiles of the fluorescent dextrans, FITC dextran (inlet 1) & TRITC dextran (inlet 4) 
were monitored from images acquired from an inverted fluorescent confocal microscope. Two 
FOV located at ~50m(Ai) and ~250m(Aii) from the start of the main channel were imaged over 
time for each device. Diffusion profiles from a total of four devices generated the data represented 
in the graphs. Images were acquired every minute. Fluorescent dextran diffusion was assessed 
post image acquisition. A line profile was taken across the transverse section of the main channel 
(the width) to generate intensity values for each fluorescent dextran. Fluorescence background 
(Fb) intensities levels were removed from all fluorescence intensities values. Fluorescent intensity 
(F1) values along the line profile of the main channel were normalised with respect to the 
corresponding fluorescence intensity in the side channel, (F1-Fb/F0-Fb). Green symbols represent 
dextran movement from inlet 1. Red symbols represent dextran movement from inlet 4. Error 
bars represent standard deviation from the mean and represent four devices. Red and Green 
symbols with a black outline represent dextran movement after the pressure switch. The pressure 
switch occurs at minute 23. For the pressure values of each inlet before and during the pressure 
switch see figure 4.6. 
 
4.1.4 Cell seeding within the 2D device 
Prior to cell introduction, the device was primed with a 1x PBS solution. Priming 
the device minimised the risk of trapped air in the small microchannels. The best 
results were achieved when the device was fully submerged in PBS and left 
overnight before any experimentation was conducted to remove any gas 
dissolved with the gas-permeable PDMS. Care was taken to de-gas media before 
introduction into the device. Next, PBS containing 10g/mL fibronectin was 
introduced into the device to provide a substrate for cell adhesion. The device was 
incubated for 1 hour at 37 C with this solution. This was then washed out with 
PBS.  
 
 A bespoke cell seeding method was devised to position the cells in the centre of 
the main channel and prevent cell movement and aggregation at the entrance of 
the microchannels. Blockage of the microchannels would hinder delivery of the 
chemoattractant. Cells were introduced into the device (inlet 3) at a high 
concentration, (10-15x106/mL).  Inlet 1 and Inlet 4 introduced media at high 
pressures (~200mbar), while inlet 2 was blocked. All outlets were left open. High 
fluid flow entering the main channel from the microchannels focused cells into a 
central stream within the main channel. At this point all tubing connecting inlets 
and outlets were then rapidly blocked with the aid of arterial surgical clamps. 
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This rapid blockade of internal flow allowed cells to settle through gravity and 
adhere to the fibronectin substrate. Figure 4.8 A is an example of cell focusing 
then subsequent settling through gravity, while figure 4.8 B is an example of cell 
settling in an environment where there is internal flow, e.g. inlets and outlets have 
remained open. Unfortunately, due to time constraints no chemotaxis 
experiments could be performed using this device.  
 
Figure 4.8: Alternative cell seeding approaches in the 2D device 
Cells were introduced into the main channel of the 2D device. Cell seeding was imaged using 
brightfield and a 10x objective. A) Cell seeding in the main channel, inlet 1 and inlet 4 are 
pressurised at high pressure, ~200mbar, to encourage cells to focus into the middle of the main 
channel. Once focused all inlets and outlets are rapidly closed to allow cells to settle through 
gravity. B) Cell seeding in the main channel, all inlets and outlets remained open after cell 
introduction, resulting in cell displacement towards the edge of the main channel and 
accumulation at the entrance of microchannels.  White arrows indicate cells. Scale bar is 100m. 
 
4.2 Generation of a 3D device to monitor the entire leukocyte adhesion cascade 
from capture to chemotaxis 
4.2.1 Biological rationale behind the design of the 3D device 
Currently, the methodology used to study the multi-step leukocyte adhesion 
cascade of primary human leukocytes is limited and slow evolving. Scientists 
routinely use the parallel plate flow chamber. In this setup, leukocytes are 
perfused over activated endothelial monolayers under physiological shear stress 
and cellular behaviour is recorded in real-time. Traditionally, a confluent 
endothelium is grown on fibronectin-coated coverslips, which provides a limited 
space (~1 micron) between the endothelial cells and the underlying glass for the 
Ai)	 Aii)	) B)
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leukocytes to migrate. As such, the current setup does not provide an accurate 
representation of migration of leukocytes in the extravascular connective tissue 
observed in vivo. Leukocytes will typically sense different chemoattractants as 
they pass from the blood into tissue, which is not featured in any current parallel 
plate flow chamber model. Cain et al., recently developed a transmigration assay 
that was devoid of flow, but allowed transmigrating leukocytes to move 
directionally through a 3D collagen scaffold (348). Briefly, liquid collagen was 
polymerised within transwell inserts containing polycarbonate filters. Once an 
endothelial cell monolayer was established on top of the collagen matrix, the 
entire insert was placed into a well containing a known quantity of 
chemoattractant. Timed incubations showed that leukocytes would transmigrate 
and move directionally towards the highest source of chemoattractant. Although 
this technique was the first of its kind, it did not incorporate shear stress and did 
not permit live cell imaging, as the polycarbonate filter acted as an optical barrier 
for imaging with inverted microscopes. 
 
As explained above the study of the leukocyte adhesion cascade is disjointed, with 
separate assays to monitor leukocyte behaviour before and after transendothelial 
migration. The second part of this chapter will focus on the design and 
optimisation of a device, which will permit visualisation of the entire multi-step 
adhesion cascade: from initial tethering to interstitial chemotaxis through a 3D 
collagen scaffold.  For simplicity, this device will be referred to as the “3D device”.  
 
4.2.2 Design and fabrication of the 3D device 
The 3D device was designed around fixed specifications, summarised below 











Table 4:1: The specifications and justifications for the design of the 3D device. 
 
Briefly, the device consists of a thick PDMS frame irreversibly bonded to a glass 
coverslip. This frame supports a collagen matrix, which in turn supports an 
endothelial monolayer (figure 4.9). Within the frame, there are two 
microchannels, which can be used to introduce chemoattractant/s into the 
collagen (figure 4. 9). The device is open top, allowing it to be easily interfaced 
with the pre-existing parallel plate flow chamber within the Ivetic lab (figure 
4.9& table 4.1). Dimensions for the device were imposed by the need for 
compatibility with the present experimental setup. For example, the diameter 
(1.8cm) of the plastic parallel plate flow chamber dictated the distance between 
the microchannel inlet and the collagen trough, (figure 4.9), while the 5cm 






ECM component able to support a 
HUVEC monolayer.  
A confluent endothelial monolayer 
is required to mimic 
transendothelial migration.  
3D ECM permissible for neutrophil 
migration.  
Non-optimal matrix porosity will 
hinder migration. 
Stable chemoattractant gradient 
formed within the ECM.  
Allow neutrophils to follow a graded 
response to a chemoattractant 
source. 
Couple to a pre-existing parallel 
plate flow chamber.  
 
Allow introduction of neutrophils 
across the endothelium at 
physiological stress.  
ECM thickness ~ 125m in the 3D 
device. 
Thickness will enable sufficient 
depth for neutrophil migration and 
acquisition of z-stacks at high 




















Figure 4.9: Schematic of 3D device design.  
A) Side view of the 3D device interfacing with the parallel plate flow chamber. B) Aerial view of 
the 3D device. Dimensions represent the true dimensions of the 3D device. Endothelium and 
parallel plate flow chamber not shown for simplicity.  
 
Prior to fabrication of the 3D device, the design with the above dimensions 
(figure 4.9) was drawn using AutoCAD and transferred onto a black emulsion 
mask (JDphotodata). In the black emulsion mask, features to be patterned onto 
















































Figure 4.10: Black emulsion mask for the 3D device 
 
The 3D device was constructed using a staged approach, summarised in 
schematic figures figure 4.11 &figure 4.12.   
 
Fabrication is initiated with the cleaning of a 3-inch silicon wafer (WRS 
materials), as described in section 4.1.2, (figure 4.11 stage 1). An epoxy-based 
negative photoresist, SU8 2025 (Microchem), was spun coated at 1750 rpm to 
achieve a 50m thick layer. This thickness determined the microchannel feature 
in the 3D device (figure 4.11 stage 2). After, the coated wafer was baked (pre-
exposure) for 2 minutes at 65C and for 5 minutes at 95C (figure 4.11 stage 3).   
The features were then cross-linked onto the wafer. For this, the emulsion mask 
(figure 4.10) was aligned with the wafer using the Karl Suss MJB3 mask aligner. 
The wafer was exposed to U.V light for 10 seconds at 20 mJ/cm2 (figure 4.11 
stage 4).  U.V light passed through the transparent regions of the emulsion mask 
and cross-linked the photoresist to form irreversible features adhered to the 
silicon wafer. The wafer was baked (post exposure) for 2 minutes at 65C and 5 
minutes at 95C (figure 4.11 stage 5). Finally, the wafer was developed in 
Microposit EC solvent-11 for 5 minutes until all residual resist was removed, and 
hard baked at 150C for 4 minutes (figure 4.11 stage 6).  The wafer was then 





Figure 4.11:  Schematic representing the 7 stages of the photolithography process for the 
3D device fabrication 
1) The silicon wafer is cleaned. 2) The silicon wafer is spin coated with a SU8 2025 photoresist to 
produce a 50m thick layer. 3) Silicon wafer is baked. 4) Silicon wafer is aligned with the black 
emulsion mask and then exposed to U.V light. U.V only passes though transparent areas of the 
black emulsion mask generating permanent features on the wafer, this occurs through U.V 
dependent cross-linking of the photoresist 5) Silicon wafer is baked. 6) Chemical development to 
remove uncross-linked photoresist. 7) The silicon-patterned wafer is visually inspected.  
 
The patterned wafer can then act as a master mould. PDMS was poured over this 
master mould (figure 4.12 A). Prior to covalent plasma bonding of the PDMS to 
the glass coverslip, a rectangular PDMS cuboid 2.3cm (h) x 0.5cm(w) is excised 
with a scalpel from the central part of the device (figure 4.12 B). Biopsy 
punching. After plasma bonding to the glass, two microchannels are formed, 
separated by a large rectangular void. This excised region now acts as a trough, in 
which collagen can be polymerised to provide a substrate for endothelial cells 



























Figure 4.12:  Schematic representing the soft lithography and 3D device assembly process.  
A) PDMS is poured onto the patterned silicon wafer, which acts as a master mould. The PDMS is 
left to polymerise, once set the PDMS can be cut free. B) 1) Inlets are generated using a biopsy 
punch; a PDMS cuboid is excised from the centre of the device.  The remaining PDMS is 
irreversibly bonded to a glass coverslip, feature side down, to generate the microchannels and a 
trough. 2) Collagen is placed into the trough and left to polymerise. The polymerised collagen gel 
can support an endothelial monolayer. Chemoattractant/s (green) are introduced into the trough 
from the microchannel/s (one inlet filled here). 3) Finally, the device is interfaced with a parallel 
plate flow chamber to perfuse leukocytes across the endothelium at physiological shear stress.  
 
 
4.2.3 Optimising extracellular components to support a HUVEC monolayer 
 The extracellular matrix (ECM) is a non-cellular protein meshwork component 
surrounding all cells of the human body. In the interstitial space the ECM 
underlying the endothelium is produced through secretion by endothelial cells 
and pericytes (140),(141). Here, the two basic forms of the ECM are the basement 
membrane and the loose fibril-like interstitial matrix. Crucially, the ECM provides 
structural and signalling properties to support blood vessel formation and 
provides chemotactic properties to encourage leukocyte diapedesis (see section 
1.4.2). Therefore, it is important to not only generate a suitable ECM to provide a 
matrix where the HUVEC would reproducibly form a confluent monolayer (table 
4.1) but also to encourage TEM events.  
 
To this end, the commercialised hydrogel Matrigel was trialled. Matrigel is the 
solubilised basement membrane fraction from Engelbreth-Holm-Swarm (EHS) 
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proteoglycans (a protein proven to aid diapedesis). Matrigel was polymerised in 
bespoke cut PDMS troughs (as designed in section 2.12.4) at a concentration 
range of 2-4 mg/mL. After 30 minutes polymerisation, HUVECs were seeded at a 
density of 0.5X106/mL. In these conditions, HUVECs consistently failed to form 
cell-cell junctions, instead adopting an elongated “fibroblast like” phenotype 
(figure 4.13 A). It became apparent that Matrigel contained undocumented 
factors, promoting HUVEC to differentiate and form tubules. To prevent this, 
Matrigel  (25% (v/v)) was mixed with rat-tail collagen (75% (v/v)); this ECM 
composition did generally promote formation of a confluent HUVEC monolayer. 
However, confluent monolayers could not be reproducibly established. This is 
likely due to batch variability of the Matrigel . Thus, for ease of replication rat-
tail collagen was used as the only ECM component within the troughs. Rat-tail 
collagen is prepared as described in section 2.12.1. Collagen concentrations 
between 1.5-3mg/mL were tested and all promoted formation of confluent 
HUVEC monolayers (figure 4.13 B). As the device is open top, pericytes could be 
added in the collagen matrix in the future. This addition would aid endothelial cell 







Figure 4.13: HUVEC growth on different ECM components 
Phase contrast images of HUVECs grown on either A) Matrigel matrix or B) rat–tail collagen 
matrix, were acquired using a 10x objective. White arrow indicates, endothelial tube formation.  
Table 4.2: HUVEC grown on different ECM components 
 
4.2.4 Factors contributing to collagen pore size  
Cell migration within a 3D environment depends on three factors: 1) matrix 
metalloproteinases (MMPs) driven ECM digestion, 2) the degree of cell 
deformability and 3) the physical tissue constraints. If MMPs are inhibited; an 
additional constraint for a cell moving through a 3D meshwork is nucleus 
deformability. As neutrophils have a multi-lobed nucleus, the cells and their 
nuclei have a high deformability and therefore can migrate through pore sizes 
larger than 2 m2. In contrast, T cells and cancer cells need a cross sectional space 
of 4m2 and 7m2 respectively (349),(350). Previous work by Wolf et al., has 
shown that temperature and collagen concentration can affect the pore size of 
collagen gels (351). Therefore to assess how temperature and concentration of 
collagen contribute to the fibre density, reflection microscopy and post-
acquisition binary processing was performed. Using this technique, the 
organisation of the collagen fibres could be assessed to give an indirect indication 
of pore size.   
ECM	composi+on	(v/v)	 Repeat	number		 Comments	
A)100%	Matrigel®	 3	troughs	 Formed	tubes	









To analyse pore size, 50 µL of rat-tail collagen at concentrations of 1.5 mg/mL or 
2 mg/mL were added to PDMS troughs and left to set for 30 minutes. The 
polymerisation temperature was also a variable: 20 or 37C. The fibrous matrix 
architecture was imaged by confocal reflection microscopy (see section 2.12.1). 
For each condition, 8 troughs were assessed at three optical z-planes: 10 µm, 30 
µm and 60 µm above the glass substrate. To assess the pore size of each collagen 
preparation, a binary image of the collagen fibres was converted into a “distance 
map” provided within the tools of Fiji image analysis software. This is a Euclidian 
distance map also known as a distance transformation (figure 4.14 A) where each 
black pixel is replaced with a value, which directly correlates to its distance from 
the nearest white pixel. A black pixel that is further from a white pixel will have a 
higher value.  This is simplified in figure 4.14 B. The percentage of black pixels 
plotted against the transformed distance to the nearest white pixel gives an 
indication of how densely assembled the fibres are and the maximum distance 
between a black pixel (pore) to nearest white pixel (fibre). The distance in pixels 
is converted to m to calculate the correct distances between black and white 
pixels. Hence, this method can act as a faithful indicator of pore size (figure 4.15).  
This analysis does not take into account the 3D nature of pores; instead it 
represents pores as 2D circular structures. For clarity, all analyses start at a 
minimal distance of 2.3µm to the nearest white pixel. The graph indicates that 
changing the gelling temperature of rat-tail collagen from 37C to 20C caused an 
increase in pore size, the same effect was observed when the protein 
concentration was decreased (figure 4.15). Encouragingly, Wolf et al obtained 
similar results in a study (351).It is important to note that collagen pore size and 
fibre thickness can be manipulated through other parameters for example pH and 
polymerization time (352),(353). These variables where not varied within this 
thesis. 
 
This section highlights how changing parameters can have a profound effect on 
pore size. In order to maintain the highest degree of reproducibility, when 
conducting experimentation using the 3D device, protein concentration and 
polymerization temperature were carefully controlled.  
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Figure 4.14: Image analysis for estimating collagen pore size 
A) Polymerised rat-tail collagen was imaged using reflective confocal microscopy. Images were 
converted into binary where fibres were white and pores were black. Black pixels were given a 
value to representing their respective distance to the nearest white pixel (fibre); this can be 
represented as a distance map or tabulated as a distance transformation table. Scale bar is 50m. 
B) A simplified example of a binary picture, 0 = white pixels and 1 = black pixels; when 
transformed the pixels in the centre that are furthest from the 0 border have a higher value, this 











Figure 4.15: Graph demonstrating the effect of change in collagen concentration and 
polymerisation temperature on gel pore size.  
Polymerised rat-tail collagen was imaged using reflection confocal microscopy. For each condition, 
a total of 8 experiments were conducted with 3 confocal z-slices per experiment. Post acquisition 
analysis was conducted as explained in figure 4.14.  The graph represents the percentage black 
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from the mean. This was a qualitative assessment, so no statistical analysis was conducted. For 
clarity data points where a black pixel had a distance less than 2.3 m away from a white pixel was 
excluded, this represented the majority of pixels.  
 
4.2.5 HL-60 migration through a collagen matrix  
As shown in figure 3.10 addition of 1.3% (v/v) DMSO into the cell culture media 
of the HL-60 cell line induced differentiation into a neutrophil-like cell line. 
Differentiated HL-60 cells have routinely been used as a neutrophil model to 
monitor migration through a collagen gel.  
 
An important factor in the design specification was to ensure that the ECM 
components chosen, in this case rat-tail collagen, supported neutrophil migration 
(table 4.1). Thus, it was crucial to confirm that this cell line would successfully 
migrate within this matrix.  To monitor cell migration, 1x106 differentiated WT L-
selectin–GFP HL-60 cells, also known as WT, were mixed into 100L of 2.5mg/mL 
rat-tail collagen solution and placed into one well of a 96 well plate. The collagen–
cell mix was placed in a cell culture incubator for 30 minutes to allow for gel 
polymerisation. To confirm gel polymerisation had occurred, collagen fibres were 
observed by phase contrast microscopy. To prevent the collagen/cell mix from 
drying out, 200L HL-60 cell culture media was pipetted on top of the gel. Cell 
migration was monitored for 30 minutes with time-lapse microscopy. Imaging 
was conducted on three separate occasions; each time all cells in the FOV were 
tracked using the manual tracking software MtrackJ. Cells were only tracked if 
they remained in the FOV for the 30-minute window of imaging. The average 
speed of migration was 1.89 m/min  +/- 0.14 (figure 4.16).   
 
As successful migration was observed in 2.5mg/mL collagen, this concentration of 
collagen was used in the trough of the 3D device.  Due to time constraints, the 
pore size was not evaluated at this collagen concentration and no further 
examination of additional migration assays in alternative collagen concentrations 





Figure 4.16: HL-60 migration through collagen gel  
Differentiated WT L-selectin-GFP HL-60 cells (WT) were mixed into liquid collagen. Once the rat-
tail collagen (2.5mg/mL) was polymerised, cell migration was observed using an inverted 
fluorescence microscope.  The experiment was conducted on three separate occasions. In total 90 
cells were tracked for a 30 minute period. A) The average speed was 1.89 m/min +/-0.14; error 
bar represents the standard error of the mean. B) To visualise the length of cell trajectories, tracks 
were adjusted to have a 0,0 start point; X and Y-axis represent pixels.  
 
 
4.2.6 Optimising the collagen depths with the 3D device  
The depth of the collagen within the device was an important design feature 
(table 4.1). Indeed, the depth of the trough needed to allow neutrophil invasive 
migration for 1 or 2 hours, yet the depth needed to be compatible with the 
working distances of high magnification objectives in order to observe specific 
membrane protein localisation. 
 
The working distance of an objective is the distance between the front edge of the 
objective lens and the specimen surface. In general, as the magnification of the 
objective increases the working distance decreases. Using the common working 
distance for a 60x oil immersion lens (Nikon) as 0.21mm, and taking into account 
the thickness of the coverslip (or base of the 3D device) as 0.085mm, the depth of 
the collagen should be no more than 0.125mm(0.21mm-0.085mm=0.125mm). By 
definition collagen is a hydrogel, capable of retaining large amounts of water 
within the three dimensional network. Therefore, it was important to monitor 






















2.5mg/mL rat-tail collagen were prepared as described in section 2.12.1, and 
pipetted into the centre of the 0.5cm by 2.3cm trough. Prior to collagen 
deposition, devices were chilled on ice to prevent premature collagen 
polymerisation; the collagen was levelled by eye. Producing a level surface of 
polymerised collagen in a trough is problematic. Surface tension at the edges of 
the trough results in the collagen solution naturally forming a meniscus, setting 
thicker at the edges and thinner in the middle. To minimise this effect, the edges 
of the trough were lined with a hydrophobic barrier pen to reduce surface 
tension.   
 
Once the collagen had polymerised within the troughs, HUVECs were seeded and 
left for 48 hours to form a confluent monolayer. Prior to imaging, HUVECs were 
stained with 1M Celltracker TM Orange (see section 2.5.3).  Collagen depths were 
monitored with confocal microscopy using a line scan in Z. Using the stained 
endothelium and reflection microscopy for the collagen fibres the depth of 
collagen could be gauged. Line scans in Z were taken at four positions within each 
trough to determine collagen depths. Twelve troughs for each different collagen 
volume were analysed on three separate days. There were significant differences 
in the depths for each collagen volume.  The mean depth for each volume was 132 
m  +/- 22.9 (30L), 536 m +/- 29.2 (50L) and 860 m +/- 29.5 (70L) (figure 
4.17). Therefore, 30L was used within the trough as this generated the optimal 
thickness to allow high-powered magnification imaging. Smaller volumes of 
collagen (10L and 20L) were trialled but were hard to manipulate, and 
frequently resulted in the collagen completely drying out and peeling away from 
























Figure 4.17: Optimising collagen depths within a trough 
PDMS troughs (0.5cmx2.3cm) were filled with varying volumes of liquid collagen. Once 
polymerised the collagen supported a HUVEC monolayer. When confluent, this HUVEC monolayer 
was stained with 1M Celltracker Orange. Collagen depths were assessed through confocal 
microscopy using a line scan in Z. Collagen fibres were imaged through reflection microscopy and 
the position of the endothelial monolayer was assessed through the Celltracker stain. For each 
collagen volume, 12 troughs were assessed with 4 line scans in Z for each trough. Statistical 
assessment was conducted using a one-way ANOVA followed by Tukey’s multiple comparison 
tests. **** p<0.0001.  
 
4.2.7 Generating a chemoattractant gradient within the 3D device  
Another specification for the device was the production of a stable 
chemoattractant gradient produced in the collagen (table 4.1).  To assess the 
gradient formation and stability in the 3D device, 30L of 2.5mg/ml collagen was 
placed in the trough of the device and left to polymerise for 30 minutes.   HUVECs 
were grown to confluence on top, prior to gradient assessment the monolayer 
was stimulated with TNF- for 12-16 hours, to mimic the “leakiness” of the 
junction under inflammatory conditions. To visualise the HUVEC monolayer, the 
cells were stained with 1M Celltracker TM Orange,(section 2.5.3). The gradient 
was formed using the source/ sink principle (figure 4.18). The source in these 
preliminary experiments was visualised with a 10,000 MW FITC-dextran.  The 
weight of the dextran represents the average molecular weight of a chemokine 
~8-11 kDa (figure 4.9).  Introduction of the dextran was achieved through the 
use of a Harvard syringe pump, running at a rate of 0.2L/min. The sink is the 
large reservoir of medium above the HUVEC monolayer. To establish a gradient, 
the volume of the sink must be either far larger than that of the source, or the sink 
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must be continually replenished to prevent accumulation of the FITC-dextran 
molecules. In experiments conducted in chapter 5, cell medium above the HUVEC 
monolayer is continually being replenished by the parallel flow system. The 
HUVEC monolayer acts as a permeability barrier; dextran can only diffuse 
through the junctions between ECs. As a result, this physically constrains 
diffusion within the collagen gel, slowing down the release of the dextran from the 
gel into the medium.  
 
To monitor the FITC-dextran movement through the collagen, line scans in Z were 
acquired using a 10X objective (figure 4.18). Confocal line scans were taken at 
regions proximal to the entrance of the microchannel either in XZ or YZ (figure 
4.19).  Images were acquired every minute for 60 minutes. The dimensions of the 
line scans were ~1.5 mm in the X or Y-axis and 150 m in Z.  
 
Figure 4.18:  A line scan in XZ demonstrating FITC-dextran diffusion  
Rat-tail collagen 2.5mg/mL (30L) was added to the trough within the 3D device. Once 
polymerised, this matrix allowed formation of an endothelial monolayer. Prior to diffusion 
experiments, the endothelium activated and stained with 1M Celltracker TM Orange. FITC- 
dextran was introduced into one of the microchannels in the 3D device at a rate of 0.2 m/min. 
Line scans in Z were taken to monitor diffusion profiles. A) Endothelium only. B) Dextran and 
endothelium.  Post acquisition, line profiles (black dashed line) were taken through the transverse 
line scans Scale bar is 30m.  
 
Post acquisition, analysis was conducted on the line scans in XZ or YZ using a line 
profile intensity tool implemented in Fiji (figure 4.18). Fluorescence intensity 
values (F1) for each line profile were normalised with respect to the fluorescence 
intensity in the microchannel prior to diffusion (F0). In addition, background 












experiments characterized the stability of the diffusion in time and along the XZ 
and XY axis (figure 4.19).  
 
 
Figure 4.19: Fluorescence intensity line profiles demonstrating the establishment of a 
concentration gradient along the z axis.  
A) A line scan in XZ (within the proximal region) was acquired every 1 minute. FITC-dextran 
diffusion over time was monitored by taking a line intensity profile (see black dashed line in 
figure 4.18 B) from line scans in XZ at 5 minutes, 30 minutes and 1 hour. Background 
fluorescence values were subtracted from the fluorescence intensity values prior to normalisation. 
Data from one 3D device is shown. B) Three separate line scans in XZ were conducted within the 


























































proximal region in three separate 3D devices. FITC-dextran diffusion was monitored 1 hour after 
dextran introduction by taking a line intensity profile (see black dashed line in figure 4.18 B). 
Fluorescence intensity values were normalised and background fluorescence removed. C) 
Experiments were conducted in the same way as B) except that a YZ line scan was acquired within 
the proximal region.  Red line in each schematic right of the graph demonstrates the position of 
the line scan in z. 
 
The FITC-dextran gradient remained relatively stable for 1 hour within the device 
(figure 4.19 A). Gradients formed in both the XZ and YZ were similar (figure 4.19 
B&C) indicating that within this 1.5mm2 region diffusion profiles were 
characterised. This 1.5mm2 area will now be called the proximal region, and the 
far ends of the trough will be termed remote regions. The remote regions are 
expected to have a lower concentration of chemoattractant. Although this has not 
been fully explored using dextran modelled diffusion profiles, the diffusion of 
TRITC-dextran (10,000Da) in the proximal and remote positions have been 
observed using an inverted fluorescence microscope and show clear differences 





Figure 4.20:  Gradient observation during flow assays 
TRITC-dextran was introduced into a microchannel of the 3D device. Collagen and HUVEC are 
present, but not shown.  TRITC-dextran could be observed in the proximal region of the 3D device, 
(B), but no TRITC-dextran could be observed in the remote region of the 3D device, (A). TRITC-











indicating the locations of the remote and proximal regions (black rectangles) in the 3D device. 
Image acquisition parameters remained the same for both locations. 
 
4.2.8 Optimising neutrophil recruitment under flow conditions 
Introducing neutrophils under flow is important; shear stress is responsible for 
strengthening cell adhesion molecules, section 1.2.2, (table4.1). Upon coupling 
the 3D device to the parallel plate flow chamber; it became apparent that the 
height of the PDMS in the 3D device played an important role in determining how 
the leukocytes interacted with the activated endothelium. When the PDMS height 
of the 3D device was > 4mm, HL-60 cells perfused through the device at 1.24 
dynes /cm2 failed to roll and form any interaction with the endothelium (figure 
4.21 B). However, when the height of the device was controlled to ~2mm, HL-60 
cells perfused across the 3D device were successfully captured from flow and 
underwent tethering and rolling (figure 4.21 A). Subsequently, the height of the 
3D device was controlled through adding a constant volume of PDMS (~3mL) to 















Figure 4.21:  Leukocytes flowing across an activated HUVEC in the 3D device  
Neutrophils (green) were perfused at 1.24 dynes /cm2 across a cytokine activated endothelium 
within the 3D device. Neutrophil behaviour was monitored over time (0-25 minutes) using an 
inverted fluorescence microscope. A) A 3D device when the PDMS height is ~ 2mm. Neutrophils 
are captured from flow after 3-5 minutes. At 25 minutes, most neutrophils had been captured, and 
are firmly adhered to the endothelium and undergoing mTEM or fTEM events. B) When the PDMS 
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height was >4mm, neutrophils failed to be captured from flow.  White asterisk denotes cells 
slowing down from the flow and starting to roll. Scale bar is 100m. The timing of each panel is 
indicated in the right hand top corner. 
 
4.3 Discussion  
The ultimate aim of the work presented in this chapter was to design, 
manufacture and optimise two microfluidic devices to monitor a) cell migration 
when subjected to hierarchical chemical signals and b) the complete adhesion 
cascade coupled with interstitial chemotaxis.  
4.3.1 The 2D device  
The first aim of the project was to generate a device where leukocytes could be 
subjected to different chemoattractants with differential hierarchies. Through the 
use of a computerised flow control system, inlets can be independently and 
rapidly pressurised. The main channel of the device is connected via an array of 
microchannels to two side channels. A bifurcation channel allows two fluids to 
travel in parallel without mixing into one of the side channels. Through 
systematically altering the pressures at each inlet, an optimised inlet pressure 
protocol was empirically determined which allowed a rapid switch in the 
chemoattractants that the cells were exposed to (figure 4.6). Altering the 
pressures at the inlets connecting to the bifurcation channel allows a rapid 
exchange of fluids diffusing into the main chamber; the new fluid stabilises within 
1 minute, becoming a stable linear gradient in the main channel (figure 4.6 & 
figure 4.7) with the previous fluid disappearing.  Importantly, the gradient 
produced from the opposite side channel remains stable after the pressure switch 
and resultant fluid exchange in the opposite side channel. Here, the 2D device 
produces two stable linear gradients of opposite slopes for 20 minutes in the 
main channel (figure 4.7).  The 2D device enables cells to respond to one 
chemoattractant initially (for 20 minutes) then be exposed to the other while still 
in the presence of the initial chemical cue (figure 4.5). The gradients were 
established through an empirical approach that was time consuming for both 
optimisation and analysis. To define diffusion, fluorescence intensities were 
analysed over time from two transverse line profiles taken across the width of the 
main channel at two FOVs (50m and 250m from the start of the first 
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microchannel). In order to interpret diffusion throughout the main channel, it 
would be advantageous to simulate this. COMSOL is a software platform that is 
routinely used to model diffusion gradients within microfluidic devices. For this, 
the diffusion coefficient of the monitored chemokine would be required alongside 
the geometry of the device. 
 
In future studies, the 2D device could be used to monitor the cellular response to 
both end-target and intermediary chemoattractants, paying particular attention 
to L-selectin shedding. To monitor L-selectin shedding in real time, neutrophils 
could be incubated with the fluorescently conjugated non-function blocking 
antibody LAM1-14 and their response to an array of chemotactic molecules could 
be investigated to understand if shedding is a prerequisite to chemotaxis towards 
certain molecules.  
4.3.2 The 3D device  
The 3D device will allow researchers for the first time to interrogate all aspects of 
the multi-step adhesion cascade. Currently, two disjointed experimental 
techniques are used to explore the adhesion cascade in humans: (i) recruitment 
from flow on to 2D endothelial monolayers and (ii) interstitial migration through 
3D environments. It is highly likely that interstitial migration could be heavily 
influenced by mechanotransducive force. Indeed, exposure to shear stress may be 
an essential prerequisite to the molecular events that lead to interstitial 
migration. Thus, this device will allow investigation of fundamental questions that 
can only be explored in vivo while affording the user a higher degree of control 
over the environmental conditions than can be achieved in vivo.  
 
 The device was designed around a series of criteria to image the whole adhesion 
cascade as a continuous event (table 4.1). Devices were reproducibly 
manufactured with approximate 135m vertical height of collagen to allow for 
high magnification imaging. Incorporation of a hydrophobic coating around the 
perimeter of the PDMS trough prevented formation of a collagen meniscus thus 
levelling the collagen within the 3D device.  
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To measure chemokine gradients, microchannels introduced 10,000Da 
fluorescent dextran into the collagen gel, which reliably produced a linear 
gradient in a 1.5mm2 area, also known as the proximal region.  The gradient was 
stable over a 60-minute period. However, it is important to note that the diffusion 
profiles of the dextran do not represent the diffusion profile of the end-target 
chemoattractant fMLP. Indeed, as the molecular weight of fMLP is 437.55 Da, 
fMLP would diffuse further than chemokines within the gel matrix. In the future, 
an alterative method of chemokine visualisation could be used. Incorporation of a 
fluorescent dye at the c-terminus of chemokines would allow direct monitoring of 
their gradients. This has already been achieved with the chemokines- CCL7, CCL1, 
CCL3 and CXCL8. These labelled chemokines displayed wild type behaviour in 
receptor binding and calcium mobilisation assays(354). 
 
 Using reflection microscopy, collagen fibres were visualised and pore size 
diameters were estimated through pixel distance mapping. The importance of 
collagen concentration and polymerisation temperature was characterised.  
Differentiated HL-60 cells successfully migrated through 2.5mg/mL rat-tail 
collagen at an average speed of 1.89m/min.   
The device has also been successfully interfaced with the parallel plate flow 
chamber allowing capture of leukocytes by the endothelium from flow conditions.  
4.3.3 Final thoughts 
To conclude, this chapter has developed two proofs of principle devices, the 3D 














Chapter 5. Understanding the role of L-selectin shedding in 
regulating neutrophil chemotaxis through 3D scaffolds.  
5.1 Biological rationale  
Interstitial leukocytes are required to undergo chemotaxis to arrive to their target 
site, a process that is highly dependent on cell polarity. Numerous 
chemoattractants are responsible for regulating chemotaxis. Over the past ten 
years, several studies have demonstrated that L-selectin is responsible for 
mediating a cell’s chemotactic ability. Several studies have documented that the 
absence of L-selectin, and the prevention of L-selectin shedding inhibits directed 
migration towards chemoattractants (284)(212)(264), with little understanding 
of the mechanism behind these observations. Alternatively, L-selectin can act as a 
signalling molecule to enhance both CXCR4 and CCR7 driven chemotaxis, see 
section 1.11.2, (292)(290). As very few chemoattractants have been studied in 
respect of L-selectin-dependent chemotaxis, it is not clear whether L-selectin also 
regulates chemotaxis towards end-target chemoattractants.  
The data presented in chapter 3 outlined that polarity and migration defects 
were produced in both primary human neutrophils and HL-60 cells when L-
selectin shedding was blocked either pharmacologically or genetically. The data 
presented in chapter 4 describes the fabrication and optimisation of a bespoke 
device that carries the potential to observe the entire multi-step adhesion 
cascade: from leukocyte capture from flow to chemotaxis within a 3D collagen 
matrix. The work from the two previous chapters will be integrated into this final 
chapter to understand how L-selectin shedding impacts chemotaxis towards 
intermediary or end-stage chemoattractants.  
The main body of work discussed in this chapter uses the self-designed self-
generated 3D device (chapter 4). This device is open top, allowing easy coupling 
of the parallel plate flow chamber to the collagen-supported endothelium, see 
figure 4.8, for a more detailed description. The device has two feeder microfluidic 
channels, which allow chemoattractant to diffuse through the collagen.  Leukocyte 
interactions with the apical surface of the endothelium can be monitored in real 
time, using an inverted fluorescence time-lapse microscope. Additionally, 
Deleted: introduction into the 
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monitoring fluorescently conjugated dextran molecules enabled assessment of 
the chemoattractant gradient. Gradients were maintained using the source and 
sink principle. Here, chemoattractant introduced from the microchannel (source) 
is so small in volume compared to the constantly replenishing HL-60 media (sink) 
that the media will never become saturated with chemoattractant. In this system 
the cytokine activated HUVEC acts as a semi-permeable barrier between the 
source and sink see section 4.2.7.  
 
As shown in section 4.2.4, collagen pore size is heterogeneous (no uniform pore 
size) and the size of the pores generated is highly dependent on protein 
concentration, polymerisation time and temperature. To control for this pore size 
heterogeneity the above conditions remained constant and co-perfusion of 
control and experimental cell lines were carried out where possible. Such co-
perfusion studies could not be conducted using primary human neutrophils, as 
blocking the shedding of these cells could only be achieved using a the soluble 
synthetic inhibitor TAPI-0, here TAPI-0 was required to remain present 
throughout the assay time. Therefore, , “minus inhibitor (DMSO)” experiments 
could not be conducted with “plus inhibitor (TAPI-0)” primary neutrophils. All 
studies conducted in this chapter use 2.5mg/mL rat-tail collagen, which is 
prepared as described in section 2.12.1.  
5.2 Results  
5.2.1.  Blocking L-selectin shedding alters directional migration of HL-60 cells within 
collagen matrices.  
To comprehend if L-selectin shedding contributed to neutrophil migratory 
behaviour within the ECM, HL-60 cell expressing: WT or MN L-selectin-GFP or 
GFP alone were individually mixed with liquid rat-tail collagen into wells within 
96 well plates, see section 2.12.1 for instruction on collagen preparation. Here, 
neutrophils had no prior exposure to endothelial cells or chemoattractants. Once 
the collagen had polymerised (to create a surrounding 3D scaffold), neutrophil 
movements were recorded for 30 minutes using an inverted time-lapse 
fluorescence microscope, 3 fields of view (FOV) were selected at random within 
each well of a 96 well plate. All the cells within each FOV were manually tracked 
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using the Fiji plugin, MtrackJ, to quantify cell speed and directionality, see section 
2.5.2.Cells exiting the FOV during the 30-minute imaging period were excluded 
from analysis.  
Expression of either WT or MN L-selectin-GFP into the HL-60 cells produced no 
significant difference in cell speed compared to GFP cells (figure 5.1 A).  WT, GFP 
and MN cells averaged a speed of 1.89 m/min +/- 0.14, 1.83m/min +/- 0.13 
and 1.86m/min +/- 0.16, respectively. Comparatively, there was a significant 
difference in the directionality of migration between the three cell lines (figure 
5.1 B&C).  WT Cells had the greatest directional persistence with an averaged 
directionality ratio of 0.42 +/- 0.04, while GFP and MN displayed reduced 
straightness of travel, 0.29+/-0.03 and 0.25+/-0.03, respectively.  
 
Figure 5.1: Expression of WT L-selectin augments directional migration of HL-60 cells 
within 3D collagen scaffolds.  
WT, MN or GFP cells were separately mixed into liquid rat-tail collagen (2.5mg/mL). Cells 
(1x106) were mixed into 100L of collagen and introduced into a well of a 96 well plate. Collagen 
polymerisation took place at 37 C under humidifying conditions for 30 minutes. Cell migration 
was imaged every 30 seconds and cells were tracked manually for 30 minutes with the Fiji plugin 
MtrackJ. A total of 90 cells were tracked for each cell line, conducted across 3 independent 
experiments. A) Cell speed. One-way ANOVA, followed by Tukey’s multiple comparisons test. B) 
Directionality ratio. One-way ANOVA followed by Tukey’s multiple comparisons test. * p<0.01, 
**p<0.001. C) Representative tracks (WT=41, GFP=32 MN=25) from one experiment start of each 












































































5.2.2 Blocking L-selectin shedding impairs invasion into collagen matrices under 
static conditions 
As HL-60 cells expressing WT, and therefore cleavable, L-selectin displayed 
significantly greater directional persistence in migration within a 3D collagen 
matrix compared to GFP and MN cells. Previous experiments outlined in figure 
3.24 A revealed that little difference in TEM rates were observed between WT 
and MN cells. This would suggest that, under static conditions, HL-60 cells 
undergoing TEM would likely be equal between WT and MN cell lines, but 
possibly differ in respect of their invasion through collagen scaffolds. To gauge if 
blocking L-selectin shedding influenced cell invasion, the depths of migration 
through the collagen scaffold was measured at two time points: 1 hour and 4 
hours. Experiments were initially conducted on primary human neutrophils (pre-
treated for twenty minutes with either the DMSO carrier or 10m TAPI-0). The 
TAPI-0 and DMSO treated primary neutrophils could not be used in conjunction 
with one another. This static assay was designed as described in section 2.12.4, 
for simplicity a “trough” is manufactured from excising a cuboid of PDMS. The 
remaining PDMS frame is then plasma bonded onto a glass 5cm coverslip, within 
the “trough” 50L of collagen is left to polymerise, after which acts as a scaffold 
for the HUVEC monolayer.  For each of the two time conditions (1 hour or 4 hour) 
3 separate static transmigration assays (or troughs) were conducted. Primary 
neutrophils were labelled with Celltracker Orange (see section 2.5.3), for easy 
identification.  
 
After 1-hour or 4-hours of neutrophil incubation with the endothelium, PBS was 
carefully introduced to remove any unbound neutrophils, then the sample was 
fixed with 4% PFA, permeabilised and then labelled with FITC phalloidin. Cell 
depths were monitored through spinning disk confocal microscopy, taking Z 
stacks directly below the endothelium. The Z stack position was chosen at 
random, with the only criteria that the endothelial monolayer was intact and 
complete. Stacks were discarded if the endothelium was not intact (which could 




position was chosen when only the endothelium was in focus to avoid 
preferentially picking areas rich or void of neutrophil migration. For each static 
assay (e.g. one trough) three Z stacks, were taken at random positions, each stack 
was composed of 200 slices each 1 m thick. Taking multiple positions within a 
trough controlled for the heterogeneous nature of the collagen. Cell depths were 
manually enumerated post image acquisition at 10 m increments, (equivalent to 
10x 1 m slices), figure 5.2 A. In short, the 200m stack was divided into 20 sub-
stacks (each 10 m in depth) and the amount of neutrophils in each sub-stack 
scored. To aid neutrophil visualisation a 16-colour scale heat map was applied. 
The heat map directly correlates to fluorescence intensity. Here, cells within the 
field of focus (higher fluorescence intensity) were distinguishable by a hotter 
colour e.g. red, compared to a cell not within the field of focus (lower fluorescence 
intensity), which had a colder colour e.g. blue (figure 5.2 B). 
 
Figure 5.2:  Cell invasion assay  
Each assay was conducted in the 3D device, where TNF-activated endothelial monolayers were 
established on a bed of 2.5mg/mL rat-tail collagen. Static assays were conducted for either 1 or 4 
hours, after which samples were fixed in 4 % PFA and stained with FITC-phalloidin. Neutrophils 
were observed through spinning disk confocal microscopy, using a 30x oil immersion lens. Three Z 
stacks (comprising of 200 slices each 1m thick) were taken beneath the endothelium for each 
trough. (A) Schematic representing the uniquely stained HL-60 cell lines, which were labelled with 






























microscope. Each 200m stack was sub divided into 20 lots of 10m stacks. Cell within each 10 
m subsection were scored. (B) To visualise neutrophils a 16-colour scale was applied to the 
acquired images, using the image visualising software, Fiji. Here, the colour scale directly 
correlates with the fluorescence intensity. 
 
Quantification revealed that in the 1-hour assay primary neutrophils migrated 
significantly deeper in the collagen bed when treated with the DMSO carrier 
(figure 5.3 A). Pre-incubation with 10m TAPI-0 appeared to decrease the 
“invasiveness” of neutrophils (figure 5.3 A). The averaged mean invasion depths 
at 1 hour were -36.4m +/- 2.10 and -45.8m +/- 3.30 for TAPI-0 and DMSO 
treatments, respectively. However, no recognisable differences where observed in 
the 4-hour static transmigration assay (figure 5.3 B). As TAPI-0 was present in 
the cell culture media throughout the duration of this assay it is not possible that 
the concentration of TAPI-0 was diluted. However, long-term effects of TAPI-0 
incubation are unclear, it is possible that over time the inhibitor stability is 
compromised. To clarify whether preventing L-selectin shedding did reduce the 
“invasive behaviour”, the assay was repeated using the HL-60 cell lines: WT, MN 
and GFP.  The assays were conducted as described above. However, unlike the 
primary neutrophil assay, here, all the three cell lines were mixed and co-
introduced on to TNF--activated endothelial monolayers. Each cell line was 
uniquely labelled with different cell tracker dyes for easy identification (see 
section 2.5.3). To avoid bias and prevent a dye producing an adverse effect on cell 




Figure 5.3: Blocking L-selectin shedding in primary neutrophils reduces invasion 
Primary neutrophils were isolated and pre-treated with either a DMSO carrier or 10 m TAPI-0 


























































































































monolayer supported on a bed of rat-tail collagen. Static transmigration assays were conducted 
then fixed with 4 % PFA, permeabilised and stained with FITC-phalloidin. Neutrophil invasion was 
manually enumerated, as described in figure 5.2.  Error bars represent the standard error +/- of 
the mean. Each data set represents three separate static transmigration assays, where each assay 
has three 200m deep stacks A) Distribution of migratory positions within the collagen after 1 
hour static migration. A total of 150 and 146 cells were scored for TAPI-0 and DMSO conditions, 
respectively.  Statistical analysis, unpaired Student t test, *p<0.01. B) Distribution of migratory 
positions within the collagen after 4-hour static migration. A total of 178 and 201 cells were 
scored for TAPI-0 and DMSO conditions, respectively. Statistical analysis unpaired Student t test.  
 
Importantly, when the assay was conducted using the cell lines, a significant 
defect in invasion was observed in MN cells (figure 5.4). This defect was 
observed in both the 1-hour and 4-hour time scales, possibly suggesting that the 
navigation of HL-60 cells is more cumbersome through the collagen scaffold than 
primary human neutrophils. Additionally, over the 4-hour assay the lack of L-





Figure 5.4: WT L-selectin increases invasiveness of HL-60 cells through collagen.  
The HL-60 cell lines: WT, MN and GFP were added to confluent TNF--activated endothelial 
monolayer, which were established on a bed of collagen. To ensure identification of each cell line, 
cells were labelled with 1 M Celltracker (orange, far red or unlabelled). To protect against bias, 
Celltracker  dyes were interchanged between cell lines for each independent experiment. Static 
transmigration assays were conducted and then fixed and stained with 4 % PFA and FITC-
phalloidin, respectively. Neutrophil invasion was manually scored, as described in figure 5.2.  
Error bars represent the standard error +/- of the mean. Each data set represents three separate 
static transmigration assays. A) Distribution of migratory positions within the collagen after 1 
hour of adding HL-60 cells to activated endothelial monolayers. A total of 98, 94, 118 cells were 
scored for GFP, MN and WT, respectively. Statistical analysis, one-way ANOVA followed by 
Tukey’s multiple comparisons test, *p<0.01. B) Distribution of migratory position within the 
collagen after 4 hours of static migration. A total of 112, 123, 97 cells were scored for GFP, MN 
and WT, respectively. Statistical analysis, one-way ANOVA followed by Tukey’s multiple 
comparisons test, *p<0.01.  
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5.2.3 Understanding the effect of L-selectin shedding in regulating chemoattractant-
driven invasion in primary neutrophils  
Under static conditions, it was apparent that blocking L-selectin shedding 
decreased the neutrophil invasiveness through collagen matrices. Hydrodynamic 
shear stress is a fundamental feature of the leukocyte adhesion cascade. This 
could indeed act as a vital priming step for neutrophils prior to their exit from the 
circulation. To mimic a more physiologically relevant assay, the assay was 
conducted under flow conditions. In addition the following chemoattractants 
were perfused beneath the collagen gel: fMLP, IL-8 and Gro-, as described in 
section 4.2.7. All the remaining work described in this results chapter uses the 3D 
device, for full description see section 4.2. It is noteworthy to mention that 30L 
of collagen is present in each 3D device. The depth (measured between coverslip 
base to endothelium of this collagen) averaged 132 m +/- 22.9, therefore often 
the 200 m Z stack used imaged past the collagen and through to the cover glass. 
The large Z stack (200 slices x 1 m thick) ensures that all cell invasions are 
recorded.  
 
Primary neutrophils, pre-treated for twenty minutes with either the DMSO carrier 
or 10 m TAPI-0, were introduced into the 3D device at 1.24 dynes/cm2 for five 
minutes.  Introducing neutrophils at a density of 0.5x106/mL ensured good 
binding to the underlying activated endothelium.  After 5 minutes, neutrophil 
perfusion was ceased and replaced with cell culture media (supplemented with 
10 m TAPI-0, where appropriate). Chemoattractants were delivered using a 
Harvard syringe pump, at a flow rate of 0.2 l/min, which was initiated after the 
5-minute perfusion of neutrophils. It is noteworthy to mention that the gradient 
profiles were only characterised for a maximum of 1 hour, section 4.2.7. 
Therefore gradient stability could only be guaranteed for 1 hour. 
Chemoattractants were used at a concentration of 200nM fMLP, 100ng/mL IL-8 
and 100ng/mL Gro-. The concentrations for fMLP and IL-8 had previously been 
used in micropipette assays, (figures 3.20 & 3.21), and successfully promoted 




Controls assays were also performed using 3D devices without the presence of 
chemoattractant. After the 2-hour perfusion the 3D devices were prepared for 
spinning disk confocal imaging and analysis, as described in section 5.3.2. For 
each 3D device, Z stack imaging was acquired in the trough at positions remote 
and proximal to the chemoattractant source, see figure 4.20. For each 3D device, 
6 Z stacks were imaged (3 proximal and 3 remote with respect to the 
chemoattractant source), unless stated otherwise data from these stacks are 
pooled. For each chemoattractant (fMLP /Gro-/IL-8) a total of 3 separate 3D 
devices were used. As above in section 5.2.2, Z stacks were only imaged if the 
endothelium was intact.  
 
Treatment of primary neutrophils with 10 M TAPI-0 led to a significant decrease 
in cell invasiveness compared to their DMSO controls in the presence of fMLP or 
Gro- or absence of chemoattractant (figure 5.5).  The average invasive depth of 
primary neutrophils chemotaxing towards a gradient of fMLP was -45.3 m +/- 
0.6 and -32.7 m +/- 0.60 and, in the presence of DMSO and TAPI-0, respectively. 
Interestingly, blocking L-selectin shedding did not alter chemotaxis and therefore 
the invasiveness towards IL-8. This suggests IL-8-dependent chemotaxis is not 
influenced by L-selectin shedding (figure 5.5).  The average invasive depth of 
neutrophils chemotaxing towards a gradient of IL-8 was -48.1 m +/-1.08 and -
46.5 m +/-0.50, in the presence of DMSO and TAPI-0, respectively.  








Figure 5.5: Blocking L-selectin shedding reduces invasiveness towards gradients of fMLP 
and Gro-, but not IL-8.  
Primary neutrophils were pre-treated for twenty minutes with either a DMSO carrier or 10M 
TAPI-0. Prior to the assay neutrophils were labelled with 1 M Celltracker  Orange for post 
acquisition analysis. Neutrophils were perfused across TNF-- activated HUVEC monolayers. Each 
assay was conducted for 2 hours, after which the 3D devices were fixed in 4% PFA, and F-actin 
was labelled using FITC-phalloidin. Neutrophil position within the collagen gels were imaged 
using spinning disc confocal microscopy and manually scored, as described in figure 5.2.  Error 
bars represent the standard error +/- of the mean. Each data set represents the three independent 
experiments, and data sets are pooled from a minimum of 6 Z stacks. A) Invasion assay in absence 
of chemoattractant. A total of 3740 and 2985 cells were scored for TAPI-0 and DMSO treatments, 
respectively. Statistical analysis, unpaired Student t test **** p<0.0001. B) Invasion assay in the 
presence of 100ng/mL IL-8. A total of 2572 and 2286 cells were counted for TAPI-0 and DMSO 
treatments, respectively. Statistical analysis unpaired Student t test. C) Invasion assay in the 
presence of 100ng/mL Gro-. A total of 820 and 1072 cells were counted for TAPI-0 and DMSO 
treatments, respectively. Statistical analysis, unpaired Student t test **** p<0.0001 D) Invasion 
assay in the presence of 200nM fMLP. A total of 989 and 1836 cells were counted for TAPI-0 and 
DMSO treatments, respectively. Statistical analysis, unpaired Student t test **** p<0.0001 
 
Side-by-side comparisons of the invasive depths of neutrophils responding to 
chemoattractants revealed a significant increase in invasiveness in the absence of 
TAPI-0 (figure 5.6A). This data clearly showed that all chemoattractants were 



















































































































dramatically reduced the invasive depth of most of the conditions tested, the most 
affected by the treatment was when neutrophils were chemotaxing towards fMLP 
gradients (figure 5.6B). As previously shown in section 3.2.14 challenging 
primary neutrophils with fMLP promotes robust L-selectin shedding. This 
suggests implies that L-selectin shedding is potentially linked to fMLP-dependent 
chemotaxis, whereas chemotaxis towards Gro- or IL-8 may involve another 
mechanism that is only partially dependent on L-selectin shedding. 
 
 
Figure 5.6. Side-by-side comparison of neutrophil invasiveness towards different 
chemoattractant gradients 
The data generated in figure 5.5 was reconfigured to confirm that the chemoattractants used 
were all biologically active. A) DMSO treated cells: a total of 2985, 2286, 1072 and 1836 cells were 
counted for the conditions: no chemoattractant (Ctrl), IL-8, Gro- and fMLP, respectively. One-way 
ANOVA, followed by Dunnett’s multiple comparisons test. **** p<0.0001. B) Invasiveness of TAPI-
0-treated cells: a total of 3740, 2572, 820 and 989 cells were counted for the conditions: no 
chemoattractant (Ctrl), IL-8, Gro- and fMLP, respectively. One-way ANOVA, followed by 
Dunnett’s multiple comparisons test. **** p<0.0001.  
 
 
As mentioned previously, based on the microfluidic delivery of chemoattractant 
to the “trough” of the 3D device, it is possible to designate regions that are 
proximal and remote to the source of chemoattractant (see figure 4.20). To 
confirm that the observed invasiveness was dependent on the chemoattractant 
concentration, data from figure 5.5 was reconfigured so that the invasive depths 
of neutrophils from the proximal and remote regions could be compared directly.  
Furthermore, under situations where no chemoattractant was used, the analysis 
















































































insight into the contribution of variations in shear stress as a result of the 
geometry of the device. Interestingly, no significant difference in invasive depths 
was observed in regions that were remote or proximal when there was no 
chemoattractant present, validating that the geometry of the 3D device did not 
bias neutrophil invasiveness  (figure 5.7 A). For DMSO treated cells the depth of 
migration was 48.7m +/- 1.02 and 54.4m +/- 1.83 for remote and proximal 
regions, respectively. Quantification of invasive depths of neutrophils responding 
to IL-8 revealed significantly greater invasive depth within proximal compared to 
remote regions. As shown in the pooled data (see figure 5.7 B), inclusion of TAPI-
0 in the assay did not affect neutrophil invasiveness towards a source of IL-8. This 
observation suggests that primary human neutrophil chemotaxis is independent 
of L-selectin shedding (figure 5.7 B). Neutrophil chemotaxis towards Gro- 
appeared to be strongly dependent on concentration, as the invasive depths of 
neutrophils varied dramatically at proximal and remote areas in DMSO-
challenged assays (figure 5.7 C). Although the statistical significance between 
proximal and remote regions of neutrophils chemotaxing towards Gro- was 
higher in TAPI-0 than DMSO-treated cells (figure 5.7 C), the overall depth of 
invasiveness was greater in the remote regions – for both treatments DMSO or 
TAPI-0 (figure 5.7 C). For DMSO treated cells the depth of migration in response 
to Gro- was 68.7m +/- 5.2 and 56.1m +/- 1.61 for remote and proximal 
regions, respectively. As increased invasive depth was confined to the remote 
region, it would suggest that the effect of Gro- on primary human neutrophils is 
concentration-dependent. Neutrophil chemotaxis towards fMLP revealed no 
significant difference in invasiveness with DMSO-treated cells (figure 5.7 D).  This 
could be explained through the comparatively small size of fMLP (~20 fold 
smaller than IL-8 and Gro-). The size difference is likely to have a dramatic 
impact on the diffusion of fMLP through the collagen matrices. Although the effect 
of TAPI-0 led to reduction in neutrophil invasion in both remote and proximal 
regions, the effect of the inhibitor on neutrophils invading proximal regions of the 
3D device was significantly higher (figure 5.7 D). These outcomes suggest that 
chemotaxis of neutrophils towards fMLP is concentration-dependent, but the 
effect of TAPI-0 could be more efficacious in proximal regions where the fMLP 
concentration is likely to be much higher than within remote regions.  




Figure 5.7: Primary neutrophil chemotaxis through collagen matrices is concentration-
dependent. 
The data generated in figure 5.5 was reconfigured to gain further insight into the effect of 
chemoattractant concentration on neutrophil invasion. For each chemoattractant used, 
approximately 400-1200 cells were scored for each region (proximal or remote) of the 3D device. 
Statistical analysis: unpaired Student t test, comparing relative proximal and remote regions for 
the same cell treatment. ***p<0.001,****p<0.0001. A) No chemoattractant present (Ctrl). B) 
100ng/mL IL-8. C) 100ng/mL Gro-. D) 200nM fMLP 
 
5.2.4. Understanding the effect of L-selectin shedding in chemotaxis of HL-60 cells 
through collagen matrices. 
Blocking L-selectin shedding in primary neutrophils dramatically reduces 3D 
chemotaxis towards a gradient of fMLP (section 5.2.3).  However, blocking L-
selectin shedding did not significantly alter chemotaxis towards IL-8. As 
mentioned previously, fMLP and IL-8 have been categorised as an end-target and 
intermediary chemoattractant, respectively. Section 5.2.3 suggests that 
chemotaxis towards fMLP is dependent on L-selectin shedding, while chemotaxis 
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independent of L-selectin shedding. In order to determine if the effect of TAPI-0 
was directly targeting L-selectin shedding and not a secondary target, similar 
experiments were conducted using the previously engineered HL-60 cell lines: 
GFP, WT and MN. Experimentation and analysis was performed as described in 
section 5.2.2. Unlike with assays using primary human neutrophils, all three HL-
60 cell lines could be co-perfused. This co-perfusion tightly controlled for collagen 
gel heterogeneity within the 3D device. Analysis was performed as described in 
section 5.2.2. Unfortunately, due to time constraints of the project, chemotaxis 
towards Gro- was not conducted.  
 
Expression of WT L-selectin promoted a significant increase in invasive depth of 
HL-60 cells, compared to GFP and M-N cells (figure 5.8 A). This data 
corroborates with what has been shown for THP-1 monocytes, albeit using a 
slightly different parallel plate flow chamber assay(212). The average invasive 
depths of WT, MN, GFP cell lines migrating without the presence of a 
chemoattractant was: –17.87 m +/- 0.64, -15.28 m +/- 0.63 and -15.59 m +/- 
0.62, respectively. Significant differences were observed between WT and MN 
and WT and GFP. No difference was observed between MN and GFP cells, 
indicating that the lack of L-selectin and preventing L-selectin shedding both 
hinder cell invasion depths, this data reflects figure 5.1 B, where WT cells have a 
greater directional persistence irrespective of chemoattractant presence. 
Although expression of WT L-selectin promoted HL-60 cell invasiveness in the 
absence of chemoattractant (figure 5.8 A), no significant difference in chemotaxis 
towards fMLP was observed between WT and GFP cells (figure 5.8 B). In contrast, 
MN cells were significantly less chemotactic towards fMLP compared to both 
WT and GFP cells (figure 5.8 B), suggesting, as shown in primary human 
neutrophils, that chemotaxis towards fMLP is strongly dependent on L-selectin 
shedding. The average invasive depth of WT, MN, GFP cell lines migrating with 
the presence of fMLP was -21.52m +/- 0.81m, -16.65m +/- 0.52, -20.52m+/- 
0.80, respectively. It appears that cell migratory behaviour towards fMLP is 
similar between GFP and WT cells. These results were also mirrored in the 
micropipette assay (see section 3.2.8), where WT and GFP both migrated towards 
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the source of fMLP in a more directed manner than MN. Therefore, although L-
selectin shedding per se is not essential for fMLP-induced chemotaxis, blocking L-
selectin shedding in cells that express it (e.g. neutrophils) dramatically impacts 
chemotaxis towards fMLP. Finally, there was little difference between WT and 
MN migration through the collagen towards IL-8, (figure 5.8 C) with WT slightly 
more invasive 27.25 m+/- 1.68 compared to MN 23.95m+/-1.23. There was 
no difference between GFP and MN or GFP and WT. This closely resembles work 
in the primary neutrophils (figure 5.5) where blocking shedding did not affect 
invasive behaviour. Side-by-side comparisons of the invasive depths of 
neutrophils responding to chemoattractants clearly showed that all 
chemoattractants were bioactive in the bespoke flow chamber assay (figure 5.9). 
The general trend in all of the cell lines is that IL-8 is more potent at driving cell 











Figure 5.8: Investigating the contribution of L-selectin shedding in HL-60 cell chemotaxis 
through collagen matrices. 
WT, GFP and MN cells were uniquely stained with 1 M Celltracker of different colours. Cells 
were perfused over the TNF- activated HUVEC monolayer within the 3D device.  To avoid bias 
and to overcome the possibility of the dye producing adverse effects on cell behaviour, 
Celltracker dyes were exchanged periodically between lines for each repeat. Each flow assay 
was conducted for a total of 2 hours, after which the 3D devices were fixed and stained for F-actin 
(using FITC-phalloidin). Neutrophil invasion was manually scored from images acquired using a 
spinning disk confocal microscope (as described in figure 5.2). Error bars represent the standard 
error +/- of the mean. Each data set represents three independent experiments. For each device, a 
minimum of 6 Z stacks were collected from proximal and remote regions. A) Invasion assay in the 
presence of no chemoattractant (Ctrl). A total of 286, 179 and 252 were counted for WT, GFP and 
MN cells, respectively. Statistical analysis, one-way ANOVA followed by Tukey’s multiple 
comparisons test, ** p<0.01, *p<0.05.  B) Invasion assay in the presence of 200nM fMLP. A total of 
277, 251 and 233 were counted for WT, GFP and MN cells, respectively. Statistical analysis, one-
way ANOVA followed by Tukey’s multiple comparisons test, **** p<0.0001. C) Invasion assay in 
the presence of 100ng/mL IL-8. A total of 111, 91 and 148 were counted for WT, GFP and MN 
cells, respectively. Statistical analysis, one-way ANOVA followed by Tukey’s multiple comparisons 










































































































Figure 5.9. Side-by-side assessment of invasiveness in GFP, WT and M-N HL-60 cell lines 
responding to different chemoattractants within the 3D device. 
The data generated in figure 5.8 was reconfigured to determine the extent of invasion between 
intermediary (IL-8) and end-stage (fMLP) chemoattractants. A) A total of 286, 277, and 111 WT 
cells were scored for the conditions: no chemoattractant (Ctrl), fMLP, and IL-8, respectively. One-
way ANOVA, followed by Dunnett’s multiple comparisons test. **** p<0.0001, ***p<0.001. B) A 
total of 252, 233, and 148 MN cells were counted for the conditions: no chemoattractant (Ctrl), 
fMLP, and IL-8, respectively. One-way ANOVA, followed by Dunnett’s multiple comparisons test. 
**** p<0.0001. C) A total of 179, 251, and 91 GFP cells were counted for the conditions: no 
chemoattractant (Ctrl), fMLP, and IL-8, respectively. One-way ANOVA, followed by Dunnett’s 
multiple comparisons test. **** p<0.0001.  
 
5.2.5 Understanding the contribution of the L-selectin tail in regulating HL-60 cell 
chemotaxis through collagen scaffolds. 
So far, the data from this chapter shows that blocking shedding of L-selectin 
either in primary human neutrophils of HL-60 cell lines dramatically impacts 
invasion trough collagen matrices. In addition to acting as a cell adhesion 
molecule, L-selectin can also transduce intracellular signals following ligand 




















































































































selectin can be phosphorylated at serine residues (RRLKKGKKSKRSMNDPY) in 
response to a variety of inflammatory agonists, including fMLP (327).  
 
 To determine if the M-N phenotype could be reverted by altering the 
phosphorylation status of the L-selectin tail, two cell lines were generated that 
expressed MN L-selectin, but where the serine residues were replaced with non-
phosphorylatable alanines (MN SSAA) or phospho-mimicking aspartates (MN 
SSDD). Perfusion experiments within the 3D device were carried out and analysed 
as described in section 5.3.2.  Quantification of invasive depths for MN SSAA and 
MN SSDD compared to MN revealed no significant difference when the cells 
were exposed to no chemoattractant, fMLP and IL-8 (figure 5.10). As before, the 
data was reconfigured to illustrate side-by-side comparisons of the invasive 
depths of neutrophils responding to chemoattractants (figure 5.11). MN cells 
response to fMLP was not significantly different to their cellular response when 
no chemoattractant was present; yet, the presence of IL-8 dramatically 
encouraged migration into the collagen (figure 5.11 A). This replicates behaviour 
already seen in the WT/MN/GFP experiments (figure 5.8 & figure 5.9 B) 
Comparatively, the cell line MN SSAA did respond significantly to both fMLP and 
IL-8 when compared to migration depths when no chemoattractant was present. 
MN SSAA invasion depths when no chemoattractant, fMLP and IL-8 was present 
were: -13.7m+/- 0.39, -15.4m+/- 0.41 and -20.4m+/-0.96 respectively (figure 
5.11 B). Finally, mutating the serine residues to aspartates (MN SSDD) produced 
an even greater response to fMLP to that than observed in MN SSAA cells. MN 
SSDD invasion depths when no chemoattractant , fMLP and IL-8 was present 
were: -13.3m+/- 0.41, -15.5m+/- 0.44 and -22.2m+/- 1.11 respectively 
(figure 5.11 C) (figure 5.11 C). Together this work suggests that mutating the 
serine residues does not alter chemotaxis towards IL-8, however the role of 
serine phosphorylation in regulating the chemotaxis towards fMLP is still unclear.  









Figure 5.10:  Understanding the contribution of the L-selectin tail in regulating chemotaxis 
through collagen matrices 
MN, MN SSAA and MN SSDD cells were uniquely stained with 1 M Celltracker  of different 
colours. Cells were co-perfused across the TNF- activated HUVEC monolayer of the 3D device. To 
avoid bias and to overcome the possibility of the dye producing adverse effects on cell behaviour, 
Celltracker dyes were exchanged periodically between lines for each repeat. Each flow assay 
was conducted for a total of 2 hours, after which the 3D devices were fixed and stained for F-actin 
(using FITC-phalloidin). Neutrophil invasion was manually scored from images acquired using a 
spinning disk confocal microscope (as described in figure 5.2). Error bars represent the standard 
error +/- of the mean. Each data set represents three independent experiments. For each device a 
minimum of 6 Z stacks were collected from proximal and remote regions. A) Invasion assay in the 
presence of no chemoattractant (Ctrl) A total of 178, 285 and 239 were counted for MN, MN 
SSAA and MN SSDD cells, respectively. Statistical analysis, one-way ANOVA followed by Tukey’s 
multiple comparisons test. B) Invasion assay in the presence of 200nM fMLP.  A total of 268, 285 
and 291 were counted for MN, MN SSAA and MN SSDD cells, respectively. Statistical analysis, 
one-way ANOVA followed by Tukey’s multiple comparisons test. C) Invasion assay in the presence 
of 100ng/mL IL-8. A total of 281, 260 and 271 were counted for MN, MN SSAA and MN SSDD 
cells, respectively. Statistical analysis, one-way ANOVA followed by Tukey’s multiple comparisons 






























































































































































Figure 5.11: Side-by-side assessment of invasiveness in MN, MN SSAA and MN SSDD HL-
60 cell lines responding to different chemoattractants within the 3D device. 
The data generated in figure 5.10 was reconfigured to determine the extent of invasion between 
intermediary (IL-8) and end-stage (fMLP) chemoattractants. A) A total of 178, 268, and 281 MN 
cells were scored for the conditions: no chemoattractant (Ctrl), fMLP, and IL-8, respectively. One-
way ANOVA, followed by Dunnett’s multiple comparisons test. **** p<0.0001, ***p<0.001. B) A 
total of 285, 285, and 260 MN SSAA cells were scored for the conditions: no chemoattractant 
(Ctrl), fMLP, and IL-8, respectively. One-way ANOVA, followed by Dunnett’s multiple comparisons 
test. **** p<0.0001. C) A total of 239, 291, and 271 MN SSDD cells were scored for the conditions: 
no chemoattractant (Ctrl), fMLP, and IL-8, respectively. One-way ANOVA, followed by Dunnett’s 
multiple comparisons test. **** p<0.0001.  
 
5.3 Discussion: 
The ultimate aim of this chapter was to understand how L-selectin regulates 
chemotaxis within collagen matrices – particularly in response to intermediary 
and end-stage chemoattractants. This was made possible through the use of the 
custom made 3D device that was fabricated in chapter 4. The importance of L-
selectin shedding, in chemotaxis towards either an end-target (fMLP) or 
intermediary (IL-8 & Gro-) chemoattractants was illustrated through the use of 
human cell lines (HL-60) and primary neutrophils. In experiments L-selectin 
shedding was either genetically or pharmacologically inhibited respectively 







































































































































endothelium was enumerated after a 2-hour perfusion. This freeze frame in time 
does not give justice to cell movements within the XY axis. To overcome this, in 
the future, the 3D device can be easily interfaced with a spinning disk confocal 
during experimentation, and cells tracked in 4D (i.e. in 3D and over time). Imaging 
was conducted here using a 30x objective lens, however the collagen depth within 
the 3D device has been previously optimised (see section 4.2.6) to allow for 
higher magnification (60x objective). This level of resolution would provide 
information on L-selectin subcellular localisation during TEM and chemotaxis. 
Chapter 3 (see section 3.2.8 and section 3.2.12) demonstrated that L-selectin 
has enriched at the uropod during chemotaxis and upon TEM L-selectin positive 
membrane was deposited, a higher imaging power will address whether these 
observations can be produced within a 3D environment.  
5.3.1 Comparing cell invasion  
The cell lines (WT, GFP, MN, MN SSAA and MN SSDD) and primary 
neutrophils (pre-treated with TAPI-0 or DMSO), all demonstrated differences in 
cell speed and directionality when assessed in the sub endothelial space (chapter 
3).  Additionally, the cell lines WT, GFP, MN exhibited substantial differences in 
directional persistence of migration when mixed into pre-polymerised collagen 
gel, (figure 5.1). These variables make it extremely difficult to clearly assess the 
contribution of L-selectin shedding in the 3D device invasion assays, where 
penetrative depth into the collagen gel is monitored. In the future a thorough 
investigation of cell directionality and speed of cells moving within collagen 
should be carried out, similar to the experimentation in figure 5.1. This work will 
be important to clearly compare cell migration through the collagen plug between 
cell lines or cell treatments, and ensure that differences in depths observed are 
not a result of reduced cell speed.  For this discussion it is assumed that between 
HL-60 cell lines or between primary neutrophils (+/-TAPI-0) there were small or 
no difference in cell speeds.  
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5.3.1.1 Cell invasions in response to the intermediary chemoattractants IL-8 and 
Gro- are L-selectin shedding independent 
Pharmacologically blocking shedding in primary neutrophils does not affect the 
cells’ ability to chemotax to both the intermediary chemoattractants IL-8 and Gro-
. Irrespective of the pre-treatment (DMSO/ TAPI-0) cells exposed to IL-8 and 
Gro-.  WT, MN, GFP all successfully responded to IL-8 .Together this suggests 
that either removal of L-selectin or preventing L-selectin shedding does not 
impact migration towards these intermediary chemoattractants. However this 
data conflicts with two previous studies carried out. Firstly, in a recent report 
(2015), blocking L-selectin shedding in THP-1 cells (a monocyte cell line) 
prevented polarisation towards monocyte chemoattractant protein-1 (MCP-1), 
which, although not a neutrophil chemoattractant, could be classified as an 
intermediary chemoattractant, this conflicts with this current study in HL-60 
neutrophils(212) .This highlights how a cell’s response to blocking L-selectin 
shedding can be very much leukocyte-specific. Secondly, in another study in vivo, 
following a superfusion of the chemokine KC to the cremaster muscle, sheddase 
resistance neutrophils (L(E)same) remained within a 50m distance from the 
venule. In contrast neutrophil migration from the WT littermates extended over 
150m further from the venule (264).This study hypothesises that preventing L-
selectin shedding prevents KC induced migration. However, the study does not 
provide dynamic information on neutrophil travel, the data is collected at one 
time point (120 minutes post superfusion), and moreover a superfusion does not 
provide a gradient, so migration towards KC cannot be defined as chemotaxis. 
Finally, imaging of the murine cremaster muscle requires detachment from the 
testicle, and spreading the cremaster radially as a flat sheet. Together, this 
handling and surgery inevitably produces local damage, releasing DAMPs (see 
section 1.1.1). Therefore, this study cannot exclude the possibility that 
neutrophils are not responding to DAMPs, for example mitochondrial-derived 
fMLP. To summarise, given the difference in either cell type or experimental set 
up it is hard to draw direct comparisons.  
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5.3.1.2 Cell invasions in response to the end-target chemoattractant fMLP are L-
selectin shedding dependent 
 Strikingly, when L-selectin was blocked in both primary neutrophils and cell line 
models, exposure to an fMLP gradient resulted in diminished chemotaxis,  
indicating there was no significant difference in invasion between their respective 
chemoattractant null controls. Flow cytometry data (see section 3.2.14) further 
supports the notion that L-selectin shedding is involved in fMLP directed 
migration. When primary neutrophils were stimulated with a range of fMLP 
concentrations (10nM-1M) all conditions produced a combined average of  
~90% L-selectin shedding. In comparison ~37% of L-selectin was shed in 
response to IL-8 and no shedding was observed in response to Gro- (both these 
chemokines were used at a the concentration range of 100ng/mL-1g/mL) (see 
figure 3.32). Therefore as L-selectin is only slightly shed and not shed at all in 
response to IL-8 and Gro- respectively, it seems logical that blocking shedding 
does not alter invasive migration into the collagen gel for these intermediary 
chemoattractants. Interestingly, complete removal of L-selectin (in the GFP cell 
line) did not hinder a cells ability to migrate towards fMLP, this implies that it is 
the prevention of L-selectin shedding has a negative effect on fMLP mediated 
chemotaxis. Section 3.2.20 demonstrated that surface expression of the fMLP 
receptors FPR1 and FPR2 were decreased in MN cells in comparison to GFP and 
WT.  Perhaps, this decrease in FPRs expression at the plasma membrane in the 
sheddase resistant cell line contributes to the lack of response towards fMLP.  A 
hypothetical model will be discussed in chapter 6.  
5.3.2 Final thoughts 
Although numerous responses have been shown to occur downstream of fMLP 
stimulation (phagocytosis and degranulation), currently, it is not known if 
blocking L-selectin shedding will impair neutrophil effector function. If blockage 
of L-selectin shedding in the presence of fMLP does prevent one or more of the 
neutrophil effector neutrophils this could have an enormous impact in neutrophil 
behaviour towards sterile injury sites for example the infarct zone in the early 
stages (days 1-3) of myocardial infarction (MI). See section 1.5.4 for a description 
of neutrophils roles in MI.    
Deleted: a
Deleted: c
Deleted: tic score of 0,
Formatted: Font: Bold, Italic
Deleted: , having a chemotactic score of 4, 
Deleted:  that
Deleted: 5.3.1.3 The MN SSDD cell line rescues the MN 
response to fMLP¶
Interestingly, when the cytoplasmic tail serines were 
replaced with aspartates to mimic permanent 
phosphorylation (MN SSDD) these cells produced a 
chemotactic score of 4 when exposed to fMLP, effectively 
rescuing the MN response towards fMLP. While MN 
SSAA cells only produced a chemotactic score of 2 when 
exposed to fMLP. The results imply that if L-selectin is 
expressed, prevention of serine phosphorylation hinders 
fMLP-driven chemotaxis. It is clear that L-selectin 
shedding and serine phosphorylation does not alter IL-8 
directed chemotaxis.  In order to fully understand the 
separate roles of L-selectin shedding and serine 
phosphorylation it would be of use to generate HL-60 cell 
lines where the L-selectin molecule is cleavage yet the 
serine residues have been exchanged with either alanine 
or aspartates. Alongside this, it would be important to 
decipher if L-selectin shedding regulates chemotaxis 
towards other chemoattractants. Neutrophil migration 
could be observed within the 3D device towards the 










6. General Discussion 
 
The primary objective of this PhD thesis was to investigate the impact of blocking 
L-selectin shedding on neutrophil TEM and chemotaxis through 3D environments.  
The study used primary human neutrophils and HL-60 cell lines to explore 
neutrophil cellular behaviour responding to synthetic inhibitors (TAPI-0) and 
genetic manipulation of L-selectin-GFP. Using classic parallel plate flow chamber 
assays, chapter 3 was designed to specifically explore how blocking L-selectin 
shedding impacted neutrophil TEM. The behavioural parameters analysed 
included: cell shape, directionality and TEM rate. L-selectin shedding was 
monitored during the course of TEM, to establish whether, as in CD14-positive 
monocytes, the process was triggered specifically during TEM (205). Primary 
human neutrophils and HL-60 cells were also challenged with various 
chemoattractants to determine if chemokines or fMLP, in isolation, could promote 
L-selectin shedding. Interestingly, challenge with Gro- led to no L-selectin 
shedding, whereas challenge with IL-8 led to ~37 % shedding. In contrast, 
challenge with fMLP led to robust (almost 95%) L-selectin shedding. 
Here, TEM assays were conducted using the parallel plate flow chamber. This 
experimental set up dictated that the endothelium was grown on a fibronectin 
substrate, and thus information regarding post TEM events (e.g. further 
interstitial migration) was limited. To fully explore interstitial migration and 
chemotaxis, a bespoke microfluidic device was designed and fabricated (Chapter 
4). The device was modelled on strict criteria, table 4.1, and successfully 
interfaced with the parallel plate flow chamber to introduce leukocytes into the 





supported on a collagen matrix, microchannels entering into the collagen deliver 
stable chemoattractant gradients. Finally, chapter 5 amalgamates work from the 
previous two chapters; the neutrophils (primary and HL-60 cell lines) were 
introduced into the 3D device where the complete leukocyte adhesion cascade 
could be interrogated.  
Taken together, this thesis has concluded that: (i) As with monocytes, L-selectin 
contributes to the invasive mechanism of neutrophils during TEM, (ii) L-selectin 
shedding occurs specifically during TEM and not before, (iii) L-selectin is 
dramatically shed in response to fMLP, but not to the chemokines IL-8, (iv) 
blocking L-selectin shedding hinders chemotaxis towards fMLP, but not to IL-8, in 
3D environments, (v) FPR1 and FPR2 surface expression is impacted by L-selectin 
shedding. Below key findings are dissected in more detail with the use of 
graphical models.  
6.1 L-selectin shedding during TEM and chemotaxis 
 
Chapter 3 demonstrates that L-selectin is shed in human neutrophils specifically 
during TEM, only previously documented using a skin blister model (312). The 
data within this thesis confirms what others have described, that L-selectin acts 
as a pro-invasive molecule, (see section 3.2.11). Blocking L-selectin shedding in 
both primary neutrophils and a neutrophil cell line model reduced cell directional 
persistence in both 2D and 3D environments, see figures 3.6/3.24/5.1. In 
keeping with this, the cell morphologies of fTEM cells were monitored and 
blocking L-selectin shedding altered cell polarity, typically producing an 
elongated cell with multiple membrane undulations, see figure 3.7 & figure 3.25. 
Leukocytes with impaired polarity frequency present with impaired chemotaxis 
(13).Indeed, blocking L-selectin shedding affects migration past the endothelium, 
and chemotaxis to the end-target chemoattractant fMLP, see section 5.2.3 & 
section 5.2.4. 
 
Recently, mice expressing a knock-in “sheddase resistant” form of L-selectin 
(where the cleavage domain of L-selectin is swapped with a similar non-cleavable 
region of E-selectin) have become available for use in the Ivetic lab (264). 
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future flow experiments. Comparing these neutrophils against WT counterparts 
in the 3D device will allow one to determine if the mutant neutrophil phenocopy 
some of the behavioural responses seen in TAPI-0-treated human neutrophils or 
the MN HL-60 cells. It will also allow one to determine if the impact of L-selectin 
shedding on neutrophil behaviour is conserved across species. Using TAPI-0 on 
neutrophils expressing the sheddase-resistant L-selectin could help determine if 
there are any additional phenotypes that are secondary to inhibiting L-selectin 
shedding. As ADAM-17 has many other substrates, this would be an extremely 
important question to address in light of the different phenotypes presented by 
primary human neutrophils and HL-60 cells. Consistency in phenotype, using this 
approach, would give confidence to the fact that TAPI-0 could be acting selectively 
to inhibit L-selectin shedding at 10 M. The mice will hopefully open up an 
avenue of in-vivo work, for example neutrophil migration towards laser injury 
(mimicking sterile injury) could be observed.   
 
6.2 Putative mechanisms underpinning L-selectin regulation during TEM and 
interstitial chemotaxis  
 
The first graphical summary, figure 6.1, demonstrates L-selectin shedding 
dependent phenotypes in TEM, while the second graphical summary, figure 6.2, 
illustrates the dynamic changes in serine phosphorylation in TEM.  
 
Recent work in monocytes has revealed that the L-selectin that is present in 
transmigrating pseudopods is exposed to ECM components, such as biglycan, 
where it is clustered(212). The study concludes that clustering of L-selectin is 
likely to preceed shedding. Although not formally investigated, it is likely that 
clustering encourages a high density of surface L-selectin for ADAM17 to cleave. 
In neutrophils, the magnitude of L-selectin clustering was not as apparent as in 
monocytes (see section 3.2.5). However, it is unclear whether the small clusters 
of L-selectin that are formed in neutrophils acts as a pre-requisite for shedding. It 
is possible that L-selectin clusters are shunted into lipid rafts (possibly through 
cytoplasmic tail phosphorylation), where ADAM-17 also resides (357) (358). p38 






clustering of L-selectin, opening up the possibility that L-selectin shedding within 
the sub-endothelium is p38 MAPK dependent(286). Blocking L-selectin shedding 
impairs fTEM cells to adopt normal polarity and migrate directionally within 3D 
scaffolds (figure 6.1). L-selectin shedding triggered by TEM could be initiated 
through K-Ras/SOS signalling; L-selectin clustering has been shown to activate 
Ras and SOS binding (209).  Interestingly, K-Ras and SOS have both been shown to 
impact the phosphorylation of p38 MAPK (359) (360).  Additionally, Ras has been 
shown to mediate tumour invasion, and recently its interaction with the PI3 





Figure 6.1:  Schematic model representing the effects of L-selectin shedding on neutrophil 
polarity 
This model was produced based on findings from HL-60 cells and primary neutrophils from within 
this thesis. A) During TEM, L-selectin within transmigrated pseudopods binds to ligands within 
the ECM (e.g. biglycan), which promotes L-selectin clustering. Although not proven, it is assumed 
that the signals transmitted downstream of L-selectin at this point are likely to “inform” the cell 
that it has entered the subendothelial space. L-selectin clustering could activate a pathway 
involving K-Ras/SOS and p38 MAPK signalling (212). B) L-selectin is shed upon completion of 
TEM, leading to neutrophils establishing front-back polarity, enabling successful directional 
migration. C) Blocking L-selectin shedding also promotes the formation of clusters with similar 
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phenotype presented in TAPI-0-treated neutrophils and MN cells, the pathways that are 
activated downstream of L-selectin in this scenario is likely to be very different. D) Importantly, 




The cytoplasmic tail of L-selectin bears no homology with its family members, E- 
and P-selectin, so there is a high probability that its regulation is highly unique. 
Chemoattractants, such as IL-8 and fMLP have been shown to induce serine 
phosphorylation of the L-selectin tail (260). As neutrophils respond to these very 
chemoattractants during an inflammatory response, it is likely that serine 
phosphorylation of the L-selectin tail is regulated dynamically during TEM and 
interstitial migration (where L-selectin shedding is blocked). In contrast to MN 
cells, expression of MN SSAA or MN SSDD in HL-60 cells led to an increased 
dwell time of neutrophil crawling on top of endothelial cells. This would suggest 
that although blocking L-selectin shedding does not impact the TEM rate, the 
serine residues in the MN tail are fundamental to driving TEM. 
 
Previous in vivo studies have shown that fragments of the uropod are detached 
from neutrophils upon completing TEM (361). This phenomenon was also 
observed in HL-60 cells expressing L-selectin-GFP. Interestingly, although the 
frequency of “uropod spots” did not differ between WT and MN cells, locking the 
phosphorylation status of the MN L-selectin tail (either to AA or DD) 
significantly impacted spot formation. MN SSAA cells left significantly fewer L-
selectin spots than MN cells (figure 6.2 B). One reason for this observation could 
be that serine phosphorylated L-selectin allows preferential binding to ezrin and 
moesin ,  known L-selectin tail binding partners, which has been shown to localise 
to the rear of polarised leukocytes (362)(363). Once within the sub endothelial 
space, the fully transmigrated MN and MN SSAA cells behaved similarly, 
suggesting that blocking serine phosphorylation does not deviate from the MN 
phenotype (figure 6.2.D).   
 
Interestingly, permanently mimicking serine phosphorylation (MN SSDD) 
rescues chemotaxis towards fMLP, indicating WT cells may be preferentially 
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phosphorylated during chemotaxis towards fMLP (figure 6.2 E) although more 
work needs to be done to confirm this. To definitively understand the pathways 
leading towards L-selectin serine phosphorylation and shedding, and how they 
collectively impact cell behaviour, WT SSAA and WT SSDD cell lines should be 
engineered and characterised to complement this study.  Serine phosphorylation 
incorporates a negative charge cloud on to the predominately basic cytoplasmic 
tail (RRLKKGKKSKRSMNDPY), which may alter binding of L-selectin with its 
partners or to phosphatidyl serines within the inner leaflet of the plasma 
membrane (211). Although there is still much work to be done to understand how 
serine residues in the L-selectin tail are regulated, it is clear that blocking L-
selectin shedding in neutrophils can profoundly impact signalling proteins at the 
plasma membrane. The lack of polarity suggests that the recruitment or activation 
of Rho GTPases is being impacted. More work is required to understand if 
blocking L-selectin shedding is therapeutically beneficial – particularly in the 




Figure 6.2:  Schematic model representing the effects of L-selectin phosphorylation 
This model was produced based on findings from HL-60 cells and currently available literature. A) 
Cyclic phosphorylation of the serine’s (S364 and S367) in the cytoplasmic tail of L-selectin is 
required for timely firm arrest to the endothelium, preventing extensive intraluminal crawling. B) 
The uropod spot formation occurs more frequently when the serines within the cytoplasmic tail 
were converted to aspartic acids. C) It is likely that cyclic phosphorylation attributes to successful 
cell polarity and cell migrational persistence. D) The disrupted cell polarity and undirected 
migration is likely due to unphosphorylated serines. E&F) How phosphorylation events contribute 














6.3 Putative mechanism underpinning L-selectin shedding and chemotaxis towards 
fMLP 
It is clear the blocking L-selectin shedding in neutrophils significantly impacts 
chemotaxis towards the end-target chemoattractant, fMLP. As demonstrated in 
primary neutrophils fMLP induces both p38 MAPK phosphorylation and L-
selectin shedding. Previous work from the Tedder group has shown that serine 
phosphorylation of the L-selectin tail occurs soon after challenge with fMLP (260) 
(figure 6.3).   
 
Serine phosphorylation of the L-selectin tail, specifically at S364, has very recently 
been shown to promote the dissociation of calmodulin from the L-selectin tail 
(205). Killock and Ivetic had also shown that activation of p38 MAPK leads to the 
mobilisation of ADAM-17 to the plasma membrane (202) (figure 6.3). Others 
have shown that the catalytic activity, rather than increased expression of ADAM-
17 at the plasma membrane, is upregulated in response to p38 MAPK 
activation(364). Both of these reports corroborate that neutrophils are better 




Figure 6.3:  Schematic model representing L-selectin dependent FPR1 regulation 
This model was produced based on findings from HL-60 cells and currently available literature 
(202)(212). A) fMLP stimulates L-selectin phosphorylation. Phosphorylation at S364 likely 
prevents calmodulin-binding rendering L-selectin susceptible to shedding. B) fMLP binding to its 
receptor stimulates p38 MAPK phosphorylation. Activated p38 MAPK mobilises ADAM-17 to the 
plasma membrane increasing surface expression. ADAM-17 is the prominent cleavage enzyme 
responsible for L-selectin shedding. 
 
 
Although this study has revealed for the first time that blocking the shedding of L-
selectin impacts chemotaxis towards fMLP gradients in 2D and 3D environments, 
the mechanism underpinning this response remains poorly understood. Figure 
3.40 showed that HL-60 cells expressing WT L-selectin have significantly higher 
levels of surface-expressed FPR1/2 compared to GFP or MN cells. Western 
blotting reveals that FPR1 and FPR2 total protein expression levels are 
unchanged amongst cell lines, only cells expressing WT L-selectin can increase the 
surface expression of FPR1 and FPR2 at the plasma membrane (figure 3.40). In 
future, it would be interesting to explore if L-selectin and FPR1/2 form a 
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FPR1/2 at the plasma membrane is associated with L-selectin, and can 
simultaneously respond to fMLP. This initial response to fMLP could lead to serine 
modification of the L-selectin tail and subsequent shedding, leading to the 
polarised distribution of FPR1/2 at the leading edge, which would allow 
chemotaxis to ensue. This could explain why the chemotaxis of MN cells towards 
fMLP gradients is significantly impaired. If serine phosphorylation of the L-
selectin tails is different between WT and MN cells, this could profoundly impact 
the association between FPR1/2 and L-selectin and FPR1/2 expression at the 
plasma membrane. Future experiments will include flow cytometric analysis of 
FPR1/2 expression levels in MN SSAA and MN SSDD cells. Clearly more work is 
required to determine the precise mechanism, and using mice expressing 
sheddase-resistant L-selectin could be a useful tool to further investigate the 
relationship between FRP1/2 and L-selectin shedding in vivo and in vitro. 
 
Recently, a study conducted in HL-60 cells demonstrated that in conditions where 
fMLP concentration is low (i.e. <500nM), p38 MAPK phosphorylates S342 of the 
cytoplasmic tail of FPR1, which prevents G-protein coupled receptor kinase 2 
(GRK2) binding (365) (figure 6.4). L-selectin clustering has been demonstrated to 
phosphorylate p38 MAPK (286). GRK2 is required for FPR1 receptor 
internalisation through phosphorylation of an intracellular residue (366). 
Interestingly, extracellular signal regulated kinase (ERK) opposes p38 MAPK 
function, enhancing the effects of GRK2.  It would be important to understand if L-
selectin shedding mediates p38 MAPK phosphorylation and conversely if blocking 
L-selectin shedding in fMLP stimulated cells induce ERK activation. This could be 
achieved through Western blots probing for phospho-ERK and phospho-p38 
MAPK in WT and MN cells, and through the use of micropipette assays releasing 
fMLP: where WT and MN cells have been pre-treated with specific ERK/p38 
MAPK inhibitors. Additionally, genetically engineering a fluorescent protein tag 
on to FPR1 would allow real time tracking of the receptor, which would be 
beneficial for the above experiment. The hypothetical model depicted in figure 
6.4 could also contribute to the differences observed in surface expression of 




Together the work conducted in this thesis and from previous reports 





Figure 6.4:  Schematic model representing L-selectin dependent FPR1 regulation 
This model was produced based on findings from HL-60 cells and currently available 
literature(286)(365)(366). A) In cells where L-selectin shedding is not inhibited. 1) During TEM L-
selectin bind to ligands within the ECM, L-selectin clustering occurs. 2) L-selectin clustering 
activates p38 MAPK. 3) P-p38 MAPK phosphorylates FPR1. 4) GPK2 interaction with FPR1 is 
prevented through p38 MAPK phosphorylation of FPR1. 5) Successful chemotaxis towards fMLP. 
B) In cells where L-selectin shedding is inhibited. 1) Potentially L-selectin is unsuccessful at indirect 
activation of p38 MAPK. 2) GPK2 phosphorylates FPR1. 3) Phosphorylated FPR1 is an 
internalisation signal; less FPR1 is expressed on the cell surface. 4) Unsuccessful chemotaxis 
towards fMLP.  
 
6.4 What is the impact of blocking L-selectin shedding on neutrophil effector 
function?  
 
Neutrophils respond robustly to fMLP, which is derived from both gram-negative 
bacteria and mitochondria. In fact, and more pertinent to this study, a recent 
report has shown that fMLP isolated from human mitochondria is a robust driver 
of L-selectin shedding and p38 MAPK activation (367). Numerous reports have 




built confidence in the notion that neutrophils home to sources of fMLP, where, 
upon arrival, undergo numerous effector functions, such as degranulation, 
phagocytosis and NETosis. As blocking L-selectin shedding impacts neutrophil 
polarity and chemotaxis towards fMLP, it would be of great importance to 
understand if blocking shedding also alters neutrophil effector function: NETosis, 
degranulation and phagocytosis, for a detailed description see section 1.5.  Below 
the contribution of L-selectin will be discussed for each effector function 
separately, and future experiments outlined to investigate whether L-selectin 
shedding is the “green light” for neutrophil effector function.  
 
NETosis  
The oral cavity creates a large exposure to external bacterial flora, and so the 
body must protect itself through appropriate antimicrobial secretions in the 
saliva. Neutrophils that enter the buccal cavity provide one such example of the 
defence weaponry. It was found that the L-selectin ligand, sialyl Lewis x (sLex), is 
presented on salival mucins(294). Salival sLex promotes L-selectin clustering that 
culminates in NETosis. The specificity of this response was demonstrated with 
function-blocking antibodies that target the L-selectin/sLex interaction – leading 
to dramatically decreased NETosis (294). NETs formation is classically defined 
through two mechanisms. The first mechanism can be induced through NADPH 
oxidase and elastase activity or candida albicans (368)(369)(370).  The second 
mechanism relies on bacteria stimulation of toll like receptors and is integrin 
dependent (371)(372). However, these oral NETs form through a unique 
mechanism that does not fall in either category. Using TAPI-0 in such studies 
could potentially address the role of L-selectin shedding in NETs formation. 
Additionally, NETs formation in vivo could be observed using mice expressing 
sheddase-resistant L-selectin (see section 6.1). NETs could be identified through 
staining the extracellular DNA with Sytox (a stain that increases fluorescence 
intensity ~500 fold upon nucleic acid binding and is cell impermeable), or 
through immunofluorescence approaches that target markers of NETosis: 




Degranulation involves the release of granules containing antimicrobial 
factors(3). As mentioned previously, ligation and cross-linking of L-selectin in 
neutrophils enhances the activation of 2 integrins (see section 1.11.1), 2 
integrin activation has been shown to be responsible for degranulation of 
eosinophils (373). L-selectin has also be shown to be responsible for directly 
encouraging degranulation: clustering (or cross-linking) L-selectin with 
monoclonal antibodies, DREG55 and DREG200, sensitises neutrophils to 
degranulation when challenged with IL-8 (286).Here, cross-linking potentiates 
the release of secondary and tertiary granules, and blocking p38 MAPK reverses 
the release of such granules (286).One method to address the contribution L-
selectin shedding in the release of secondary and tertiary granules could be to 
incubate neutrophils with TAPI-0 or a DMSO carrier (in control conditions), 
followed by cross-linking L-selectin and stimulate with IL-8. The assay would be 
carried out in suspension, cell free supernatants would then be collected and 
assayed for the specific granular markers including lactoferrin and gelatinase 
correlating to the release of secondary and tertiary granules. Lactoferrin could be 
assayed using ELISA (anti-lactoferrin antibody), while gelatinase activity could be 
assessed by zymography.  There is also evidence that L-selectin cross-linking 
enhanced both an fMLP or TNF- induced “oxidative burst(374)(296)”. Here, L-
selectin cross-linking mediated an intracellular rise in calcium and stimulates the 
cellular release of the superoxide radicals and hydrogen peroxide (374)(296). To 
clarify, if L-selectin shedding contributes to the oxidative burst, then specific 
probes (such as 2’, 7’-dichlorofluorescein diacetate) could be used to detect 
superoxide formation again in neutrophils with/without TAPI-0. Again, using the 
knock-in mice that express sheddase-resistant L-selectin mice (and their WT 
littermates) could eloquently address this issue.  
 
Phagocytosis 
There is currently no literature that links L-selectin to the induction of 
phagocytosis. However, from the studies carried out in this thesis blocking L-
selectin shedding produces clear defects in polarity. Given that phagocytosis 
involves the re-organisation of the actin cytoskeleton, it seems likely that 
phagocytosis and polarity are tightly linked. Proteins crucial for polarity; Rho A, 
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ROCK, mDia1 have all been implicated in phagocytosis(375) (376). To assess the 
effect L-selectin shedding in phagocytosis, primary neutrophils could in incubated 
with an array of fluorescent stimuli e.g. opinisised latex beads, zymosan, bacteria, 
or apoptotic cells with and without the presence of TAPI-0. Phagocytosis could be 
assessed in high throughput through flow cytometry or through fluorescence 
microscopy.  
 
It is important to note that L-selectin cross-linking also drives ectodomain 
shedding of itself (342)(340). Does clustering of L-selectin therefore become a 
self-limiting signal? As many of these cross-linking studies have been performed 
in vitro using suspension cells, it raises the question of whether they are 
physiologically relevant or whether they are just in vitro artefacts. Nonetheless, a 
fundamental question has not yet been addressed: does L-selectin shedding give 
the “green light” for neutrophils to undergo effector functions – degranulation, 
NETosis and phagocytosis?   
 
6.5 Blocking L-selectin shedding – a possible therapy for myocardial infarction?   
 
Following the rupture of an unstable atherosclerotic plaque, the rapid formation 
of a thrombotic lesion in the coronary artery will rapidly lead to restricted oxygen 
and nutrient supply downstream of the blocked artery(377). This, in essence, is 
the first step in myocardial infarction (MI). Within minutes to hours, based on the 
nature of their high-energy demand, differentiated adult cardiomyocytes will 
undergo necrosis. This is a critical event – adult cardiomyocytes are terminally 
differentiated and cannot self-regenerate. This region is known as the “infarct 
zone”, which begins to expand over a number of hours. Neutrophils are known to 
contribute to the expansion of the infarct zone. They are initially attracted 
because of the large numbers of necrotic cardiomyocytes, which are packed with 
mitochondria and are releasing fMLP (figure 6.5 A). As demonstrated in a recent 
study (2015) N-formylated peptides from mitochondria produced severe 
hypotension, vascular leakage, hyperthermia all signs classically associated in 





exhibit their effector responses: degranulation and phagocytosis. Neutrophil 
effector function plays a large contribution to the remodelling of the myocardium, 
post-MI (figure 6.5 B). Matrix metalloproteinases derived from the neutrophil, 
and the stimulation of collagen production by fibroblasts resident in the 
myocardium, can lead to dramatically altered structure of the left ventricle 
(LV)(379). The LV is particularly important as many of the coronary arteries feed 
oxygen to this chamber of the heart, and it is typically the LV that incurs an infarct 
following MI. The LV is the chamber with the largest muscle mass, as it needs to 
pump oxygenated blood to the aorta - the largest artery in the body. Failure to 
effectively pump oxygenated blood to meet the body’s demand will result in heart 
failure(380). 
 
A number of studies have shown that reducing neutrophil effector function post-
MI is therapeutically beneficial. DNAse I treatment has been shown to reduce the 
infarct zone, suggesting that NETs could be a significant driver of myocardial 
infarction (381). In a pig study, treatment with the drug BW775C (composed of 
cyclooxygenase and lipoxygenase) significantly reduced infarct size. 
Immunohistochemical staining showed ~35% decrease in infarct size compared 
to the control animal group (382). BW775C was shown to reduce neutrophil 
degranulation by ~46%, and superoxide generation was down by ~74%, 
although chemotaxis was not inhibited. Reducing neutrophil recruitment has 
additionally been shown to impact infarct size, infusion of GDF-15 (an 
endogenous inhibitor of 2 integrin function) inhibited neutrophil arrest and 
ultimately TEM, leading to a reduction in infract size (383).  
 
In the context of this study, blocking of L-selectin shedding could potentially offer 
prevention of both fMLP directed migration to the infarct zone and effector 
function once within the infarct zone (figure 6.5. C). In theory, this “double strike” 
could provide a better patient outcome. Thinking therapeutically, the 
manufacture of a biopharmaceutical (e.g. monoclonal antibody, or nanobody) to 
target the cleavage site of L-selectin and render the site unrecognisable to ADAM-
17 could result in something that mimics MN L-selectin. In the case of MI, the 
biopharmaceutical could be administered intravenously to patients by a 
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paramedic within the first hours of contact post-MI (figure 6.5. C). Continued 
administration of the biopharmaceutical over 3 days post-MI, when neutrophil 
activity is most aggressive within the infarct zone, could lead to improved patient 
outcome. Although blocking L-selectin shedding during this period may 
immunosuppress the individual, the benefit of the 3-day therapy is likely to 
outweigh the risk of infection. Indeed, other measures, such as antibiotics, could 
be put in place to decrease chances of infection during this period. Again, using 
the mice that express a sheddase-resistant form of L-selectin could be used in 
models of MI to address the therapeutic advantage of blocking L-selectin shedding 
in this pathology.  
 
Figure 6.5: A possible therapy for myocardial infarction 
This model was produced based on currently available literature and findings from this thesis 
(173)(377).A) Day 1 post myocardial infarction. 1) The anoxia environment (infarct zone) results 
in cardimyocyte death, destruction of mitochondria releases fMLP. 2) fMLP alongside other 
inflammatory factors encouraged neutrophil infiltration into the infarct zone. 3) Neutrophils 
undergo one of three effector functions. B) Day 3 post myocardial infarction – no therapy 1) 
Neutrophil presence and activity is responsible for increased cardiomyocyte death leading to 
more fMLP released. 2) More neutrophil infiltration. 3) More neutrophil activity at the infarct 
zone- the infarct zone is increased. C) Day 3 post myocardial infarction – therapy is present. 1) fMLP 


































































































neutrophils effectively chemotaxing to the infarct zone. 3) The blockage of shedding L-selectin 
therapy prevents fMLP driven neutrophil activation reducing effector functions. Here, both stages 






6.6 Concluding remark 
Although this study has set out to tackle some basic biological questions relating 
to L-selectin shedding and neutrophil chemotaxis, it has exposed some interesting 
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